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Abstract 
Neutrophils are innate immune cells that form part of the first line of defense against pathogens. 
These cells are rapidly mobilised in response to infection and inflammation and are equipped 
with a range of pathogen destruction mechanisms. In recent years it has been demonstrated that 
neutrophils can also modulate innate and adaptive immune responses. Neutrophils have been 
found to enter secondary lymphoid organs including lymph nodes, however the phenotype and 
function of neutrophils in lymph nodes is not well understood. Work in this thesis utilised an 
acute pulmonary infection model with the lung pathogen Streptococcus pneumoniae, to 
investigate neutrophil recruitment, phenotype and function in the lung draining (mediastinal) 
lymph node. It was hypothesised that neutrophil phenotype and behaviours are not cell intrinsic, 
rather dictated by the localised microenvironment of the cell. To investigate this hypothesis a 
combination of flow cytometry, immunohistochemistry, quantitative PCR and four dimensional 
multiphoton explant imaging was used.  
 
Neutrophil recruitment to the lung draining lymph node was rapid, peaking at 6 - 12 hours post 
infection. Neutrophils were localised in the lymphatic sinus, specifically in areas with medullary 
macrophages. Neutrophil migration in this region was highly dynamic, with swarms of 
neutrophils observed. When compared to blood, lung and airway neutrophils, lymph node 
neutrophils showed an intermediate activation profile, similar to lung tissue neutrophils. 
Interestingly a small population of lymph node neutrophils expressed markers of antigen 
presenting cells. Neutrophils in the lymph node utilised mainly chemotactic migration 
mechanisms involving phosphatidylinositde 3-kinase signalling and leukotriene B4, however 
migration was not completely integrin independent. Thus the results support the hypothesis that 
neutrophil phenotype and behaviours are environment dependent as opposed to cell-intrinsic, 
also they demonstrate and support the evolving view of the neutrophil as a complex cell type 
that has multiple functional profiles and mechanisms of migration. 
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Chapter 1: Introduction 
Immune responses to pathogen infection are initiated in peripheral tissues through the activation 
of innate immune cells that migrate to tissue draining lymph nodes, where they prime adaptive 
immune responses. The structural organization of both peripheral tissues and the secondary 
lymphoid tissues is required for efficient immune responses. An intricate set of interactions of 
different cell types, in the right time and space is required in order for the immune system to 
respond effectively to the pathogen infection. In peripheral tissues (e.g. lung, skin, intestines) 
multiple innate immune cells are activated through a range of pathogen and damage recognition 
receptors. These include dendritic cells (DC), macrophages, monocytes and neutrophils. The 
role of dendritic cells in the initiation of T cell mediated immune responses is a paradigm of 
modern immunology, however the role of other cells including neutrophils and tissue resident 
macrophages, in both the site of infection and the tissue draining lymph node are less clear. 
 
 Role of neutrophils in host defense 1.1
Neutrophils form the first line of defense for the immune system against infection, thus rapid 
neutrophil mobilisation, recruitment and activation is essential in early response to infection. 
Neutrophils were first discovered by Paul Ehrlich in the 19th century and classified by their 
distinct ‘polymorphous nucleus’. Ilya Ilyich Metchnikoff demonstrated in starfish larvae that 
neutrophils are recruited to sites of injury; Metchnikoff also correctly theorized that these cells 
were important for clearing bacteria. In 1908 Ehrlich and Metchnikoff shared the Nobel prize in 
physiology or medicine for their discoveries and work on immunity1. Neutrophils are the most 
abundant white leukocyte in human blood making up 50-70% of the white blood cell 
population, however in specific pathogen free mice this percentage is lower; 15-20%2. 
Neutrophils are highly granulocytic, terminally differentiated cells that are specalised in 
pathogen destruction. These cells have a characteristic lobular nucleus and thus are easily 
phenotypically identifiable. Neutrophils circulate in the blood where they have a short half-life 
in circulation; 8-12 hours, however in tissues they can last for 1-2 days1. 
 
In adult mice and humans neutrophils are produced in the bone marrow with nearly two-thirds 
of hematopoiesis dedicated to neutrophil and monocyte production. In humans during 
homeostasis 1-2×1011 neutrophils are generated per day, with this rate increasing during 
infection3. Mature neutrophils are stored in this niche, with only 1-2% found in the circulation4. 
Thus there are large numbers of mature neutrophils ready to be released in response to infection. 
The formation of mature neutrophils through the process of terminal granulopoiesis is 
dependent on granulocyte colony stimulating factor (G-CSF). Terminal granulopoiesis involves 
the sequential differentiation of common myeloid progenitors into myeloblasts, promyelocytes, 
   
 15 
myelocytes, metamyelocytes, band cells and finally functional polymorphonuclear cells. G-CSF 
regulates this process by regulating the transit time through the granulocytic compartment and 
release of mature cells from the bone marrow5. Granulopoiesis is also reliant on a set of 
transcription factors, the balance between C/EBPα, Gfi-1 and PU.1 expression is key to 
regulating neutrophil differentiation3. 
 
 Neutrophil homeostasis 1.2
1.2.1 Neutrophil retention in the bone marrow 
Under homeostatic conditions, a balance between chemokine receptor CXCR4 and CXCR2 
signalling controls release of mature neutrophils from the bone marrow4. Bone marrow stromal 
cells produce CXCL12 (SDF-1α), which binds CXCR4 chemokine receptor on neutrophils, 
maintaining their retention in specialised bone marrow niches. Deficiency in CXCL12 or 
CXCR4 results in blood neutrophilia, treatment of both humans and mice with a CXCR4 
antagonist (AMD 3100/Plerixafor) mobilises haematopoietic stem cells, inducing a rapid rise of 
neutrophil numbers in the blood4. The rise in neutrophil numbers in the blood following 
AMD3100 treatment was initially attributed to mobilisation from the bone marrow; however 
more recently it has been demonstrated that demarginiation from the lung vasculature is the 
mechanism of AMD3100 induced blood neutrophilia. This is discussed further in Chapter 1.2.3. 
A congenital disease myelokathexis (WHIM syndrome) results from a gain-of-function 
mutation in CXCR4. Patients with this disease have severe neutropenia, but normal or increased 
numbers of neutrophils in the bone marrow4. Neutropenia is likely the result of sustained 
activation of neutrophil CXCR4 and inability to desensitize to CXCL126. Integrin signalling 
also has a role in bone marrow retention, neutrophils express the integrin very late antigen-4 
(VLA-4) that can bind vascular cell adhesion protein 1 (VCAM-1) on bone marrow stromal 
cells4. However unlike CXCL12-CXCR4 signalling, adhesion is not essential in regulating 
neutrophil retention in the bone marrow. 
 
1.2.2 Neutrophil release from the bone marrow 
Upon maturation neutrophils down-regulate CXCR4 and up-regulate CXCR2. CXCR2 binds 
chemokines CXCL1 (KC) and CXCL2 (MIP-2) produced by bone marrow endothelial cells and 
megakaryocytes, permitting efficient mature neutrophil egress into circulation. G-CSF also 
contributes to this process through down-regulating VLA4 expression by neutrophils and 
CXCL12 production by bone marrow stromal cells, aiding neutrophil egress from the bone 
marrow. CXCR2 deficiency results in neutrophil retention in the bone marrow5. Under 
homeostatic conditions CXCL12 chemokine production by stromal cells, biases towards 
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neutrophil retention. In contrast, during inflammation the chemokine balance is tipped in favor 
of neutrophil egress. During acute infection macrophage derived cytokines interleukin (IL)-1β 
and IL-23 induce IL-17 production by Th17 cells, innate lymphoid cells (ILC), natural killer T 
(NKT) cells and γδT cells. IL-17 stimulates both systemic and bone marrow G-CSF levels. G-
CSF promotes granulopoiesis, production of CXCR2 ligands in the bone marrow and decreases 
expression of CXCL12 in the bone marrow, further promoting neutrophil release5. 
 
1.2.3 Neutrophil margination 
Under homeostatic conditions mature neutrophils circulate in the blood for roughly 6-8 hours, 
however in vivo studies have found neutrophils can circulate for up to 18 hours in the mouse, 
and 5 days in human. Approximately 50% of the circulating neutrophils are adhered to blood 
vascular walls in a process termed margination5. Marginated neutrophils form intravascular 
pools of neutrophils in organs such as the spleen, liver, bone marrow and lungs. Marginated 
neutrophils may be remobilized from these sites, for example in exercise the size of the 
marginated pool of neutrophils decreases and the circulating pool size increases5. Inhibition of 
CXCR4 by the antagonist AMD 3100/Plerixafor induces blood neutrophilia, a process thought 
to result from bone marrow egress. Using intravital microscopy of bone marrow this hypothesis 
has been challenged, in contrast to what was expected imaging demonstrated that CXCR4 
antagonism did not induce neutrophil egress from the bone marrow, unlike G-CSF, which 
readily induced fast neutrophil egress and increased numbers in the blood7. Rather neutrophilia 
by CXCR4 antagonism was due to rapid neutrophil release from the marginated pool in the 
lungs that, in combination with an inhibition of neutrophil homing to the bone marrow, lead to 
neutrophilia7. It was postulated that the release of neutrophils from the lung vasculature could 
have been due to altered integrin expression; CXCL12 signalling has been shown to regulate 
lymphocyte function-associated antigen 1 (LFA-1; CD11a) and VLA-4 expression in 
haematopoietic stem cells7. Thus the process of margination is key to regulating neutrophil 
homeostasis. 
 
1.2.4 Neutrophil clearance 
Upon priming neutrophils enter the site of infection where they fully activate, clear pathogens 
and undergo apoptosis. Tissue macrophages clear apoptotic neutrophils in a process called 
efferocytosis. Stimulation of tissue localised DCs and macrophages by apoptotic neutrophils 
inhibits IL-23 production leading to reduced IL-17 production by Th17 cells, ILCs, NKT cells 
and γδT cells. This leads to reduced G-CSF production, decreased granulopoiesis and the 
balance of CXCR4-CXCR2 signalling is tipped back in favor of CXCR4 signalling, and thus 
neutrophil retention in the bone marrow8. Thus the uptake of apoptotic neutrophils is key in 
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initiating inflammation resolution. In humans with leukocyte adhesion deficiency type I (LAD-
1), a condition where there is loss of CD18 expression, and in CD18 deficient mice, severe 
periodontal disease occurs. Neutrophils are unable to enter the tissue, therefore there is no 
uptake of apoptotic neutrophils by macrophages. As a result IL-23 levels are not down 
regulated, localised IL-17 levels become pathological, inflammation doesn’t resolve, bacteria 
grow uncontrolled, all leading to inflammatory bone loss9. This process may be important in a 
number of pathological conditions. 
 
In homeostatic and inflammatory conditions clearance of neutrophils also occurs in the spleen, 
liver and bone marrow, in a process mediated by macrophages5. Uptake of apoptotic neutrophils 
activates the Liver X receptors (LXRs) inhibiting inflammatory gene transcription. LXR 
signalling in splenic macrophages reduces IL-23 transcription and G-CSF systemic production. 
In the absence of LXRs, splenic IL-17A+ T helper 17 lymphocytes are increased10. Thus LXR 
signalling in tissue macrophages, upon uptake of apoptotic neutrophils, modulates G-CSF 
production in the bone marrow, and thus neutrophil production and release11. 
 
1.2.5 Neutrophil circadian rhythm and regulation of the hematopoietic niche 
Clearance of apoptotic neutrophils during infection is essential to controlling rates of neutrophil 
production and bone marrow release. Additionally, removal of aged neutrophils is important, as 
these cells have a more activated phenotype and could potentially cause pathology including 
small-vessel vasculitis12. This removal of aged neutrophils by bone marrow macrophages, also 
modulates the entire hematopoietic niche. Neutrophil numbers in the blood follow a circadian 
rhythm with clear periods of clearance and release. Neutrophil numbers are highest at Zeitgeber 
time 5 (Z5; 6 hours after the induction of the 12 hour light and dark cycle), and lowest at Z13 (1 
hour into the dark cycle). The numbers of hematopoietic stem and precursor cells (HSPC) in the 
blood follow the same pattern as neutrophil numbers. Experimental elevation of neutrophil 
numbers in the blood promotes HSPC release from the bone marrow13. Depletion of neutrophils 
promotes HSPC retention in the bone marrow, and an increase in bone marrow stromal cells and 
CXCL12 expression13. Macrophages are essential for this bone marrow niche modulation by 
neutrophils. Aged neutrophils (CD62Llo CXCR4hi) home to the bone marrow where they are 
phagocytosed by macrophages, inducing a reduction in CXCL12 production by bone marrow 
stromal cells, and thus HSPCs are release into the blood13. LXR is also essential in regulating 
this process, and it is proposed that uptake of aged neutrophils activates LXR in macrophages, 
inducing the modulatory effect on the bone marrow niche13. 
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1.2.6 Neutrophil homeostasis regulation 
The homeostatic regulation of granulopoiesis and neutrophil release is essential to maintain an 
optimal number of neutrophils in circulation. Likewise, sensing of a need for increased 
neutrophils numbers during infection, ‘emergence granulopoiesis’14, is also an essential function 
of the homeostatic loop of chemokines (CXCL1, CXCL2, CXCL12), cytokines (IL-23, IL-17 
and G-CSF) and stromal cells, macrophages and DCs, controlling granulopoiesis and neutrophil 
homeostasis. Recently it has been found that microbiota in the gut also has a key role in 
neutrophil homeostasis. A feedback circuit involving CXCR2, its ligand CXCL5, gut 
microbiota, IL-17A and G-CSF has been proposed. Cxcr2-/- mice have high plasma IL-17A and 
G-CSF resulting in blood and bone marrow neutrophilia. Transfer of CXCR2+ neutrophils into 
these mice leads to basal IL-17A and G-CSF levels. Under homeostatic conditions, CXCL5 is 
primarily produced by enterocytes in the intestine making up the lamina propria. In response to 
gut microbiota resident intestinal cells recruit neutrophils in a CXCL5 dependent process. 
Localised neutrophil apoptosis leads to down regulation of intestinal IL-23 production, 
modulating local IL-17A production and regulating systemic G-CSF levels. When neutrophils 
are unable to migrate into the intestine there is no regulation on IL-17A induction. It was found 
that microbiota in the gut, in particular segmented filamentous bacteria, induce IL-17A and thus 
G-CSF production. Therefore there is a complex relationship between different microbiota, 
localised inflammation and global immune responses15. 
 
The IL-23-IL-17 axis is not solely responsible for controlling rates of granulopoiesis. In 
neutropenic conditions steady-state G-CSF concentration in plasma is increased, resulting in an 
expansion of neutrophil progenitor cells in the bone marrow. In NOD SCID gamma (NSG) 
mice lacking that lack T, B and natural killer (NK) cells, in response to neutropenia there is no 
increase in IL-17 or IL-23 levels. However there is still an increase in G-CSF levels, this is in 
response to Toll-like Receptor 4 (TLR4) signalling resulting from stimulation by LPS16, 
however there is some evidence for endogenous TLR ligands. Thus under homeostatic 
conditions in addition to IL-17 and IL-23, TLR4 signalling stimulated by microbiota can 
modulate plasma G-CSF and thus granulopoiesis16. Multiple feedback circuits exist to control 
granulopoiesis, indeed, gcsf-/- or gcsfr-/- mice still have 20-30% of basal neutrophil numbers, and 
thus other mechanisms also modulate emergency granulopoiesis5. IL-6 is secreted in response to 
TRL4 stimulation by a number of cell types including lymphocytes, macrophages and stromal 
cells. In the absence of G-CSF IL-6 can induce granulopoiesis. This redundancy is a common 
theme in both the regulation of haematopoiesis and immune system function. 
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 The neutrophil recruitment cascade 1.3
Neutrophils in the blood are in a quiescent state, under homeostatic conditions they patrol the 
circulatory system and do not enter tissues. Upon inflammatory stimulation they become 
primed, inducing a cascade of events leading to their migration into inflamed tissue, full 
activation, pathogen clearance and finally cell death. Neutrophil recruitment from the blood 
follows a series of events that occur mainly in post-capillary venules; capture, rolling, slow 
rolling, arrest, crawling, transendothelial migration (TEM) and abluminal crawling summarised 
in Figure 1.1. 
 
1.3.1 Capture and rolling 
In order for neutrophils to enter the site of inflammation, endothelial cell activation must occur 
to allow neutrophil attachment to the endothelium. Tissue resident sentinel cells, including 
macrophages and mast cells, bind pathogen-associated molecular patterns (PAMPs) and danger-
associated molecular patterns (DAMPs) via pattern recognition receptors (PRRs), PRR 
signalling induces the production of pro-inflammatory mediators such as tumor necrosis factor α 
(TNFα) and IL-1β17. These cytokines cause endothelial cell activation, which results in up 
regulation of selectins; E- and P-selectin, P-selectin glycoprotein ligand 1 (PSGL1) and 
adhesion molecules; intercellular adhesion molecule 1 (ICAM-1) and VCAM-118. P-selectin is 
pre-stored within Weibel-Palade bodies thus appears on the cell surface within minutes, 
however E-selectin is synthesized de novo, thus up regulation is slower, taking up to 90 
minutes19. 
 
Neutrophils in the blood express L-selectin and PSGL1, these selectins are crucial for neutrophil 
capture by the endothelium. Endothelial cell PSGL1 binds L-selectin, ‘catching’ the neutrophil, 
like-wise, endothelial cell P-selectin binds neutrophil PSGL1, catching the neutrophil. Selectin 
binding has a fast on and off rate, thus adhesive bonds are quickly made and broken. This 
permits neutrophil rolling along the endothelium through breaking and forming new bonds20. 
Sheer stress generated by blood flow is important for selectin binding, in the absence of sheer 
stress the bond between selectin and PSGL1 does not form. This type of bond is known as a 
catch bond, the bond becomes stronger when a force is applied20. 
 
1.3.2 Slow rolling and arrest 
Integrins are αβ heterodimers with three confirmations; inactive (bent), primed (intermediate 
extended) and ligand bound (extended). In the bent confirmation integrin proteins cannot bind 
their ligands, however in the primed confirmation the ligand binding site is exposed. Upon 
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ligand binding the integrin fully extends and inside-out signalling occurs18. L-selectin - PSGL1 
binding induces signalling in both the neutrophil and endothelium, this induces integrin 
extension on the neutrophil and up regulation of ICAM-1 on vascular endothelium. LFA-1 
(CD11a, αLβ2 integrin) and macrophage-1 antigen (MAC-1; CD11b, αMβ2 integrin) on 
neutrophils extend and bind ICAM-1 on the endothelial surface. This binding decreases 
neutrophil speed and slow rolling occurs, it is also essential for firm adhesion18. 
 
Activation of the endothelium also induces expression of chemokines on the endothelial luminal 
surface. These cells are also able to transport chemokines from the tissue (on their abluminal 
side) to their luminal cell surface. This process is called transcytosis, and is mediated by the 
Duffy antigen receptor (DARC) which is abundantly expressed by venular endothelial cells 19,21. 
DARC is an atypical chemokine receptor that does not couple to G-protein proteins and thus 
does not signal. It can bind multiple inflammatory CC and CXC chemokines, internalising and 
transcytosing them to the luminal surface21. Chemokine is immobilized on the endothelium by 
negatively charged heparin sulfate that permits decoration of the vessel wall with chemokines 
that are positively charged19. Neutrophils express G protein coupled receptors (GPCR) that bind 
chemoattractants. During slow rolling neutrophil GPCRs bind chemokine on the endothelium18. 
Chemokine signalling inside the neutrophil induces full integrin activation, thus increasing 
neutrophil adhesion to the endothelium causing their arrest in movement3. GPCR activation of 
integrin proteins regulates the process of neutrophil transmigration through outside-in 
signalling. Chemokine signalling also induces the release of pre-stored CD11b to the neutrophil 
surface, increasing adhesion19. 
 
1.3.3 Crawling and transendothelial migration 
Once attached to the endothelium neutrophils do not transmigrate at the point of arrest, instead 
they proceed to crawl along the endothelium to find a suitable point of exit. This process is 
dependent on CD11b - ICAM-1 interactions22. Neutrophils then undergo TEM either through 
the paracellular route, where neutrophils squeeze through the junction between adjacent 
endothelial cells, or the less well understood transcellular route, where neutrophils move 
through an endothelial cell23. Paracellular migration involves endothelial cell expression of; 
ICAM-1, ICAM-2, platelet endothelial cell adhesion molecule 1 (PECAM-1), junctional 
adhesion molecule (JAM)-A, -B and –C, endothelial cell-selective adhesion molecule (ESAM), 
CD99, CD99L2 and VE-cadherin3. PECAM-1, JAM A, -B and -C, ESAM, CD99 and VE-
cadherin make homotypic bonds with molecules on adjacent endothelial cells forming a tight 
endothelial cell junction. These interactions are important for endothelium integrity and barrier 
function. Ligation of ICAM-1 on vascular endothelium by neutrophils induces cytoskeletal 
rearrangements that cause cell contractility and release of VE-cadherin interactions, thus 
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making the junctions accessible to neutrophils. ICAM-2 signalling leads neutrophils towards the 
endothelial cell junctions, JAM-A guides the neutrophil through the endothelial cell junction. 
PECAM-1 stimulates neutrophil expression of integrin α6β1 on neutrophils that binds laminin 
and allows them to migrate through the basement membrane23. JAM C is a ligand of CD11b and 
has an important role in supporting the luminal-to-abluminal migration of neutrophils. In a 
model of ischemia-reperfusion (I-R) injury, reverse TEM (rTEM) was observed whereby 
neutrophils that had already transmigrated moved in an abluminal-to-luminal direction. This 
rTEM was caused by loss of JAM-C at endothelial cell junctions as a result of I-R and could be 
enhanced by blockade or deletion of JAM-C. These rTEM neutrophils expressed ICAM-1 and 
have also been shown to be associated with injury in the lung24, underlining the importance of 
proper control of neutrophil TEM in normal immune responses. 
 
1.3.4 Abluminal crawling 
The venule wall consists of endothelial cells, pericytes and non-cellular basement membrane 
(BM). Both endothelial cells and pericytes secrete BM; a matrix structure containing laminin 
and collagen proteins. Pericytes ensheath capillaries and venules and are embedded within the 
BM25. Once through the endothelial layer neutrophils crawl along the pericyte layer to find 
suitable gaps through which they can exit into tissue parenchyma, through interactions with 
Pericyte ICAM-1 which interacts with neutrophil CD11a and CD11b. Inflammatory mediators 
such as TNFα and IL-1β act on pericytes to induce larger gaps, aiding neutrophil exit25. Pericyte 
gaps align with areas of the BM with low density of matrix deposition through which 
neutrophils preferentially migrate26. Neutrophils make and store in granules large quantities of 
proteases such as elastase and matrix metalloproteinase (MMP) 8 and 9 that can lead to BM 
degradation potentialy aiding in their interstitial migration, however the evidence that this 
process occurs is not clear18,23. 
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Figure 1.1: The neutrophil recruitment cascade.  
A diagram of the steps involved in the neutrophil recruitment cascade, leading to neutrophil 
extravasation and subsequent tissue infiltration. From Weninger, Biro and Jain, 201427. 
 
1.3.5 Interstitial neutrophil migration 
Neutrophils express multiple different chemokine receptors, and thus migrate towards various 
chemoattractants. Following extravasation, once in the tissue they respond to numerous 
chemokine gradients. To ensure they migrate to the site of infection or injury they respond 
preferentially to primary, or end-target chemoattractants, including bacterial products such as N-
formyl-l-methionyl-l-leucyl-phenylalanine (fMLP) and the complement component 5a (C5a) 
fragment. Secondary, or intermediate chemoattractants include leukotriene B4 (LTB4) and 
chemokines such as CXCL15. This prioritisation allows neutrophils to move away from 
secondary chemokine gradients at the endothelium and travel into the tissue to locate the 
infection site where there is high concentration of end-target chemoattractant. This is achieved 
by activation of different downstream signalling molecules. Secondary chemoattractant GPCRs 
such as CXCR2 activate phosphoinositide 3-kinase γ (PI3Kγ) to induce cell migration, however 
the formyl peptide receptor 1 (FPR1) GPCR also activates p38 mitogen-activated protein kinase 
(MAPK)28. Indeed PI3Kγ only accelerates migration towards fMLP, but is not required for 
migration towards fMLP29. In vitro it was shown that when neutrophils are faced with two 
opposing chemokine gradients; CXCL8 versus fMLP, they preferentially migrate towards 
fMLP, even if the concentration of fMLP is a 1/10000th of the concentration of CXCL8. When 
p38 MAPK is inhibited neutrophils are found to move out of the fMLP gradient and towards 
CXCL8. Thus neutrophils prioritise end-target chemoattractants by utilizing different signalling 
pathways; this potentially involves inhibition of PI3Kγ signalling by p38 MAPK30. 
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Intravital microscopy studies imaging neutrophil interstitial migration in real time have shown 
that the collective migration of these cells is highly coordinated. In response to sterile injury 
(laser induced tissue damage), or intradermal Leishmania major infection, neutrophil 
recruitment is observed to happen in phases31-33. First, small numbers of ‘scout’ neutrophils 
arrive at the injury site, presumably responding to PAMP or DAMP release31. These initial cells 
then amplify the recruitment of further neutrophils by releasing LTB433. Paracrine LTB4 acts as 
a relay molecule, signalling from cell to cell over long distances. It also amplifies neutrophil 
migration towards fMLP34. Recruited neutrophils move in a highly directed manner away from 
the blood vessel towards the site of inflammation31. Neutrophil interstitial migration is also 
facilitated by NG2+ pericytes that express macrophage migration inhibitory factor (MIF) on 
their surface in response to DAMPs and PAMPS35. These cells attach to the outside of 
capillaries and arterioles, thus after TEM neutrophils may migrate along them, aiding their 
guidance to the site of inflammation. After the period of amplification stabilization occurs 
where further neutrophil infiltration stops. The recruited neutrophils form a cluster that seals off 
the injury site. Neutrophil clusters can be stable as seen in laser induced tissue injury, where 
neutrophil migration arrests32,33. However they can also be highly dynamic as seen in neutrophil 
‘swarms’ induced in response to L. major31, Toxoplasma gondii36, Listeria monocytogenes, 
Escherichia coli, Pseudomonas aeruginosa33 and ischemia-reperfusion injury37. 
 
1.3.6 Neutrophil recruitment in the lung 
The process of neutrophil recruitment from the blood to tissues has been well studied and 
characterized by intravital microscopy studies, particularly in tissues such as the mesentery and 
cremaster muscle, where the tissue is thin and easily accessible to microscopy. However, in 
some tissues the recruitment cascade does not follow the same classical steps, in liver sinusoids 
neutrophils do not roll, they directly adhere to the endothelium. In sterile liver inflammation 
neutrophil adherence is integrin dependent, involving CD11b and ICAM-1 interaction19. In 
contrast during inflammation induced by systemic endotoxemia, sinusoid adherence is integrin 
independent, involving neutrophil CD44 binding endothelial cell hyaluronan38. Likewise in the 
lung, neutrophils do not follow the classical recruitment cascade. First, neutrophil TEM occurs 
mainly in the capillaries of the lung, not post capillary venules. The lung is made up of a vast 
network of very thin capillaries (mean diameter 5.5 µm); to migrate through these capillaries 
neutrophils (mean diameter 8 µm) must dramatically change their shape. Blood flow velocity is 
also low in the lungs, these two factors combined together lead to a slower neutrophil transit 
time through the lungs, and thus neutrophil margination under homeostatic conditions39. Upon 
activation neutrophils become rigid due to actin cytoskeletal rearrangements, they can no-longer 
deform their shape and become stuck40, thus arrest in the capillaries. There is no rolling step due 
to the size of the capillaries. 
   
 24 
 
Depending on the stimulus, neutrophil migration from the blood into the alveolar space can be 
selectin and integrin dependent or independent. In E- and P-selectin, and β2 integrin (CD18) 
deficient mice, neutrophil migration into the alveolar space in response to gram-positive 
Streptococcus pneumoniae, Group B Streptococcus and Staphylococcus aureus bacterial 
infection is not hindered41-43. However in bacterial pneumonia induced by gram-negative E. coli 
lipopolysaccharide (LPS) or P. aeruginosa infection, β2 integrin and E-selectin deficiency 
reduced neutrophil extravasation into the alveolar space42. However it is not only bacterial 
strains that cause opposing requirements for neutrophil recruitment; IL-1 induced neutrophil 
influx is integrin dependent, whereas C5a induced influx is integrin independent40. Thus, 
although the rolling and firm adhesion steps do not appear to occur in the lung, selectins and 
integrins still have a role in neutrophil extravasation. None of these studies involved intravital 
microscopy, thus the role of physical neutrophil trapping or adhesion molecules in neutrophil 
pulmonary extravasation in vivo has not been directly demonstated. Like in the classical 
neutrophil recruitment cascade, chemokines on the pulmonary endothelial cell surface have an 
essential role in neutrophil recruitment40. 
 
 Neutrophil activation and pathogen clearance 1.4
Neutrophils have the potential to cause tissue damage due to the contents of their granules. To 
avoid unwanted activation of neutrophils and thus tissue destruction, neutrophils must first be 
primed before they can fully activate. Priming involves exposure to activating stimuli, including 
TNFα, LPS, chemokines and adhesion molecules. A single stimuli will not fully activate 
neutrophils, however enhances their ability to activate in response to a second stimuli2. Un-
primed neutrophils stimulated with fMLP alone produce minimal reactive oxygen species 
(ROS), however stimulation of un-primed neutrophils with fMLP and TNFα induces priming, 
leading to production of large amounts of ROS44. Priming is initiated during the neutrophil 
recruitment cascade by interaction with activated endothelial cells5. Once in the tissue 
neutrophils become fully activated. Activation results in the enhancement of phagocytic 
capability, release of granular proteins (degranulation) and neutrophil extracellular trap (NET) 
release. 
 
1.4.1 Pathogen recognition by innate immune cells 
Neutrophils, like other innate immune cells, possess a number of PRRs on their surface enabling 
them to detect a wide range of different pathogenic stimuli. These include TLRs, C-type lectin 
receptors (CLRs) and nucleotide-binding oligomerisation domain (NOD)-like receptors (NLRs). 
Pattern recognition receptors allow neutrophils to distinguish gram-positive and -negative 
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bacteria, fungi, protozoan parasites and viruses, thus enabling the correct response to the 
pathogen to be generated45. Neutrophils express many TLRs including TLR1, -2, -4, -5, -6, -7, -
8, -9 and -10. Thus they can recognize lipids, carbohydrates, peptides, DNA and single- and 
double- stranded RNA. Ligation of neutrophil TLRs modulates many aspects of their function 
including migration, phagocytosis, degranulation, ROS production, NETosis and cytokine 
production45. It also regulates their life span, both directly and indirectly; in human neutrophils 
TLR4 ligation activates NF-κB and MAPK cascades inhibiting their apoptosis. Indirectly, TLR4 
activation of monocytes induces their production of neutrophil pro-survival factors, prolonging 
neutrophil life span46. This may help ensure efficient pathogen clearance, thus both direct and 
indirect TLR signalling is highly important for neutrophil function, in addition to its role in 
regulating granulopoiesis and neutrophil egress from the bone marrow. 
 
C-type lectin receptors recognize carbohydrate moieties, neutrophil CLR PRRs include Dectin-
1, Mincle, and C-type lectin domain family 2 (CLEC2). These CLRs are particularly important 
in fungal infections; Dectin-1 and Mincle recognize carbohydrates found in the fungal cell wall, 
their ligation induces phagocytosis, respiratory burst, degranulation and pro-inflammatory 
cytokine production45. Unlike in macrophages, the anti-fungal response induced by Dectin-1 
requires co-binding of the ligand by CD11b. Dectin-1 and CD11b both bind fungal β-glucan, 
Dectin-1-β-glucan ligation induces inside-out signalling, activating CD11b, thus allowing it to 
bind β-glucan, this results in phagocytosis and ROS production47. 
 
Other neutrophil PRRs include the FPR1 and FPR2 that bind bacterial and mitochondrial formyl 
peptides, including fMLP. Ligation of FPRs not only induces potent activation of neutrophil 
migration, but also degranulation, ROS production and up regulation of adhesion molecules45. 
Intracellular PRRs include NOD1 and NOD2 recognise structures in the bacterial cell wall 
component peptidoglycan. In contrast to human neutrophils, mouse neutrophils express NOD1. 
Systemic peptidoglycan derived from gut microbiota acts on NOD1 in bone marrow 
neutrophils, priming them for killing of pathogens by phagocytosis and respiratory burst ex 
vivo45. Both human and murine neutrophils express NOD2, its ligation results in up regulation 
of CD11b, chemokine production and migration45. Collectively PRRs allow neutrophils to 
detect bacterial, fungal, viral and protozoan pathogens, leading to activation of signalling 
cascades involving NF-κB and MAPK, to initiate their functional immune response to pathogen 
infection, resulting in pathogen clearance.  
 
1.4.2 Pathogen killing by neutrophils 
Neutrophils are specialised in pathogen killing. They possess a number of mechanisms to carry 
out this function. Mature neutrophils express Fcγ receptors that allow binding of opsonized 
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pathogens, also endocytic PRRs such as Dectin-1 and triggering receptor expressed on myeloid 
cells 1 (TREM-1) that assist in the phagocytic process. Binding of these receptors induces very 
rapid pathogen phagocytosis, leading to formation of a phagosome inside the neutrophil 
containing the pathogen. Unlike macrophage phagosomes, that acidify; neutrophil phagosomes 
maintain a neutral pH 748. Granules then rapidly fuse with the phogosome. Granules are 
exocytic vesicles formed by budding off from the golgi49; they start to form during 
granulopoiesis at the promyelocyte stage up to the band cell stage3. Neutrophils contain three 
different types of granules; primary (azurophil), secondary (specific) and tertiary (gelatinase) 
granules. Neutrophils also contain secretory vesicles that are seen at the final 
polymorphonuclear stage in neutrophil development, and are thought to form by endocytosis. 
Primary granules contain various lytic enzymes and anti-microbial proteins such as defensins 
that are essential to neutrophil function. Primary granules are not exocytosed upon neutrophil 
stimulation, but targeted to the phagosome, and are key in destruction of pathogens49. A key 
primary granule marker is myeloperoxidase (MPO); it makes up to 5% of the neutrophil protein 
content and is responsible for the catalysis of hypochlorous acid (HOCl), a potent oxidant that is 
bactericidal50. Secondary granules contain primarily anti-microbial substances, for example 
lactoferrin, whereas tertiary granules contain mainly matrix-degrading enzymes, for example 
MMP-8 and -9. Secondary granules are mainly targeted to the phagosome to aid in bacterial 
killing whereas tertiary granules are exocytosed to aid in neutrophil extravasation and digestion 
of extracellular matrix. Tertiary granules and secretory vesicles also contain β2 integrins that are 
rapidly exocytosed, particularly secretory vesicles, in response to stimulation to allow adherence 
of the neutrophil to the endothelium49. 
 
The anti-microbial granules released into the phagosome lead to pathogen killing through a 
number of different chemical pathways. In addition to granule content ROS are generated by 
respiratory burst within the phagosome to aid in killing. In response to pathogen binding and 
phagocytosis the NADPH oxidase assembles at the phagosome membrane. Cytosolic 
components p47phox, p67phox and p40phox associate with membrane bound gp91phox and p22phox to 
form the NADPH oxidase complex. Fully functioning GTP-bound Rac1 or -2 also needs to be 
associated with the complex48. NADPH oxidase converts oxygen into superoxide, O2-, this 
readily converts to hydrogen peroxide, H20251 and other reactive intermediates. Reactive 
nitrogen species (RNS) are also produced in the phagosome by inducible nitric oxide synthase 
(iNOS) generating nitric oxide (NO). Superoxide and nitric oxide combine to form 
peroxynitrite (ONOO-). ROS and RNS together target various microbial molecules and 
components; ROS are key in DNA damage and RNS inhibit respiration and interfere with DNA 
replication52. Together granules, ROS and RNS kill intracellular pathogens, however if a 
pathogen is too large to be phagocytosed, or it is extracellular, then degranulation occurs 
inducing release of granule contents into the extracellular milieu19. NADPH oxidase forms on 
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the cell plasma membrane generating extracellular ROS. Neutrophils also make NETs to 
capture and kill extracellular bacteria53, fungi, viruses54 and parasites55. 
 
1.4.3 Neutrophil extracellular traps 
Neutrophil extracellular traps are formed during a unique process of cell death termed NETosis. 
Following phagocytosis and ROS production, H202 causes the dissociation of neutrophil elastase 
(NE) from the primary granule membrane into the cytoplasm where it binds the actin 
cytoskeleton and is sequestered. Neutrophil elastase degrades intracellular filamentous actin, 
thus liberating itself, permitting nuclear entry. In the nucleus NE degrades and processes 
histones56, inducing chromatin decondensation, followed by the detachment of the nuclear 
membranes. At the same time the granules disintegrate. After an hour the nuclear membrane 
breaks down into vesicles and the nuclear and cytoplasmic contents mix. The cell then rounds 
up and contracts before the membrane ruptures releasing the cell contents into the extracellular 
matrix, forming a net-like structure. This entire process takes one and a half hours57. The 
NADPH oxidase and ROS production are essential for NET formation. Patients with chronic 
granulomatous disease (CGD) have mutations in the NADPH oxidase and thus cannot make 
NETs, leading to granulomatous pathology57. Additionally mice lacking NE or patents lacking 
MPO are also unable to make NETs, however the function of MPO in NET formation is not 
clear58. Not all neutrophils form NETs, however all neutrophils have the capacity to undergo 
this process, therefor this process must be regulated either by neutrophil activation or by 
localized environmental cues58. Neutrophil extracellular traps can contribute to neutrophil 
defense against viruses. Human neutrophils detect human immunodeficiency virus -1 (HIV-1) 
through endocytic TLR7 and 8. In vitro, activation of these PRRs triggers ROS production and 
subsequent NET formation that can trap HIV-1. When neutrophils are co-cultured with T cells, 
neutrophils reduce the infection efficiency of HIV-1 through NET production. However, HIV-1 
is capable of counteracting this process by activating the C-type lectin dendritic cell-specific 
intercellular adhesion molecule (DC-SIGN) on DCs, causing their production of IL-10. IL-10 
inhibits TLR7 and 8 signalling thus inhibits NETosis54. There is no evidence that this process 
occurs in vivo. 
 
The net-like structures formed by chromatin are decorated with granular proteins, particularly 
NE, and also histones. Histones themselves have bactericidal activity. In the resolution of 
inflammation DNase1 that is produced in the pancreas breaks down NETs. Additionally 
pathogenic bacteria use a similar method to evade killing by NETs; they produce extracellular 
DNase59. Indeed, one of the virulence factors of Streptococcus pneumoniae is an endonuclease 
EndA that degrades NETs, thus preventing their killing by these structures60. Neutrophil 
extracellular traps may have a beneficial role in pathogen clearance, however they are also 
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implicated in pathologies including vasculitis, sepsis and systemic lupus erythematosus (SLE) 
nephritis2. NETs are capable of trapping platelets and RBCs, and have shown to be key in the 
development of thrombus in deep vein thrombosis and implicated in the formation of 
atherosclerotic plaques. In autoimmunity, the production of pathological autoantibodies against 
neutrophil cytoplasmic components is thought to be a result of excessive NET formation19. 
 
Following pathogen killing neutrophils that have not undergone NETosis undergo apoptosis and 
are phagocytosed by macrophages. This avoids excessive release of ROS and granular contents 
that mediate tissue damage, and helps promote inflammation resolution through inhibiting 
secretion of pro-inflammatory mediators such as TNFα61 and modulation of granulopoiesis8. In 
vitro it has been demonstrated that activated neutrophils can also participate in apoptotic 
neutrophil clearance, and that this uptake inhibits pro-inflammatory function, including ROS 
production and TNFα release. This is consistent with the paradigm that clearance of apoptotic 
neutrophils is a key initiation event in inflammation resolution62. 
 
 Neutrophils in innate and adaptive immunity 1.5
Further to host protection through rapid pathogen detection and clearance, neutrophils are also 
capable of interacting with, and modulating the function of, other innate and adaptive immune 
cells. The outcomes of these interactions are both stimulus and environment dependent. 
 
1.5.1 Neutrophil-macrophage interactions 
During helminth infections a type 2 innate and adaptive immune response is required, 
characterised by Type 2 T helper cell (TH2) induction and production of IL-4, -5, -9 and -13. 
Following primary infection with the helminth Nippostrongylus brasiliensis mice are protected 
from secondary infection and worms are rapidly expelled. This protection is conferred by 
primed macrophages that are alternatively activated (M2 phenotype). Alternative macrophage 
activation and anti-helminth function is mediated by polarised neutrophils that produce IL-13, 
amongst other soluble inflammatory factors63. 
 
1.5.2 Modulation of DC activation and function 
In models of lung inflammation neutrophils are key for DC maturation and function. During 
pulmonary Mycobacterium tuberculosis infection, uptake of apoptotic neutrophils that contain 
M. tuberculosis is necessary for myeloid CD11b+ DC migration to the draining lymph node 
(dLN) and their ability to stimulate early CD4+ T cell activation64. Delaying neutrophil 
apoptosis is an M. tuberculosis virulence mechanism to prevent the induction of T cell 
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responses65. Pulmonary challenge with Aspergillus fumigatus germ tubes reveals a similar 
result; neutrophils are required for CD11b+ DC migration to the dLN and neutrophil mediated 
maturation inducing CD40, CD86, and major histocompatibility complex class II (MHC II) up-
regulation. In vitro it was found that neutrophil mediated DC maturation is dependent on the 
presence of A. fumigatus and also DC-SIGN binding on the DC. It is not clear however if it is 
DC-SIGN binding by the neutrophil or A. fumigatus or binding on both cell types that is key66. 
 
1.5.3 Neutrophil mediated T cell modulation 
There are a number of studies that find a role for neutrophils in directly modulating T cell 
functions; however the results vary, with some studies finding activating roles and other 
inhibitory roles. This complexity could be due to the variation in experimental models 
employed and endogenous microbiota. In several different system neutrophils have been shown 
to express MHC II in vivo and are able to directly activate T cells in vitro, however the 
significance of these interactions in vivo is less clear. During chronic colitis there is a large 
influx of neutrophils in the colon, these neutrophils express MHC II and the co-stimulatory 
molecule CD86. In vitro these cells can activate antigen specific (ovalbumin; OVA) CD4+ T 
cell proliferation67. Similarly, thioglycollate elicited neutrophils co-cultured in vitro with T cells 
could also induce OVA specific CD4+ T cell proliferation and skew the induction of TH1 and 
TH17 cells68. Neutrophils are also able to cross-present antigens (OVA) to CD8+ T cells, 
inducing their proliferation in vitro and differentiation into effector cells in vivo69. Conversely, 
neutrophils may inhibit T cell responses through ROS and RNS production that can inhibit T 
cell activation. In addition, activated neutrophils produce high levels of arginase I, which when 
released causes depletion of localised extracellular L-arginine, and can thus inhibit T cell 
activation, as L-arginine is essential for T cell function and cell cycle progression70. 
 
1.5.4 Neutrophil modulation of NK cell homeostasis 
Neutrophils have a role in modulating both NK cell activation and functional capacity. The full 
activation of NK cell effector function requires priming by cytokines such as IL-12, IL-15 and 
IL-18. To control Legionella pneumophila infection neutrophils are required, however L. 
pneumophila is resistant to neutrophil antimicrobial mechanisms. Instead the mechanism of 
bacterial killing is through the activation of NK cells. Neutrophils, along with DCs, form a 
tripartite complex with NK cells, where neutrophil derived IL-18 stimulates NK cell interferon γ 
(IFNγ). IL-12 produced by DCs is also important for NK cell IFNγ production stimulation71. It 
is the localised IFNγ production that drives macrophages to clear the infection. 
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Further to effector function activation neutrophils regulate NK cell maturation and homeostasis. 
In a random chemical mutagenesis screen, Gentista mice were generated that had a mutation in 
the growth factor independent-1 (Gfi-1) transcription factor, which resulted in a defect in 
terminal differentiation of neutrophils. These mice therefore lacked mature functional 
neutrophils. In these mice, NK cells were hyporesponsive, blocked in an immature stage of 
development and showed poor survival. In humans who lack mature neutrophils; severe 
congenital neutropenia (SCN) patients, NK cells were also found to have the same 
hyporesponsive, immature phenotype. Thus neutrophils, both in humans and mice are required 
for full NK cell maturation and function. This process may be a contact dependent process due 
to the co-localisation of neutrophils and NK cells in mouse lymphoid organs and human 
tissues72. Further evidence of how neutrophils are capable of modulating immune responses, 
particularly adaptive immune responses in secondary lymphoid organs is discussed in Chapter 
three. 
 
 Streptococcus pneumonaie 1.6
1.6.1 Bacterial pneumonia 
The main cause of bacterial pneumonia infection is Streptococcus pneumoniae. Invasive 
pneumococcal disease (IPD) is a major cause of morbidity and mortality in the young (under 
five years old), elderly and immunocompromised73. It is the leading cause of death for children 
worldwide; 18% of deaths of children under-five worldwide are due to pneumonia. Pneumonia 
kills on average 1.1 million children per year and is particularly prevalent in South Asia and 
sub-Saharan Africa. Bacterial pneumonia can be treated by antibiotics, however only 30% of 
children worldwide receive antibiotics74 and it is a major causative agent in antibiotic resistance. 
 
1.6.2 Streptococcus pneumonaie colonization and treatment 
S. pneumoniae is a gram positive encapsulated cocci that grows in pairs or short chains. There 
have been ninety different capsule types identified that differ in polysaccharide chemical 
structure75. The capsule polysaccharide is used to define S. pneumoniae serotypes76. A small 
number of S. pneumoniae serotypes are associated with IPD75. S. pneumoniae asymptomatically 
colonises mucosal surfaces in the upper respiratory tract; 8-20% of healthy individuals are 
carriers, however local infection can cause sinusitis and otitis media (inflammation of the 
middle ear)77. If the bacteria reach the sterile lower respiratory tract, this can result in robust 
bacterial growth, causing pneumonia and a massive inflammatory neutrophil influx into the 
lung. Should S. pneumoniae cross into the blood sepsis ensues which can be fatal78. To colonise 
the human respiratory tract and spread to the lower respiratory tract S. pneumoniae has many 
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virulence factors. The main virulence factor is the capsule, this provides resistance to 
phagocytosis, complement binding and entrapment in NETs79. Another major virulence factor is 
pneumolysin, which forms pores in mammalian cells directly killing them and is critical in 
pneumonia and lung pathology79. Pneumococcal disease is treated with antibiotics including; β
-lactams (penicillin G, amoxicillin, cephalosporins), respiratory fluoroquinolones, macrolides, 
and vancomycin, often requiring hospitalization and intravenous antibiotics. However there is 
increasing antibiotic resistance, 69.4% of pneumonia isolates are resistant to one or more 
antibiotics80. This is strongly associated with particular pathogenic serotypes, thus making 
treatment of some cases, particularly in the young and elderly, challenging. 
 
Pneumococcal vaccines are available against select serotypes. Early antibody has a key role in 
reducing colonization of the lower lung and thus reduces the incidence of invasive disease 
particularly in the young, however overall death rates particularly in the elderly have not 
changed81. All vaccines are designed to target the capsule polysaccharide which is serotype 
specific, however no current vaccine covers all serotypes and most vaccines have poor 
immunogenicity in children and the elderly81. The current licensed vaccine PCV13 (Prevnar, 
Pfizer) is a pneumonococcal-protein conjugate, 13-valent vaccine and is immunogenic in 
children82. It covers 13 serotypes including serotype 19A, the most common cause of IPD. This 
vaccine is mainly used in children under two years of age. In adults the vaccine PPV23 
(Pneumovax II, Sanofi Pasteur MSD) is commonly used to prevent IPD. This is a 23-valent 
pneumococcal polysaccharide vaccine that protects against 23 serotypes that are responsible for 
more than 95% of IPD83. However studies have found that although vaccination has 
dramatically reduced the incidence of IPD caused by the serotypes targeted by vaccines, 
colonization by non-targeted serotypes is occurring as a result, causing the incidence of IPD by 
non-targeted serotypes to increase, particularly in adults84. Thus efforts are being made to 
design vaccines against other virulence factors that are more widely conserved81. 
 
1.6.3 The immune response to Streptococcus pneumonaie 
One to three days after the initial colonization by S. pneumoniae, neutrophils migrate to the 
nasal passage, phagocytose and directly kill the bacteria. Clearance is not complete though and 
some bacteria remain once the inflammation has subsided81. S. pneumoniae is recognized by 
PRRs including TLR2, which binds lipoteichoic acid (LTA) and lipoproteins in the bacterial 
cell wall, TLR4 that interacts with pneumolysin and TLR9 that recognises unmethylated CpG 
motifs in the bacterial DNA. Toll-like receptor signalling induces inflammatory cytokine and 
chemokine production, triggering the activation of multiple immune and non-immune cells in 
the tissue and tissue draining lymphoid organs. Toll-like receptor 2 and TLR9 signalling 
enhances phagocytosis and intracellular killing of the bateria79, this is key to the innate defense 
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against S. pneumoniae. Mice lacking the TLR signalling adaptor molecule MyD88, and humans 
with defects in TLR signalling are highly susceptible to S. pneumoniae invasive infection79,85. 
 
1.6.4 Animal models of pneumonia 
S. pneumoniae pneumonia has been widely studied in numerous animal models to investigate 
disease pathogenesis, to understand host immune response to infection, and to test vaccines and 
anti-microbials to treat pneumonia and sepsis. Mice are the most frequently used infection 
model; the main routes of infection employed to induce pneumonia are intratracheal (i.t.) and 
intranasal (i.n.). The i.t. route is most invasive but achieves the best delivery of bacteria to the 
lower lungs. The i.n. route is easier to perform and more commonly used, it closer resembles the 
natural human route of infection, however it is unclear how the dosing of bacteria correlates to 
human lungs77. Various serotypes of S. pneumoniae have been investigated; virulent serotypes 
in mice are 2-6. Classic strains, for example strain D39, serotype 2, have been widely used 
because they produce consistent features of disease, and thus results can be compared between 
research groups, however significant variation in pathogenesis can occur due to culturing and 
handling conditions77. Most mouse models of pneumonia also result in sepsis. Bacteremia is not 
common in human pneumonia, thus these mouse models are less helpful investigating disease 
pathogenesis exclusively in the lung77.  
 
 Structure and function of the lung 1.7
The function of the lung is to ensure that blood is oxygenated by absorbing oxygen from 
breathed in air, while allowing release of carbon dioxide (CO2) from the blood, into the air. 
Thus its structure is designed to maximize the surface area available for this exchange process, 
and additionally to minimize the distance through which the gases diffuse. The trachea divides 
into two bronchi that enter the lungs. The bronchi then further divide and branch off to form 
many smaller airways that narrow into terminal bronchioles. At the end of the bronchioles are 
acini that are made up of multiple alveoli. Alveoli are covered with a network of fine capillaries 
that carry oxygenated and oxygen poor blood. The alveoli are the site of respiratory gas 
exchange and thus the distance between the capillaries and the alveolar airspace is never more 
than 1µm. To create this microenvironment type I alveolar epithelial cells spread out to make a 
very thin respiratory surface, in contrast type II alveolar cells have a rounder structure. Type II 
cells function to produce surfactant that is a mixture of lipids (90%) and protein (10%). 
Surfactant reduces the surface tension of alveoli to prevent their collapse86. 
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1.7.1 Lung defenses 
In serving its function the lungs take in large amounts of air that contains particular matter, 
pollen and airborne pathogens. Thus the lungs are designed to trap and clear particulate matter 
and pathogens to maintain sterility. In the lung airways, specialized epithelial cells have ciliated 
surfaces. Mucus produced by sub-mucosal tracheobronchial glands and epithelial goblet cells 
traps particles, then the beating of the cilia moves them up and out of the airways. Additionally 
airway epithelial cells form a continuous layer, joined by tight junctions, thus providing a 
barrier to the airspace. In the alveoli these mechanisms do not exist and would impede gaseous 
exchange, however inhaled pathogens such as S. pneumoniae cocci or A. fumigatus fungal 
spores are able to get into the alveoli, thus alternative protection is required86. 
 
Surfactant produced by type II alveolar epithelial cells forms a thin layer over the alveolar 
surface. Surfactant also functions to trap particles, however further to this it contains surfactant 
proteins (SP) A, -B, -C and -D. Surfactant proteins A and D are C-type lectins that bind 
carbohydrate moieties on pathogens, they cause pathogen agglutination, enhancing 
phagocytosis and killing by macrophages and neutrophils87. In addition, SPs can modulate 
immune cell function, including inhibiting DC maturation and T cell proliferation87. 
 
1.7.2 Immune defenses in the lung 
The airways, alveoli and interstitial space contain a number of prepositioned immune cells. 
Alveolar macrophages (AM) are tissue resident, non-motile cells that lay flat to the alveolar 
surface. They phagocytose and clear any particulate antigen or pathogen that has not been 
caught by mucus. Dendritic cells are also resident in the lung, they project their dendrites into 
alveoli to capture antigen. They then move to the larger airways and LNs where they activate T 
cells88. Neutrophils are also present in the lung under homeostatic conditions due to their 
margination within the narrow capillaries. Thus they are prepositioned and rapidly infiltrate, in 
large numbers, in response to an inflammatory insult where they then patrol the interstitium. 
This has been imaged in vivo and it is found that infiltrating neutrophils follow a leading 
monocyte. Neutrophils were observed to form large dynamic clusters around these cells, and 
clodronate liposome mediated monocyte depletion resulted in inhibition of neutrophil TEM and 
cluster formation37. 
 
 Lymph node structure 1.8
Lymph nodes function to filter antigen and pathogens from the lymph fluid and support 
formation of high affinity adaptive immune responses proximal to tissues. Under homeostatic 
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conditions they provide a microenvironment for rare naïve lymphocytes to survey and respond 
to cognate antigen. T lymphocytes undergo a process of recirculation; exiting the blood vessels, 
surveying LNs, and then re-entering the blood, spending on average four days with the 
parenchyma of the LN. Pathogen or adjuvant activated DCs drain from peripheral tissues to 
LNs to present antigens to T cells. This process permits the efficient detection of infection, 
tissue damage and cellular stress.  
 
Lymph nodes are highly organized complex structures containing a plethora of different cell 
types, enabling the effective induction of immune responses (Figure 1.2). Lymph nodes have 
three main regions; the cortex, paracortex and the medulla. Within the cortex are the B cell 
follicles, these are the sites of high affinity antibody production. In the paracortex is the T cell 
zone, this is where interactions between DCs and T cells occur, leading to T cell activation. The 
medulla is made up of the medullary sinus, where cells exit the LN and particulate antigen is 
cleared from the lymph. The medullary cords are a niche for antibody secreting plasma B cells. 
Blood vessels in the medulla branch into post-capillary high endothelial venules (HEV) that run 
throughout the paracortex and are the main route of entry for lymphocytes into the LN and 
provide oxygen and nutrients to the LN parenchyma. Lymphatic vessels make up a network in 
the LN that can be divided into the subcapsular sinus (SCS), paracortical sinus and medullary 
sinus (MS)89. Encasing the LN is a collagen rich capsule, below this is the SCS where cells and 
antigen enter the LN. Lymph fluid enters the LN through afferent lymphatic vessels, into the 
subcapsular space, it then flows through the sinuses and out into efferent lymphatics draining 
the LN. Particles of 20-200 nm in size may enter the LN passively through the lymphatics, this 
size range includes some viruses. Large particles, greater than 500nm in size, are not able to 
enter the unless actively transported by antigen presenting cells (APC)90. However during an 
inflammatory immune responses an increase in interstitial fluid flow is observed allowing entry 
of larger particles90. This change in lymphatic flow has been shown to assist T. gondii parasite 
access to the tissue draining LN36. During bacterial infection, degradation by immune cell 
derived proteases, or secretion of antigenic material permits access of bacterial antigens to the 
lymphatics to initiate adaptive immune responses90. 
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Figure 1.2: Lymph node basic structure and cellularity.  
A diagram of the basic structure of a lymph node, including key cell populations and their 
location. From Girard, Moussion and Forster, 201291. 
 
 Lymph node stromal cells 1.9
Mesenchymal stromal cells form the ultrastructure of the LN and are required for productive 
immune responses making sure the right cells come together at the right time and place92.  
 
1.9.1 Fibroblastic reticular cells 
Fibroblastic reticular cells (FRCs) are specialized stromal cells of the T cell zone. They 
ensheath pericytes that surround the HEVs and form a lattice like cellular frame work within the 
paracortex92. Fibroblastic reticular cells express the T cell and DC chemoattractants CCL19 and 
CCL21, and a subpopulation expresses CXCL12. CCL21 is immobilized on the FRC surface by 
heparin sulfate residues, thus the chemokine receptor CCR7 on DCs and T cells binds 
immobilized CCL21 guiding migration along the FRCs. This migration is termed haptotaxis; 
cell migration along an adhesive gradient92,93. Fibroblastic reticular cells are also characterised 
by expression of the glycoprotein gp38 (podoplanin). Dendritic cells express the C-type lectin 
receptor CLEC-2, binding of gp38 by this receptor activates DC migration on FRCs94. Thus 
FRCs are able to guide T cells from the HEVs to the paracortex where they survey antigen 
loaded DCs for cognate antigen. Fibroblastic reticular cell guidance of both T cells and DCs 
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increases the chance of these cells finding each other, thus aiding productive immune response 
generation95. 
 
Additional to migration cues, FRCs produce the T cell survival factor IL-7, that regulates T cell 
homeostasis95. In the steady state they express TLR4, and in response to LPS induced 
inflammation they are found to up-regulate MHC II expression and also mRNA encoding 
molecules involved in the acute-phase response, inflammatory cytokines and interferon and 
TLR4 inducible genes96. Depletion of FRCs, either resulting from lymphatic choriomeningitis 
virus (LCMV) infection where the FRC network is killed by virus specific CTLs, or by 
conditional ablation of CCL19 expressing cells using CCL19-Cre x Rosa26-DTR mice, 
demonstrates the essential role of these cells in LN function. Following LCMV infection of 
stromal cells, loss of the FRC network occurs rendering the host unable to respond to secondary 
antigens97. Conditional depletion of FRCs results in a reduction in T cell viability, numbers and 
aberrant T cell positioning in the cortex. In the absence of FRCs, in response to ovalbumin-
expressing, inactivated influenza virus, there is a major defect in T cell activation and responses, 
and a significant reduction in immunoglobulin (Ig) M and IgG2b influenza-specific antibody 
production resulting in part from small disorganized germinal centers (GC) likely due to a loss 
of T helper and follicular helper cells98. There is no apparent defect in FDC function, thus this 
effect is due to loss of FRCs. Thus FRCs are able to promote hematopoietic cell survival, 
interaction, and activation, whilst regulating their recruitment and localisation emphasising the 
critical role of stromal cells in the organization and proper functioning of the LN. 
 
The FRC network is also responsible for permitting access of low molecular weight (less than 
70kDa) lymph borne molecules such as chemokines, cytokines, small molecules and soluble 
antigen into the lymph node parenchyma. Fibroblastic reticular cells ensheath and form conduits 
that are comprised of extracellular matrix surrounding a collagen I core that connect the 
lymphatic vessels with the HEVs. Small soluble molecules can enter these conduits, thus 
delivering proteins to T cells and dendritic cells deep in the paracortex99. Resident DCs attached 
to the conduits are able to take up soluble antigens from these and preset them to T cells100. This 
process represents an early ‘wave’ of antigen presentation in the lymph node as it has been 
demonstrated that soluble antigen can arrive in lymph node conduits within minutes of 
injection100. These conduits can also deliver chemokines to HEVs aiding lymphocyte entry into 
the lymph node99. 
 
1.9.2 Fibroblastic dendritic cells 
Fibroblastic dendritic cells (FDCs) are a specialised stromal cell type found in adult B cell 
follicles that develop post-natal in a TNFα and lymphotoxin (LT) β dependent process. These 
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cells make the B cell attractant chemokine CXCL13 and B cell activating factor (BAFF), which 
is required for B cell recruitment and survival101. Thus the FDC network attracts and maintains 
B cells within the follicle in a TNFα/CXCL13 dependent process. B cells have been found to 
migrate along FDC processes, thus FDCs act like FRCs to aid rapid B cell migration and survey 
for antigen90. Fibroblastic dendritic cells express high levels of complement receptor (CR) -1 
and -2, and capture and display opsonized antigen on their surface to cognate B cells in the form 
of immune complexes (IC) that compete for antigen driving high affinity immune responses. 
They can also acquire complement ICs from non-cognate B cells through CR2102. These IC are 
then processed in an endocytic pathway that does not degrade the IC, but recycles them to the 
surface for recognition by cognate B cells90. 
 
Fibroblastic dendritic cells have an essential role in the formation of the GC reaction where B 
cells undergo rounds of selection, proliferation and apoptosis to select for high affinity class 
switched antibody responses103. Germinal centers contain a light zone, which contains FDCs, 
that is located near the SCS and a dark zone where B cells undergo rapid proliferation that 
extends towards the T cell zone containing a CXCL12 producing stromal cells90. Fibroblastic 
dendritic cells retain B cells within the GC by promoting their survival and through providing 
antigen complexes. If FDCs are depleted during the GC reaction then GC B cells disperse and 
die101. 
 
1.9.3 Marginal zone reticular cells 
Marginal zone reticular cells (MRCs) are the stromal cells found beneath the SS floor, on the 
edge of the B cell follicles, and also in inter-follicular regions. Within the MRC zone small 
numbers of NK cells, ILC type 1 and 3 (ILC1, ILC3), and invariant NKT cells are found and 
have roles in the initiation of antibody responses. They form reticular fibers, like FRCs, and 
express CCL19, CCL21, CXCL13, IL-7 and mucosal vascular addressin cell adhesion molecule 
1 (MAdCAM-1), and have a role in regulating antigen delivery to the B cell follicles104. 
Marginal zone reticular cells have been shown to act as a pool of precursor cells that can 
differentiate into FDCs during an immune response105. They are involved in B cell migration 
and entry of DCs and memory T cells into the LN104. 
 
 Lymph node macrophages 1.10
Lymph nodes also contain resident macrophage populations; subcapsular sinus and medullary 
sinus macrophages (SSM and MSM) that are strategically located within the LN. Subcapsular 
sinus macrophages line the bottom of the SS and they have dendrite-like protrusions that extend 
into B cell follicles. Intravital microscopy studies have shown that these cells, including their 
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protrusions, are immobile90. Subcapsular sinus macrophages are characterised by expression of 
CD11b and CD169 (sialoadhesin), they also express low levels of CD11c and are negative for 
F4/80106. Subcapsular sinus macrophages are poorly endocytic and have low degradative 
capacity102. The SSMs function to remove any particulate antigen in the lymph fluid by capture 
on their surface99. This includes capture of viral particles90,107. Upon capturing antigen on their 
surface in the SS they then move these antigens along their protrusions into the B cell follicle 
for recognition by cognate B cells via their B cell receptor (BCR)106. Subcapsular sinus 
macrophages also capture opsonized antigen and translocate it to the B cell follicle. In the 
follicle non-cognate B cells take up the antigen by CR1 and 2 and transport the antigen 
complexes to FDCs in the germinal center, where it has an essential role in driving affinity 
maturation and development of memory B cells102. Intravital imaging studies have visualized 
this transfer of particles along the SSM surface, however, due to the resolution of multiphoton 
microscopy it can’t be eliminated that these cells may take up particles into non-degradative 
early endosomes and recycle them to the surface90. The interaction between SSM and B cells is 
bidirectional, the development and maintenance of SSM is dependent on B cell derived LTα1β2 
102,107. Without B cells, or when B cells specifically lack LTα1β2, SSM numbers are reduced, and 
in contrast when LTα1β2 is overexpressed SSM numbers increase, the SSM layer becomes 
thicker102. Unpublished results from the Coles laboratory indicate that MRCs and ILC3s also 
have an important role in maintenance of the SSM positioning and function. 
 
Subcapsular sinus macrophages have several key roles in immunity including prevention of 
systemic spread of viruses by clearing them from the draining lymph fluid; this is mediated by 
capture of viruses from the lymph, and is important in induction of antiviral antibody responses. 
During a subcutaneous vesicular stomatitis virus (VSV) infection SSM prevent VSV spread to 
peripheral nerves that are situated in the LN. Selective depletion of SSM results in spread of 
VSV to the central nervous system and paralysis of the mice. Type I interferon (IFN-α) 
production by SSM is essential for prevention of VSV spread and replication within nerves108. 
Replication of VSV within the SSM is required for induction of Type I IFN production. Anti-
viral antibodies are important for protection from VSV, however even with high antibody titers 
approximately 60% of mice lacking SSM die. Even though antibody was not, B cell LTα1β2 was 
essential for survival. In the absence of B cells or when B cells lacked LTα1β2, SSM did not 
develop properly and thus VSV was able to spread to the central nervous system107. Subcapsular 
sinus macrophages are not only permissive to VSV infection, they are also permissive to dengue 
virus, vaccinia virus, cow pox, murine cytomegalovirus106 and the parasite T. gondii36. 
 
Medullary sinus macrophages (MSM), are highly phagocytic macrophages that express CD169 
and CD11b, additionally they are also characterized by F4/80, SIGN-R1, macrophage receptor 
with collagenous structure (MARCO), mannose receptor (MR) and lymphatic vessel endothelial 
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hyaluronan receptor 1 (Lyve-1) expression106. SIGN-R1 is a C-type lectin and is a receptor for 
bacterial dextrans, including the polysaccharide capsule from S. pneumoniae. MARCO is a 
scavenger receptor that binds unopsonised bacteria and particles. Thus due to the location in the 
lymph and the expression of PRR and scavenging receptors on the MSM surface it is 
unsurprising that the main function of MSM is clearance of particulate antigen in the lymph, 
thus preventing spread of pathogens beyond the dLN. Injection of labeled antigen in peripheral 
tissues is observed in MSM phagosomes within minutes of injection106. 
 
 Medulla function 1.11
The medulla of the LN is a region that is less well understood, its main functions are to clear 
particulate antigen from the lymph by MSMs, support cellular egress from the LN and provide a 
niche for long lived plasma cells. An extensive lymphatic sinus network connects to the efferent 
lymphatic vessels and is the site of lymphocyte exit from the LN back into circulation. The 
localised production of sphingosphine-1-phosphate (S1P) by lymphatic endothelial cells is 
essential in enabling lymphocyte egress from the LN. An additional role for the medulla is as a 
niche for plasmablasts and mature plasma cells. During B cell activation a proportion of 
activated B cells differentiate into plasmablasts. These cells down-regulate chemokine receptors 
CXCR5 and CCR7, and thus they are no longer retained in the B cell follicles. Instead they up-
regulate CXCR4 and migrate to CXCL12 rich areas; these include the lymph node medulla, 
splenic red pulp and bone marrow109. Here they differentiate into long-lived plasma cells. In the 
medulla plasma cells are non-migratory 110 and produce large amounts of antibody that is 
transported out of the LN in the lymph. These cells die in the medulla and are cleared by 
medullary cord macrophages106. Long lived plasma cells reside in the bone marrow which 
provides a niche for their long term survival. 
 
 Lymph node entry and exit 1.12
1.12.1 High-endothelial venules 
Entry to the lymph node occurs through the blood, through specialized post-capillary venules; 
HEVs or from the lymphatic system through afferent lymphatic vessels. Naïve lymphocytes 
enter through HEVs that run through the LN. Crossing the HEV endothelium involves a similar 
cascade of events as seen in neutrophil TEM. First, lymphocytes tether to the endothelium 
through L-selectin (CD62L) binding to HEV mucin-like glycoproteins, these are highly 
sulfated, fucosylated and sialylated. These sialomucins are also known as peripheral node 
addressins (PNAd)111. PNAd binding causes lymphocytes to begin to roll on the endothelial 
surface. Critical for CD62L binding is the recognition of 6-sulpho sialyl Lewis X which is 
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found specifically in HEV sialomucins91. Once rolling lymphocytes are in close proximity to the 
HEV endothelium, chemokine receptors can bind heparin sulfate immobilized chemokine. 
CCL21, CXCL12 and CXCL13 are the key chemokines involved in lymphocyte extravasation. 
High endothelial venules and pericytes produce CCL21, however CXCL12 and CXCL13 are 
made by FRCs and FDCs respectively, and are transcytosed to the endothelial surface 112. 
Endothelial cell heparin sulfate has been shown to bind CCL21 and immobilise it on the cell 
surface. T cells express chemokine receptors CCR7 and CXCR4 that bind CCL21 and 
CXCL12, B cell express CXCR5 that binds CXCL13, but also CCR7 and CXCR4. Chemokine 
receptor signalling, in addition to sheer stress from blood flow, induces inside-out signalling, 
resulting in integrin activation, allowing the extension of CD11a and binding to ICAM-1 or 2 on 
the endothelium, this process causes lymphocyte arrest, B and T cells then crawl along the HEV 
lumen91. This process is thought to lead to the lymphocyte finding a suitable exit point through 
which it can transmigrate through the vessel wall, other lymphocytes follow and use the same 
route. Lymphocytes then move in perivascular channels to find a location to enter the lymph 
node parenchyma. 
 
High endothelial venules also have a key role in controlling the rate of lymphocyte entry into 
the parenchyma of the LN. Lymphocytes were found to be held in HEV pockets formed 
between endothelial cells. When lymphocyte egress was blocked the number of lymphocytes 
held in these pockets increased. It was hypothesized that due to the close proximity of HEV and 
paracortical lymphatic sinuses (where lymphocytes exit the lymph node parenchyma), during 
homeostasis when lymphocytes enter the lymphatic sinuses lymphocytes are released from 
these pockets to balance the loss113. Central memory and FOXP3+ regulatory T cells also enter 
the lymph node via HEVs, in the same way as naïve T cells. Plasmacytoid DCs and precursors 
to conventional DC also enter LNs through HEVs, as do a small number of NK cells, thus HEV 
are important for the entry of other immune cells, not exclusively B and T cells91. 
 
1.12.2 Lymphatic vessels 
Immune cells migrating from peripheral tissue sites enter the lymph node through the afferent 
lymphatics. This process has been most widely studied in dermal DCs93,114. In tissues resident 
DC enter terminal lymphatic vessels in a mechanism dependent on CCR7 expressed by DCs and 
CCL21 made by lymphatic endothelial cells. CCL21 is located in distinct pockets; immobilized 
on the abluminal side of lymphatic vessels by heparin sulfate. CCL21 is also found immobilized 
in the interstitium, either on cell surfaces or matrix components, immobilization is mediated by 
heparin sulfate binding93. The interstitial CCL21 forms a gradient by which DCs can migrate 
along to reach the lymphatic vessels. Dendritic cells dock to the lymphatics by binding CCL21, 
they then move through gaps in the basement membrane and cross the lymphatic endothelium, 
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entering the lymph vessel. Lymphatic endothelial cells in initial lymphatics are oak leaf shaped 
and overlapping, unlike blood vascular endothelium they are not tightly joined together by 
conventional zipper-like junctions; rather they are joined by discontinuous button junctions. 
Thus DCs can squeeze through valves between button junctions to access the vessel lumen115. 
Once inside initial lymphatics in vivo imaging studies revealed that DCs crawl along the luminal 
lymphatic endothelium in the direction of lymph flow. Once in collecting lymphatics DCs 
drifted freely with lymph flow114 towards the LN. 
  
Dendritic cells enter the LN through afferent lymphatic vessels, into the SCS. They then move 
through the SCS floor into inter-follicular regions, then to the CCL19 and CCL21 rich areas of 
the T cell zone. This directed migration is dependent on sensing of a CCL21 gradient through 
CCR7 on the DC; there is little CCL21 in the SCS lumen, however from the SCS floor into the 
paracortex there is an increase in CCL21. This gradient is maintained by the atypical chemokine 
receptor CCRL1 expressed specifically on the lymphatic endothelial cells lining the ceiling of 
the SCS. CCRL1 binds CCL21, internalizing it and degrading it, maintaining low CCL21 
concentration in the SCS lumen. In mice deficient of CCRL1 this gradient is lost and DC 
migration across the SCS floor into the paracortex is inhibited116. 
 
All cells exiting the LN leave through the medullary sinus into efferent lymphatic vessels. Cells 
then rejoin the circulation through the thoracic duct. Egress from the parenchyma of the LN 
occurs predominantly in blind ended paracortical lymphatic sinuses in the paracortex, fluid in 
these vessels flows to the medullary sinus. The process of lymphocyte egress from LNs is 
dependent on the phospholipid S1P. Naïve T cells express the GPCR S1P receptor 1 (S1PR1) 
on their surface. Lymphatic endothelial cells express high levels of S1P kinase and thus make 
S1P that is released into the lymph117. T cells probe paracortical sinuses, upon binding S1P G 
protein signalling is activated driving the cell to enter the sinus. T cells then flow to the 
medullary sinus where they are released into the subcapsular space and egress through efferent 
lymphatic vessels118. Lack of S1PR1 expression blocks entry into the paracortical sinuses and 
thus lymphocyte egress from the LN, resulting in blood lymphopenia. B cell and plasma cell 
egress is also dependent in S1P-S1PR1 signalling119. 
 
 Early events in immune response generation in the lymph node 1.13
Soluble antigen rapidly drains to the LN within minutes, however APC that have phagocytosed 
antigen take a considerably longer period of time to migrate to the LN. This is due to a 
requirement for DCs to mature and up-regulate CCR7, required for entry into the lymphatics. 
The presence of antigen in the LN can lead to T and B lymphocyte activation, inducing the first 
steps in the adaptive immune response. T and B cell activation takes several days and requires 
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multiple signals and different cell types to ensure that the response is robust, goes on to develop 
memory and that inappropriate activation that could lead to autoimmune disease does not occur. 
 
1.13.1 T cell activation 
Upon exposure to inflammatory stimuli, or microbial products DCs change from immature, 
antigen-capturing cells, to mature, antigen presenting cells. This maturation includes up-
regulation of antigen processing machinery, MHC II, T cell stimulation molecules CD80/86 and 
chemokine receptors that allow them to migrate to the draining LN120. Migratory and resident 
mature DCs in the LN present MHC II restricted antigens or MHC I restricted antigens to naïve 
T cells. CD4+ T cells recognize MHC II via their T cell receptor (TCR). The CD4 co-receptor 
was thought to stabilise the interaction, however studies have found this is not the case, the co-
receptor functions to bring the src family kinase p56(lck) to the TCR121, this is an essential 
molecule for TCR signalling. This interaction is signal-1, the first signal required for T cell 
activation, however to fully activate T cells further stimulation is required. Dendritic cell 
CD80/86 molecules bind T cell CD28 thus co-stimulating the T cell and providing signal-2. 
Signals 1 and 2 trigger CD40 ligand (CD40L) expression on T cells, which binds CD40 on DCs 
promoting cytokine release, the third signal in T cell activation. The cytokine produced by the 
activating DC can determine which subset of TH cell the naïve cell differentiates into; TH1, TH2, 
TH17, regulatory T cell (Treg), follicular T helper (TFH) or regulatory TFH cell (TFR). The type of 
PAMP and tissue factors released by resident cells such as mast cells, epithelial cells and 
macrophages, determines DC polarisation and patterns of cytokines production122. 
 
Following activation, T cells undergo multiple rounds of cell division termed clonal expansion. 
During clonal expansion T cells differentiate into effector cells that migrate to the infection site 
and memory cells that protect against any future infection by the same pathogen123. Memory 
cells are divided into central memory (TCM) or effector memory (TEM) subsets, central memory 
T cells are in a quiescent state and are able to enter and patrol LNs through CD62L and CCR7 
expression. In contrast, effector memory T cells resemble effector T cells and produce effector 
cytokines, however they lack CD62L and CCR7, thus do not enter LNs. It is TCM cells that are 
thought to provide long-term antigen specific memory124. Upon exposure to the same antigen 
memory cells are able to respond through both effector function and proliferative capacity more 
rapidly than naïve T cells on a per cell basis. 
 
Clonal expansion is required to rapidly increase helper T cell numbers. This results in a pool of 
effector cells to directly fight the infection, however also a pool of cells required for the 
activation of other lymphocytes. T follicular helper cells are characterised by expression of high 
levels of CXCR5, permitting migration into B cell follicles where they are required for 
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activation of B cells. Cytotoxic CD8+ T cells also require T cell help for activation123. 
Activation of CD8+ T cells by DCs is similar to CD4+ T cell activation, requiring 3 signals, 
however DC ‘licensing’ by CD4+ T cells is also needed for effective CD8 activation through 
CD40 - CD40L signalling125. CD4+ T cells also provide help directly to the CD8+ cells through 
IL-2 and IFNγ, enabling their full differentiation into cytotoxic T lymphocytes (CTL)125. Upon 
activation CD8+ T cells also undergo clonal expansion, differentiating into CTLs and memory 
CD8+ T cells, with a key role in intracellular pathogen, virus and tumor clearance126. 
 
1.13.2 B cell activation 
Naïve B cells are located in organized follicle structures beneath the SCS. In response to antigen 
binding to the BCR, they migrate to the interface of the follicle and T cell zone, there they 
present antigen to CD4+ T cells. If the T cell recognizes the antigen through its TCR, then it 
provides the B cell with a survival and proliferation signal from CD40L, binding CD40 on the B 
cell. Proliferating B cells remain at the follicle edge and continue presenting antigens to CD4+ T 
cells for 2-3 days. The isotype of immunoglobulin the B cell will produce is guided by cytokine 
produced by TH1 and TH2 cells. TH1 IFNγ stimulates IgG2a, whereas TH2 IL-4 induces IgE 
production. Approximately 2-4 days after antigen exposure, the B cells then differentiate into 
GC B cells, memory B cells or short-lived plasma cells127. Germinal center B cells migrate into 
the follicle, guided by FDCs, and the GC forms. Germinal centers can last for many weeks 
depending on antigen availability and adjuvant. Germinal center B cells rapidly proliferate, 
undergo somatic hypermutation of their BCR variable region and Ig class switch recombination 
in a TFH cell dependent process. T follicular helper cells produce IL-21 and IL-4, and provide 
CD40L, which are essential signals for GC B cell survival, proliferation and persistence. 
Germinal center B cells either survive or undergo apoptosis depending on the strength of their 
BCR for foreign and self-antigens. Thus self-reactive antibodies generated by somatic 
hypermutation are eliminated by negative affinity selection in a FAS dependent process127. 
 
Germinal center B cells can differentiate into long-lived memory B cells or long-lived plasma 
cells. Plasma cells can survive and produce protective antibodies for years. Plasma cells migrate 
to lymphoid tissues including the LN medullary cords, red pulp of the spleen and the bone 
marrow. They reside in niches where BAFF and a proliferation-inducing ligand (APRIL) are 
provided by a number of cell types including medullary cord macrophages, CD11chi DCs, 
stromal cells in the spleen and bone marrow macrophages and stromal cells110. Plasma cell 
homing is mediated by CXCR4 expressed by plasma cells and CXCL12 by stromal cells127. 
 
Classically B cell activation occurs in response to thymus-dependent (TD) antigens, relying on 
T cells for help. However B cells can also activate in response to thymus-independent (TI) 
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antigens. This occurs in the splenic marginal zone and the intestinal lamina propria128. Thymus-
independent antigens are divided into type 1 and type 2 antigens. Thymus-independent type 1 
antigens, for example LPS, activate the BCR, but also B cell TLRs (in mice but not humans), 
thus inducing polyclonal B cell activation. Thymus-independent type 2 antigens are multivalent, 
for example S. pneumoniae capsular polysaccharide, or antigens with repeating epitope units. 
Thus multiple BCRs on one B cell bind the antigen resulting in receptor cross-linking, and 
inducing antigen-specific B cell activation129. Thymus-independent type 2 antigens can induce 
GCs and effector plasma cells, but not memory B cells or long lived plasma cells130. Thymus 
independent antigens generate low affinity IgM response that are highly potent at inducing 
complement mediated lysis of bacteria and have an important role in early protection to 
bacterial infection. 
 
 Lymph node function during inflammation 1.14
During the induction of adaptive immune responses in the LN there is an increased rate of 
lymphocyte migration into the LN. T cell clonal expansion and the proliferation of B cells in the 
GC reaction also helps drive the large net increase in the number of cells in the LN. Thus the 
LN needs to increase in size to accommodate an up to a tenfold increase in cellularity, a process 
termed LN hypertrophy. 
 
1.14.1 HEV network expansion 
To enable increased lymphocyte ingress into the LN rapid vasculature remodeling must occur. 
The HEV network expands, thus allowing entry of more lymphocytes, and vasodilation of 
capillaries permits entry of nutrients and oxygen into the LN. Inflammation can induce 
expansion of the HEV networks in LNs in a multi-step process. The initiation phase happens 
during the first two days post immunisation and involves rapid proliferation of blood 
endothelial cells resulting in a selective increase in the number and thus length of the HEV 
network. This proliferation is independent of B and T cells but reliant on vascular endothelial 
growth factor (VEGF) produced by FRCs. Fibroblastic reticular cell VEGF is produced upon 
LTβ receptor (LTβR) stimulation131 and resident CD11chi cells have a critical role in its 
upregulation132. The next phase is an expansion phase lasting 2-7 days, where continued HEV 
cell proliferation is dependent on B and T cell proliferation. After this phase the HEVs become 
quiescent with reduced proliferation and trafficking of lymphocytes through the HEVs. During 
the resolution of LN hypertrophy, FRCs tightly ensheath the HEVs leading to a reduced rate of 
lymphocyte entry into the LN, a process dependent on CD11chi cells. The depletion of these 
cells results in HEV proliferation, FRC disorganization and increased vascular permeability133. 
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The FRC network can also expand in response to inflammation, upon immunization with OVA 
in Complete Freund’s Adjuvant (CFA) the FRC network dramatically expands and remodels134. 
Expansion of the FRC network follows the same kinetics as HEV expansion132. However, these 
processes are entirely stimulation dependent and LN remodeling and HEV dynamics do not 
occur by these mechanisms in S. pneumoniae infection. This process is dependent on mast cell 
mediated secretion of histamine and TNFα that drives NO production by SSM, inducing rapid 
vasodilation of HEVs and FRCs. This permits rapid changes in LN size without stimulating 
proliferation of either HEVs or FRCs (Coles laboratory, unpublished data). 
 
1.14.2 Lymphangiogenesis in the draining lymph node 
During an inflammatory immune response lymphangiogenesis can lead to the growth of new 
lymphatic vessels throughout the LN changing its structural organization. This process enables 
increased numbers of DC and activated myeloid cells to enter the lymph node135. It also enlarges 
the size of the medulla to accommodate the increased numbers of plasma cells generated during 
an immune response136. Lymph node lymphangiogenesis in response to some inflammatory 
signals has been shown to be dependent on B cells135,136. In mice lacking B cells, or B cells that 
can’t home to the LN, lymphatic remodeling does not occur in these model systems, however in 
the absence of T cells or myeloid cells this process is intact. Blocking vascular endothelial 
growth factor receptor 2 (VEGFR-2) or VEGFR-3 or both reduces LN lymphatic growth, 
however does not block it. In another study, it was found that blockade of LTβR also decreased 
lymphatic remodeling, however does not block it. Thus it is likely that there is redundancy and 
that both VEGFR and LTBR signalling are involved in LN lymphangiogenesis, possibly other 
molecules could be involved too which makes interpretation of these results difficult. In these 
models there is an absolute role for B cells, possibly through the production of VEGF-A and 
LTα1β2, acting indirectly or directly on lymphatic endothelial cells135,136. However, these 
processes are very model dependent, in contrast to the published results we observe significant 
lymphangiogenesis in RAG deficient mice (no T or B cells) when mice are injected 
subcutaneously with adjuvants containing TLR4 adjuvants (monophosphoryl lipid A and 
glucopyranosyl lipid adjuvant; MPL and GLA). Thus the molecular mechanisms likely depend 
on the pathogen or adjuvant working by distinctly different mechanisms, consistent with 
multiple different mechanisms being involved depending on the type, duration and location of 
inflammation (Coles laboratory, unpublished data). 
 
During the initiation of an immune response a reduction in lymphocyte egress can accompany 
the increased influx of immune cells. A transient block in T cell egress is important to allow full 
activation of responding T cells and the expansion of the effector T cell pool, in a process 
termed lymph node ‘shut down’137. This works by an IFNα/β and S1P dependent process. Upon 
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T cell activation CD69 is transiently expressed at high levels on lymphocytes by both TCR 
stimulation and by type I interferons, CD69 binds to S1PR1 on the surface of the same cell, 
inducing receptor internalization of S1PR1. Thus the T cell is unresponsive to S1P and cannot 
exit the lymph node137,138. This block in lymphocyte egress lasts for several days, allowing time 
for clonal expansion of an effector T cell pool. Once CD69 expression is lost S1PR1 is then re-
expressed on the cell surface allowing T cells to respond to lymphatic S1P gradients and exit the 
lymph node. 
 
The stromal cell compartment must also remodel to accommodate the large numbers of 
accumulating lymphocytes. It has been proposed that the FRC cells proliferate, however in 
other model systems the FRCs stretch. In S. pneumoniae infection the FRCs stretch, rather than 
proliferate (Coles lab, unpublished data). This is likely a result of distal lung mast cell 
degranulation in regulating this process rather than being DC driven due to the early timing of 
this event. Collectively lymph node hypertrophy is a result of rapid changes to HEVs, stromal 
cells and the lymphatic network; however the mechanisms that drive this process are situation 
dependent.  
 
 Innate immune defenses in the lymph node 1.15
Lymph node macrophages form an important line of defense in the LN, removing pathogens 
and antigen entering the LN in the lymph. However these are not the only innate cells 
functioning to protect the LN. Natural killer cells, NKT cells, γδ T cells and innate-like CD8+ T 
cells can be found in LNs in steady state, positioned in the medulla and interfollicular regions. 
During skin infection with P. aeruginosa and Salmonella typhimuurium, tissue dLN 
macrophages stimulate these cells to produce IFNγ, which boosts macrophage antimicrobial 
resistance. If this axis is disrupted then systemic pathogen spread can occur139. Innate cells not 
only function to clear lymph pathogens, they are also involved in regulating immune responses. 
Certain adjuvants including AS01 (MPL/QS-21) induce tissue NK migration to the draining 
lymph node where they are an early source of IFNγ and thus involved in TH1 polarization140. In 
L. major infection NK cells were also found to produce IFNγ, and migrated to the paracortex 
where CD4+ T cell activation occurs141. During Schistosoma japonicum infection, NK and NKT 
cells migrate to the mesenteric lymph node where they activate and express IL-4 and IL-17 
cytokines115. Thus NK cells have an important role in early LN cytokine production and 
modulation of T cell polarization. NK cells were also found to directly interact with B cells 
where they migrate to and patrol the LN, in particular the follicle periphery. They can also form 
stable contacts with and eliminate MHC mismatched target B cells142. Neutrophils are also 
recruited to the LN in response to distal bacterial, fungal and parasitic infections and in response 
to vaccine challenge; the role of neutrophils in lymph nodes is explored in Chapter three. 
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 In vivo live cell imaging 1.16
Techniques such as flow cytometry, immunohistochemistry and quantitative polymerase chain 
reaction (Q PCR) provide us with lots of information about cells and how they respond in 
inflammation. However to gain a greater understanding of how cells function in their normal 
tissue environment live in vivo cell imaging is required. Since 2002, when pioneering works 
were published utilizing in vivo cell imaging to demonstrate live T cell dynamics and behavior 
in the thymus and LN143-145, the use of this technique has revolutionized and enhanced our 
understanding of how immune cells function, and the importance of tissue structure to their 
function. This permitted the discovery that paracortical T cells utilize FRCs to migrate along in 
order to scan for cognate antigen presented by DCs that adhered to the FRC network92,146. The 
intricacies of the neutrophil recruitment cascade; rolling, crawling, adhesion and abluminal 
crawling, and also swarming were all revealed through high-resolution in vivo live cell imaging 
techniques utilizing spinning disk and one and two photon (multiphoton) microscopy.  
 
1.16.1 Visualising cells 
To enable high resolution imaging of cells, in real time, laser scanning microscopy is used, 
however cells need to be tagged with fluorochromes or fluorescent proteins to visualise them. 
Cells can be labeled ex vivo with dyes such as carboxyfluorescein succinimidyl ester (CFSE), 
and then transferred back into the animal for visualization. This allows specific labeling of cells 
of interest, however the removal and manipulation of cells can often cause their activation, 
maturation or death, indeed only low percentages of adoptively transferred cells are observed, 
therefore this method is not ideal147. Injection of fluorochrome tagged monoclonal antibodies 
(mAb) can be used to label cells in situ, for example blood vasculature endothelial cells can be 
visualized by injection of mAbs to CD31 (PECAM1)24, however this approach requires large 
amounts of antibody that can drive immune responses to the antibody and inhibit protein 
function. Fluorescent reporter mice have been extensively used in in vivo imaging. The DNA 
encoding fluorescent proteins such as green fluorescent protein (GFP), DsRed fluorescent 
protein (RFP) is inserted into the gene of interest, when that gene is transcribed and translated, 
so is the fluorescent protein, thus the resulting protein of interest is labeled in situ with the 
fluorescent protein allowing its visualization. When investigating neutrophils, classically, 
LysM-GFP mice have been used. These are knock-in mice, where GFP is inserted into the 
lysozyme M (LysM) locus148. Lysozyme M is specifically expressed by myelomonocytic cells; 
macrophages and neutrophils with high levels in neutrophils. The drawback to fluorescent 
protein knock-in mice is that the target gene will likely be either knocked-out or miss-expressed 
potentially effecting cellular function. Thus the reporter mice can only be used as heterozygotes 
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to avoid impacting cell function. Alternatively tissue specific Cre reporter mice crossed with 
Rosa26, floxed fluorescent reporter mice can be utilised. 
 
1.16.2 Live cell imaging techniques 
Two techniques have commonly been used to image cells in situ; tissue explants and intravital 
imaging of live mice. Tissue explants involve the excision of the tissue of interest then imaging 
it whilst embedded in agarose or in culture medium. This allows access to the whole organ for 
imaging. This is a major advantage for tissues that are not easily accessible in a live animal, for 
example the thymus and certain LNs. Some tissue draining LNs can be difficult to image in situ, 
the hilum, where blood vasculature enters and lymphatics exit, is buried deep thus not easy to 
access without disrupting these vessels and other tissues147. However, in explant cultures there 
is no flow of blood, lymph, nutrients and oxygen or entry of cells in this system. This is a major 
limitation that may alter cell behavior. Intravital imaging has the major advantage in this 
respect. Tissues are imaged in situ, with intact blood and lymph flow, thus true in vivo cell 
behavior is observed. However movements of the animal as a result of breathing or muscle 
contractions can make it difficult to obtain high quality images. Additionally it is possible that 
anesthetics may impact on cell behavior, an effect that has been observed in sheep. Finally a 
drawback of surgery in intravital microscopy is the possibility of generation of inflammatory 
immune responses to the surgery, thus events observed may be responses specific to the 
surgery147. 
 
1.16.3 One and two-photon microscopy 
In confocal, single-photon microscopy, lasers emit single photons of light to excite the 
fluorescent tags. Emitted light is then focused through a pin hole that restricts out of focus light 
from above and below the focal plane reaching the detector. Therefore only light from the focal 
plane is detected, this generates high-resolution images. However the short wavelength of light 
used means penetration into tissue is low due to scattering of the laser and emitted light in the 
sample, thus deep tissue imaging is not possible147. Tissues that are thin and easily exteriorized, 
such as the cremaster muscle and mesentery are well suited to this method of microscopy. To 
image deep into tissue two-photon microscopy is utilised. Two-photon lasers emit two-photons 
of longer wavelength infrared light that are near simultaneously absorbed by fluorochromes. 
Their combined energy results in fluorescent light emission in the visible range149. The longer 
wavelength allows deeper tissue penetration due to reduced light scattering, however also 
reduces the resolution147. Single-photon microscopy causes tissue damage and photo-bleaching 
due to excitation of the whole sample. In two-photon microscopy this is limited due to the 
infrared photons simultaneously exciting fluorochromes in the focal plane only, the rest of the 
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tissue is only exposed to infrared light which is not harmful150. A further advantage of two-
photon microscopy is the ability to visualize fibrillar collagen without the need to label it due to 
secondary harmonic generation from the multiphoton laser. This provides a further layer of 
detail when investigating how cells move in 3D in the interstitial environment. It also highlights 
their impact on the collagen structure in tissue, for example neutrophils swarming in the dermis 
of the ear, in response to sterile laser-induced injury, move collagen fibers generating a 
collagen-free core at the swarm center33. 
 
Three-dimensional (3D) images are acquired by the laser scanning in x and y planes, followed 
by changing the focus to the microscope to image successive z planes, generating a z stack. The 
repetition of this process over time generates four-dimensional (4D) data to form a time-lapse 
movie. These movies can be analysed using software such as Imaris (Bitplane) and Velocity 
(PerkinElmer) to quantify cellular behavior, for example velocity, directionality and co-
localisation with other cells or molecules. 
 
 Summary and aims 1.17
Neutrophils are key innate immune cells, through a range of powerful mechanisms including 
phagocytosis, degranulation, NETosis and cytokine production neutrophils are essential for 
protection against bacterial, fungal, viral and protozoan pathogens. However they function 
further than first-line innate defenses and are capable of modulating both innate and adaptive 
immune cells. Thus they are capable of regulating other responding immune cells and thus the 
host immune response. Neutrophils are known to be terminally differentiated cells, generated 
and stored in the bone marrow and released as a mature cell. However it is clear that they are 
capable of adapting to the environment and the stimulus they encounter to alter their 
transcriptional profile, and thus generate the correct, specific tailored functional response.  
 
Using the model human pathogen, S. pneumoniae, this project aims to investigate neutrophil 
responses to pulmonary infection with this bacteria. Specifically, their recruitment to and 
function in the tissue draining, mediastinal LN, including differences in their phenotype and 
function in comparison to neutrophils in the blood and lung. Utilising fluorescent reporter mice 
and multiphoton laser scanning microscopy technology this project will also investigate 
neutrophil migration; their dynamics and the underlying mechanisms controlling their 
movement and migration in the lung draining LN. Much work has been done on neutrophil 
migration in vitro, and in vivo investigating their extravasation and interstitial migration, 
however little is known of their dynamics in secondary lymphoid organs. 
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 Hypothesis 1.18
We hypothesise that in response to pulmonary Streptococcus pneumoniae infection, in addition 
to a robust influx into the lung, neutrophils will also traffic to the LdLN. Neutrophil phenotype, 
function and migration mechanisms will be environment dependent rather than cell-intrinsic. 
The LdLN location will require adjustment of neutrophil phenotype from the highly activated, 
pathogen killing, destructive phenotype required at the site of infection, in order to avoid 
damage to the LdLN architecture, which could severely disrupt the development of a productive 
immune response. 
 
 Specific aims 1.19
• Define neutrophil recruitment kinetics to the LdLN during pulmonary Streptococcus 
pneumoniae infection. 
• Investigate neutrophil location within the LdLN. 
• Characterise neutrophil phenotype and function in the LdLN, and compare to blood and 
lung neutrophil phenotype. 
• Utilise an explant imaging system, in combination with multi-photon laser scanning 
microscopy, to investigate neutrophil dynamics in real time, in 3D. 
• Use pharmacological interventions, including GPCR antagonists, small molecule 
inhibitors and blocking antibodies to uncover some of the molecular mechanisms 
governing neutrophil migration within the LN. 
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Chapter 2: Materials and Methods 
2.1 Reagents 
Table 2.1: General reagents. 
Selected Reagents Brief Description/Use Supplier 
AccuCheck counting beads 
Absolute cell number quantification in flow 
cytometry. 
Invitrogen 
Agar 
Used to make BHI agar plates for S. 
pneumoniae culture. 
Fisher 
BHI broth S. pneumoniae culture medium. Oxoid 
BSA Used as a protein source for cells. Sigma-Aldrich 
CampyGen sachets 
Absorb oxygen, generate carbon dioxide, 
producing microaerobic conditions. 
Oxoid 
CellMask Deep Red Plasma membrane stain. Invitrogen 
Chamber slides 8 wells, No 1.5 glass.  Fisher 
Collagenase D 
Enzyme used in tissue digestion to degrade 
collagen. 
Roche 
Columbia horse blood agar 
plates 
S. pneumoniae culture. Thermo Scientific 
Cover slips 22 x 50 mm, No 1.5 glass. Fisher 
CTV Plasma membrane stain. Invitrogen 
DAPI Nuclear stain. Fisher 
DHR 123 ROS detection. Invitrogen 
DMEM medium Cell culture medium. Invitrogen 
DMSO Used to dissolve compounds. Sigma-Aldrich 
DNase1 
Endonuclease that cleaves DNA, used in 
tissue digestion. 
Sigma-Aldrich 
DTx Used in vivo to deplete DTR expressing cells. Sigma-Aldrich 
EDTA 
Used in FACS buffers and tissue digestion to 
prevent cation dependent cell-cell bonding. 
Fisher 
FCS Used as a protein source for cells. Thermo Scientific 
Fine bore polythene tubing Used to perform BAL. Smiths Medical 
Giemsa stain 
Used to visualise cell nuclear and cytoplasmic 
morpholgy. 
VWR 
Glass bottom dishes 
35 mm dish diameter, No 1.5 glass, 10 mm 
glass diameter. 
MatTek 
Corporation 
Goat serum 
Used to block non-specific Ab binding in 
IHC. 
Sigma-Aldrich 
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GoTaq Flexi DNA 
Polymerase 
Kit for PCR using GoTaq DNA polymerase 
and green GoTaq buffer. 
Promega 
Hematocrit capillary 
Sodium heparinized, used to collect exactly 
100 µl of blood. 
Hirschmann 
Laborgeräte 
Heparin Used for blood collection to prevent clotting. Sigma-Aldrich 
High Capacity cDNA 
Reverse Transcription Kit 
Kit containing reverse transcriptase for cDNA 
synthesis from RNA. 
Applied 
Biosystems 
ImmEdge Pen Wax pen used in immunohistochemistry 
Vector 
Laboratories 
MicroAmp Optical 96-well 
reaction plate 
96 well Q-PCR reaction plate. 
Applied 
Biosystems 
miRNeasy micro kit miRNA and RNA extraction kit. Qiagen 
OCT 
Tissue embedding material for tissue 
sectioning. 
Agar Scientific 
Optochin disks 
Used for the optochin sensitivity test to 
identify S. pneumoniae. 
Sigma-Aldrich 
PBS 
Sterile PBS used as vehicle for administering 
substances or bacteria to mice. 
GE Healthcare 
PHK26 Plasma membrane stain. Sigma-Aldrich 
Poly-L-lysine slides Used for frozen sectioning. VWR 
Power SYBR Green 
Master mix for Q-PCR containing AmpliTaq 
Gold DNA polymerase and SYBR Green. 
Invitrogen 
ProLong Gold Anti-fade reagent in IHC. Fisher 
QIAshredders 
Column for homogenising cell lysates before 
RNA extraction. 
Qiagen 
Rat IgG 
Polyclonal antibody used for Fc receptor 
blocking in flow cytometry. 
Sigma-Aldrich 
RNeasy mini kit RNA extraction kit. Qiagen 
RPMI medium Cell culture medium. Invitrogen 
Titertube micro test tubes Used as flow cytometry tubes. Bio-Rad 
TruStain fcX 
anti-mouse CD16/32 Ab, Rat IgG2a, clone 93, 
used for Fc receptor blocking in flow 
cytometry. 
Biolegend 
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Table 2.2: Primary antibodies. 
Specificity Fluorophore Clone Host Isotype Supplier Use 
CD11b PE Cy7 M1/70 Rat IgG2b Biolegend FC 
CD11c A647 N418 
Armenian 
Hamster 
IgG eBioscience 
FC, 
IHC 
CD169 FITC MCA884F Rat IgG2a AbD Serotec IHC 
CD4 PB RM4-5 Rat IgG2a eBioscience FC 
F4/80 A647 BM8 Rat IgG2a eBioscience 
FC, 
IHC 
F4/80 PB BM8 Rat IgG2a Biolegend 
FC, 
IHC 
Gr1 PE RB6-8C5 Rat IgG2b BD Pharmingen FC 
ICAM-1  PE YN1/1.7.4 Rat IgG2b eBioscience FC 
Ly6C PE HK1.4 Rat IgG2c Biolegend FC 
Ly6C PerCP Cy5.5 HK1.4 Rat IgG2c Biolegend FC 
Ly6G A647 1A8 Rat IgG2a Biolegend 
FC, 
IHC 
Ly6G FITC 1A8 Rat IgG2a Biolegend 
FC, 
IHC 
Lyve-1 purified Poly Rabbit IgG AngioBio Co. IHC 
MECA79 A488* MECA79 Rat IgM Nanotools IHC 
MHC II e450 M5/114.15.2 Rat IgG2b eBioscience FC 
MHC II PE M5/114.15.2 Rat IgG2b Biolegend FC 
SIGNR1  A647 eBio22D1 
Armenian 
Hamster 
IgG eBioscience IHC 
TCRB FITC H57-597 
Armenian 
Hamster 
IgG eBioscience FC 
* labelled in house by Lisa Newman using an Invitrogen Alexa488 labelling kit 
 
Table 2.3: Secondary antibodies. 
Specificity Fluorophore Clone Host Supplier Use 
Rabbit IgG (H+L) A594 Polyclonal Goat Invitrogen  IHC 
Rat IgG (H+L) A647 Polyclonal Goat Invitrogen  FC 
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Table 2.4: In vivo and ex vivo use antibodies. 
Specificity Clone Host Isotype Supplier 
CD11b* M1/70 Rat IgG2b eBioscience 
Ly6G 1A8 Rat IgG2a Bioxcel 
Isotype 2A3 Rat IgG2a Bioxcel 
* Functional grade purified.     
 
Table 2.5: Primers for quantitative PCR. 
Gene Refseq Direction  Sequence 
Hprt NM_013556.2 Forward AGGAGTCCTGTTGATGTTGCCAGT 
  
Reverse GGGACGCAGCAACTGACATTTCTA 
Ifng NM_008337.3 Forward CGGCACAGTCATTGAAAGCCTA 
  Reverse 
GTTGCTGATGGCCTGATTGTC 
Mmp9 NM_013599.3 Forward GTCCAGACCAAGGGTACAGC 
  
Reverse ATACAGCGGGTACATGAGCG 
Nos2 NM_010927.3 Forward TTCACAGCTCATCCGGTACG 
  
Reverse CGATGCACAACTGGGTGAAC 
Ptgs2 NM_011198.3 Forward ACTCATAGGAGAGACTATCAAG 
  
Reverse GAGTGTGTTGAATTCAGAGG 
S100a8 NM_013650.2 Forward GTCCTCAGTTTGTGCAGAATATAAA 
  
Reverse TTTGTGAGATGCCACACCCA 
S100a9 NM_001281852.1 Forward TAGCCTTGAGCAAGAAGATGGC 
  
Reverse TTATGCTGCGCTCCATCTGA 
Tnf NM_013693.3 Forward CTGTAGCCCACGTCGTAGC 
  
Reverse TTGAGATCCATGCCGTTG 
Tnfsf13 NM_001159505.1 Forward TGGAAGGATGGGGCGAAATC 
  
Reverse TGTCACGTCAGAGTCCTTGG 
Tnfsf13b NM_033622.1 Forward GCTGGAGTCAAACTCCTGACA 
    Reverse GCTGCAGACAGTCTTGAATGAT 
 
2.2 Mice 
C57BL/6, B6J.CD45.1, B6.CX3CR1GFP/GFP151, B6.IL-7 Cre152, B6.Rosa26 eYFP153, B6.hCD2-
DsRed.B154,155, B6.LysM Cre156, B6.Rosa26 mT/mG157, B6.CD11c Cre158, B6.Rosa26 iDTR159 
mice were bred and housed in microisolator cages in the Biological Services Facility (BSF) at 
University of York, under specific pathogen-free conditions. All mice used were between 7-12 
weeks of age, all strains were on a C57BL/6 background (Harlan, NIMR or Jackson) with a 
minimum of 6-8 backcrosses. B6.IL-7 Cre transgenic mice were crossed with B6.Rosa26 eYFP 
mice, Cre negative Rosa26 eYFP negative mice and B6.hCD2-DsRed.B mice were used as wild 
type control mice in experiments where tissue was taken for histology. B6.CD11c Cre mice 
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were crossed with B6.Rosa26 iDTR mice and also B6.Rosa26 mT/mG to generate B6.CD11c 
Cre x B6.Rosa26 iDTR F1 and B6.CD11c Cre x B6.Rosa26 mT/mG F1 progeny. B6.LysM Cre 
mice were crossed with B6.Rosa26 mT/mG mice to generate B6.LysM Cre x B6.Rosa26 
mT/mG F1 progeny. B6.CX3CR1GFP/GFP mice were crossed with C57BL/6 mice to generated 
B6. CX3CR1GFP/+ heterozygous mice with a functional CX3CR1 receptor. CX3CR1 
heterozygous mice were used in experiments. All animal procedures were performed under UK 
Home Office license 60/4129 (Mark Coles) in compliance with the ARRIVE guidelines. 
 
2.3 Bacteria 
2.3.1 Streptococcus pneumoniae culture 
Streptococcus pneumoniae Glasgow strain D39 was a gift from Dr. Andreas Wack (National 
Institute for Medical Research). S. pneumoniae was cultured in brain-heart infusion broth (BHI) 
(Oxoid). Forty microliters of S. pneumoniae frozen glycerol stock was inoculated into 5 ml of 
BHI broth and incubated overnight (approximately 16 hours) at 37°C under anaerobic 
conditions; in an anaerobic jar containing one CampyGen sachet (Oxoid) to scavenge oxygen. 
The next day 5 ml of fresh BHI broth was inoculated with 100 µl of the overnight culture and 
incubated for 3-4 hours at 37°C. One milliliter of culture broth was sampled and the optical 
density (OD) at 600 nm determined by spectroscopy. When the OD600 was 0.4-0.6 the cultures 
were considered to be in log phase growth, once they reach this OD the cultures were spun 
down for 10 min at 2000 g at 4°C. The bacteria pellets were resuspended in BHI broth 
containing 30% glycerol. One microliter was removed for colony forming unit (CFU) 
determination on BHI agar plates, cryovials containing the stock bacteria were then placed at -
20°C until required for in vivo infections. Bacteria were stored for no more than 24 hours before 
use, with one exception where bacteria were stored for three days for a time course experiment. 
 
To prepare the bacteria for infection, an aliquot of bacteria from the stock corresponding to 
approximately 108 CFU/mouse (based on CFU calculation) was resuspended in sterile 
phosphate-buffered saline (PBS) and washed twice (10 min at 2000 g, 4°C) to remove any 
remaining traces of broth. The bacterial pellet was then resuspended in sterile PBS at a density 
of 108 CFU in 50 µl. This working bacterial stock was used for intranasal infection. One 
microlitre of bacteria was taken to check the CFU. Due to the freezing step following culture, 
prior to infection, the CFU of S. pneumoniae that infects the lung was often lower than 108 and 
sometimes closer to 107. The lower CFU induced fewer neutrophils to migrate to the lung 
draining LN (LdLN). This could not be avoided due to the method used to culture the bacteria 
and short time points between infections required for the project; however this variability was 
captured and quantified for all experiments undertaken. 
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2.3.2 CFU calculation 
To calculate CFU, a 1 µl aliquot of S. pneumoniae culture was diluted to 1 in 100,000 and 1 in 
1,000,000 in BHI broth. Fifty microliters of the diluted culture was added to a BHI agar plate 
and spread using sterile glass beads. The plates were incubated overnight at 37°C in anaerobic 
conditions. Agar plates with approximately 30-300 colonies on were counted (Figure 2.1 A) and 
number of CFU calculated as follows: 
 
CFU/ml = No colonies/0.05 * dilution factor 
 
2.3.3 Heat-killed S. pneumoniae 
In explant imaging experiments heat-killed (HK) S. pneumoniae was used. Once the S. 
pneumoniae culture had reached OD600 0.4-0.6 it was spun down as described above, the pellet 
was resuspended in 1 ml of sterile PBS and incubated at 60°C for 20 min. The HK S. 
pneumoniae was subsequently spun down and resuspended in sterile PBS. HK S. pneumoniae 
was stored at 4°C for no longer than 5 days. To demonstrate that the S. pneumoniae was heat 
killed, 20 µl of HK S. pneumoniae was spread on Agar plates and cultured overnight. No 
colonies grew, demonstrating that incubation at 60°C for 20 min was sufficient to HK the 
bacterial culture (Figure 2.1 B). 
 
2.3.4 S. pneumoniae validation 
To ensure that the bacterial culture only contained S. pneumoniae and not closely related 
Streptococcus or Staphylococcus strains with similar morphologies two tests were carried out; 
the optochin sensitivity test, and culture on blood agar. S. pneumoniae are exclusively sensitive 
to optochin antibiotic. When cultured on blood agar S. pneumoniae form small grey colonies 
with a zone of alpha-hemolysis around them that is green. The alpha-hemolysis is caused by the 
pneumolysin they produce that lyses red blood cells. Figure 2.1 (C) shows that a zone of 
inhibition of 18 mm was observed around optochin disks (Sigma) after 24 hours of culture on a 
Columbia horse blood agar plate (Thermo Scientific). The colonies on Columbia horse blood 
agar were characteristic of S. pneumoniae; small and grey, with clear alpha-hemolysis around 
them (Figures 2.1 D-F). Thus the bacterial cultures could be verified to be S. pneumoniae. 
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Figure 2.1: Streptococcus pneumoniae culture and verification. 
(A) Representative image of 1:1,000,000 dilution of S. pneumoniae culture plated on BHI agar. 
(B) Confirmation of heat inactivation of S. pneumoniae. (A); before, (B); after heat inactivation 
at 60°C, 20 min. (C) Optochin sensitivity test. Validation of S. pneumoniae culture was 
demonstrated by zone of inhibition of 18 mm. (D) S. pneumoniae colonies on Columbia horse 
blood agar plates at 24 hours. (E) Close up of plate in (D), α haemolysis was visible around the 
colonies. (F) Plate in (D) at 48 hours, α haemolysis around S. pneumoniae colonies was clear. 
A B 
C D 
E F 
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2.3.5 Fluorescent labeling of S. pneumoniae 
Heat killed S. pneumoniae were labeled with either PKH26, CellTracker Violet (CTV), or 4′, 6-
Diamidino-2-phenylindole dihydrochloride (DAPI). PKH26: Heat killed S. pneumoniae were 
resuspended in 5 ml Diluent C from the PKH26 labeling kit (Sigma). In a separate tube 20 µl 
PKH26 was added to 5 ml Diluent C, this was added to the HK S. pneumoniae in Diluent C and 
incubated at room temperature for 5 min, whilst gently rocking. Ten milliliters of fetal calf 
serum (FCS) was added and incubated for a further 5 min, this time at 37°C. Next, 20 ml of 
Roswell Park Memorial Institute medium (RPMI) containing 5% FCS was added and bacteria 
spun down. The bacteria were washed a further two times in sterile PBS. The supernatant was 
collected each time and spun down again to reduce the amount of HK S. pneumoniae lost during 
the spins. CTV: Heat killed S. pneumoniae were resuspended in 5 ml of sterile PBS containing 1 
in 2500 dilution of CTV (Invitrogen) and incubated at 37°C for 30 min. Bacteria were spun 
down then resuspended in 5 ml PBS 5% FCS, and incubated at 37°C for 30 min. The bacteria 
were then washed twice in sterile PBS. As with the PKH26 spin steps, supernatant was 
collected each time and spun down again. DAPI: During the PKH26 and CTV labeling many of 
the bacteria were lost during the labeling process. Thus DAPI (Fisher) was used as an 
alternative due to fewer incubations and wash steps required. Heat killed S. pneumoniae were 
resuspended in 5 ml sterile PBS containing 1 in 5000 dilution of DAPI and incubated at room 
temperature for 5 min. The bacteria were then washed twice in sterile PBS 
 
2.3.6 Intranasal administration of S. pneumoniae 
Mice were anaesthetised in an anesthetic chamber using isoflurane (3%) at a flow rate of 2 
liter/min. Fifty microliters of S. pneumoniae (alive or HK) in PBS (or PBS alone as a vehicle 
control) was administered onto the nostrils of the mouse. The mouse was held horizontal until 
all the liquid was inhaled and the mouse had regained consciousness. The mouse was then 
returned to the cage and observed until it had fully recovered. 
 
2.4 Tissue and Sample collection 
Blood: Exactly 100 µl of blood was taken from tail vein using a sodium heparinized glass 
hematocrit capillary (Hirschmann Laborgeräte). The blood was placed in a 1.5 ml Eppendorf 
that had been coated in heparin and contained 100 µl of heparin. This was put on ice. The 
mouse was then sacrificed straight after using CO2, death confirmed by exsanguination after 
cutting the vena cava. This is a schedule 1 kill methodology as approved by the UK Home 
Office. 
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Bronchiolar lavage (BAL) fluid: After the mouse was S1K the neck was exposed and muscle 
trimmed away to expose the windpipe. Using forceps approximately 10 cm of cotton was pulled 
through underneath the windpipe. A small hole was made in the windpipe using a scalpel blade, 
a BAL tube was then placed into the windpipe and secured using the cotton. The BAL tube was 
made of a 2 cm length of 0.58 mm diameter (inner diameter) fine bore polythene tubing (Smiths 
Medical) with a 23-gauge needle inserted at one end. A 1 ml syringe containing 500µl of PBS 
0.25% bovine serum albumin (BSA) was attached to the BAL tube and then the lungs inflated 
with the liquid. The rib cage was massaged before the liquid was removed using the syringe. 
The BAL fluid was collected in a 15 ml flacon tube. The lavage was repeated a total of four 
times giving approximately 2 ml of BAL fluid. This was placed on ice. 
 
Lungs and LdLN: The vena cava was cut (if not already done) and chest cavity was opened. 
Five milliliters of PBS was injected into the right ventricle. This inflated the lungs and flushed 
out blood in the vasculature. At this point the LdLN was excised and placed in 500µl RPMI 2% 
FCS on ice. The lungs were then removed and placed in 2ml RPMI 2% FCS on ice. 
 
2.5 Flow Cytometry 
2.5.1 Sample preparation 
Buffers: 
• Red blood cell (RBC) lysis buffer; 0.15 M NH4Cl, 1 mM NaHCO3 and 0.1 mM 
ethylenediaminetetraacetic acid (EDTA). 
• Fluorescence-activated cell sorting (FACS) buffer/wash; PBS 0.5% BSA, 2 mM EDTA. 
• Digestion buffer; RPMI 2% FCS, 2.5 mg/ml Collagenase D and 1.7 µg/ml DNase I. 
 
A wash step refers to the resuspension of cells in FACS wash, centrifugation at 300 g for 5 min 
at 4°C, then removal of the supernatant.  
 
Blood: To lyse the RBCs 1 ml of RBC lysis buffer was added directly to the blood and 
resuspended, then incubated for 5 min at room temperature. Three hundred microliters of FACS 
wash added to the tube, then spun at 1500 rpm in the microfuge for 5 min. The leukocyte pellet 
was washed and resuspended in FACS wash, the cells were then pipetted into a V-bottom 96 
well plate ready for antibody staining. 
 
BAL fluid: Samples were spun down in a centrifuge for 5 min, 4 °C at 300 g. The supernatant 
was removed, then if needed RBCs lysed using RBC lysis buffer. BAL fluid cells were then 
washed, resuspended in FACS wash, then pipetted into a V-bottom 96 well plate. 
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Lungs: Lungs were diced in a petri dish using a scalpel, then transferred to a 15 ml falcon tube 
containing 2 ml of digest buffer and incubated at 37°C in a water bath for 30 min, vortexing 
every 10 min. At the end of the incubation the lung homogenate was poured into a 70 µm cell 
strainer in a petri dish and crushed using the end of a 2.5 ml syringe plunger. The strainer was 
then placed in the top of a 50 ml falcon tube, the lung cell suspension was passed through the 
strainer a second time, into the falcon tube. The cell suspension was washed then RBC lysis 
performed. The cells were then washed, resuspended in FACS wash and pipetted into a V-
bottom 96 well plate. 
 
LdLN: In a petri dish, in 500 µl of digestion buffer LdLNs were teased apart using forceps. The 
pieces of LdLN and digest buffer were then transferred into a 1.5 ml Eppendorf tube and 
incubated at 37°C for 10 min, whilst shaking at 1400 rpm. Five microliters of 0.5 M EDTA was 
added and the LdLN suspension resuspended thoroughly to break up any remaining pieces of 
tissue. If there were large undigested pieces left then the sample was incubated for a further 5 
min at 37°C, shaking. The suspension was passed through a 70 µm cell strainer into a 15 ml 
falcon tube. The cells were washed, resuspended in FACS wash, and pipetted into a V-bottom 
96 well plate. 
 
2.5.2 Reactive oxygen species detection 
Reactive oxygen species production by neutrophils was investigated by flow cytometry using 
dihydrorhodamine 123 (DHR 123, Invitrogen). Dihydrorhodamine 123 is non-fluorescent and 
cell permeable. Inside the cell it is oxidized by ROS to rhodamine 123, which is fluorescent. 
Neither NO, superoxide or hydrogen peroxide are able to do this, thus the effect is specific to 
ROS. After single cell suspension preparation, cells in the 96 well plates were resuspended in 
RPMI 2% FCS containing 5 µM DHR 123 (Invitrogen) and incubated at 37°C for 30 min. Cells 
were then washed twice and stained for surface markers. Care was taken to keep samples in the 
dark. 
 
2.5.3 Surface marker antibody staining for flow cytometry 
Flow cytometry staining was performed in a V-bottom 96 well plate. Cells were first 
resuspended in 100 µl Fc block mix made up in FACS wash and incubated for 10 min on ice (or 
at 4°C). The Fc block mix included TruStain fcX (rat anti-mouse CD16/32 antibody) used at a 
dilution of 1:200 (BioLegend) and rat IgG, 10 µg/ml (Sigma). Following the incubation the 
plate was spun for 5 min, 4 °C, 300 g and supernatant discarded. Cells were then resuspended in 
100 µl of antibody staining master mix containing fluorescent labeled monoclonal antibodies 
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(mAbs) in FACS wash and incubated for 25-30 min on ice (or at 4°C) in the dark. Single stain 
controls were also prepared; samples were stained with a single mAb used in the master mix, at 
the same concentration used in the master mix. A list of all antibodies used is detailed in Table 
2.2. Cells were washed twice, resuspended in 200 µl FACS wash and transferred into micro 
tubes (Titertube micro test tubes, Bio-Rad) then put on ice. The samples were run on a 
Beckmann Coulter CyAn ADP flow cytometer using the software Summit (Beckmann Coulter). 
Flow cytometry data was analysed using FlowJo (Treestar) software.  
 
2.5.4 Live cell/dead cell discrimination  
Following the first wash after antibody staining cells were resuspended in 100 µl of PBS 
containing DAPI (a 1:5000 dilution), then incubated for 5 min at room temperature in the dark. 
Cells were then washed and resuspended in 200 µl FACS wash and transferred into micro tubes 
and kept on ice. The samples were run on a Beckmann Coulter CyAn ADP flow cytometer with 
the acquisition boost turned off. 
2.5.5 Calculating total cellularity using flow cytometry 
Accucheck counting (Invitrogen) beads were used to calculate accurately total cellularity of 
samples. Following antibody staining pellets were resuspended in 100 µl FACS wash and 
transferred into micro tubes. Counting beads were mixed for 1 min using a Pasteur pipette to 
ensure beads were evenly resuspended, then, 100 µl of beads was added to each tube. The cell 
and bead suspension was resuspended thoroughly before running on the flow cytometer. The 
counting beads have very low forward scatter so during acquisition there was very low 
threshold applied (0.5%). Figure 2.2 shows the counting beads on a flow cytometry plot. To 
ensure accuracy the beads are made up of two types of beads that differ in their fluorescent 
intensity in the FL2 channel. The beads should be at an approximate 50:50 ratio for the 
calculated cell number to be accurate (the exact ratio and accepted limits of difference vary 
between lots). The right hand plot in Figure 2.2 demonstrates this. To calculate cell number 
beads were gated on, the cell population of interest, for example neutrophils, was also gated on 
to obtain the number of events acquired. The following calculation was then made:  
 
The number of beads per µl was provided on the information with the counting beads. The total 
cellularity could be calculated using the value of cells per µl and final volume of FACS wash 
that containing the cells. 
 
  
Number of cells per µl = 
Number of events 
Number of events (beads) 
× Number of beads per µl  
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Figure 2.2: AccuCheck counting beads were used to calculate absolute cell number by flow 
cytometry. 
Representative flow cytometry plots. AccuCheck counting beads were added to flow cytometry 
samples after staining. The beads had high side scatter (SS) and low forward scatter (FS), as 
shown in the plot on the left. The counting beads were made up of two sets of beads with 
different fluorescent intensities in the FL2 channel. The near 50:50 ratio of the beads indicated 
that they had been homogeneously mixed. 
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2.6 Cell sorting 
Pure populations of neutrophils were obtained from blood, BAL fluid, lungs and LdLNs of S. 
pneumoniae infected mice using cell sorting. To ensure sufficient numbers of neutrophils were 
collected samples from 5-10 mice were pooled. Samples were processed and stained for flow 
cytometry as described in section 2.5; however the samples were not stained in a 96 well plate, 
but a 15 ml falcon tube. After staining the cells were resuspended at a density of 107 cells/ml in 
FACS wash and placed on ice. Cells were sorted into PBS 10% FCS using a Beckman Coulter 
MoFlo Astrios. A purity sort was performed, Figure 2.3 (A) shows the sorting strategy used. 
Following sorting an aliquot of sorted cells was run on the cell sorter to check the purity (Figure 
2.3 B). Table 2.6 summarises the purity of each sample sorted. 
 
Table 2.6: Purities of sorted neutrophils. 
  Population purity (%) 
  Sample 1 Sample 2 Sample 3 
Blood neutrophils 88 97 94 
Lung neutrophils 96 Not done 96 
BAL neutrophils 98 99 97 
LdLN neutrophils 75 97 94 
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Figure 2.3: Cell sorting neutrophils using flow cytometry. 
Representative flow cytometry sort plots. (A) Gating strategy used for cell sorting neutrophils, 
cells in the purple box were sorted. (B) Post-sort analysis of cells sorted in (A). A 99% pure 
neutrophil population had been sorted. Table 2.6 contains the purities of all populations sorted 
and used in Q-PCR experiments. 
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2.6.1 Giemsa staining 
Sorted cells were spun down at 300 g for 10 min at 4 °C. The supernatant was removed and 
cells resuspended at a density of 105 cells in 30 µl. Thirty microlitre aliquots of each sample 
were placed on a poly-L-lysine coated microscope slide (VWR). The slide was then left to dry 
overnight. The cells were fixed using 100% methanol, methanol was dropped gently over the 
slides using a Pasteur pipette until the slide was covered. The methanol was then left to 
evaporate in the fume hood overnight. The slides were submerged in Giemsa stain (VWR), 
diluted 1 in 10 in dH2O, and incubated at room temperature for 30 min. The Giemsa was 
washed off with water from a tap and slides left to dry before mounting coverslips using DPEX 
mounting medium (Sigma-Aldrich). The slides were imaged using a Zeiss light microscope. 
Images were processed using Volocity image analysis software (PerkinElmer). 
 
2.7 Quantitative PCR 
2.7.1 RNA extraction 
Sorted cells were spun down at 300 g for 10 min at 4 °C. Supernatant was removed, taking care 
to remove as much as possible. The cells were then lysed using RLT buffer (Qiagen); the cells 
were resuspended in 350 µl RLT buffer, ensuring all the cells were resuspended. If the number 
of cells collected was less than 1 × 105 only 75 µl RLT buffer was used, however if 5 × 106 to 1 
× 107 cells were collected 600 µl RLT buffer was used. The lysates were then stored at -20°C 
overnight. The next day RNA extraction was performed using an RNeasy mini kit (Qiagen) 
following the manufacturer’s instructions. For the samples resuspended in 350 µl or more RLT 
buffer, lysates were first passed through a QIAshredder column (Qiagen). For the samples with 
low cell number (< 1 × 105) the same RNA extraction protocol was followed, however spin 
columns from a miRNeasy micro kit (Qiagen) were used. This kit is designed for small cell 
numbers, with the final elution performed in a volume of 15 µl as opposed to 30 µl used for the 
RNeasy columns. Thus the RNA was less dilute. The quality and quantity of RNA was 
measured using a NanoDrop spectrophotometer, RNA samples were deemed suitable for use if 
the 260/230 nm ratio was above 1.8. Samples were then stored at -80°C 
 
2.7.2 Complementary DNA synthesis 
One microgram of RNA was diluted in nuclease free water to a final volume of 10 µl. In most 
samples the yield of RNA was low, less than 1 µg total, thus for these samples 10 µl of the RNA 
extract was used. The RNA was then mixed with 10 µl of a reverse transcriptase (RT) master 
mix made up of 4.2 µl H20, 2 µl RT Buffer, 0.8 µl dNTP mix, 2 µl RT Random Primer and 1 µl 
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MultiScribe RT from a High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). 
Samples were placed in a thermo cycler PCR machine for cDNA synthesis. The thermo cycling 
conditions were 10 min at 25°C, 120 min at 37°C, 5 min at 85°C, the machine then stayed at 
4°C until samples were removed. At the end of the synthesis samples were made up to 100 µl 
with nuclease free water and stored at -20°C. Two batches of cDNA were made for each 
sample; these were pooled together for use in Q-PCR. 
 
2.7.3 Primer design 
Primers suitable for SYBR Green Q-PCR were designed using Primer BLAST software (NCBI) 
and ordered from Sigma. Primers were designed to span an exon-exon junction, in order to 
decrease the chance of genomic DNA amplification, have a melting temperature (Tm) of 60 °C ± 
1, and have a resulting product length of 60-250 base pairs. Primers to Ptgs2 were pre-designed 
by Sigma. 
 
2.7.4 Primer testing 
Primers were hydrated using nuclease free water to 100 nM concentration. A 10 nM aliquot of 
each primer was then made; this was the primer working stock. Primers were stored at -20°C. 
To test the optimum melting temperature (Tm) of the primers, and to check they were specific a 
gradient PCR was performed using GoTaq polymerase in green buffer (Promega). Following 
the PCR, products were run on a 2% agarose gel containing ethidium bromide. Single bands 
corresponding to the expected product length indicated that the primers were specific. Primers 
generating multiple PCR products were discarded. All primers worked optimally at Tm 60°C, 
except the Ptgs2 primers, optimum Tm was 62°C. Table 2.5 lists the gene targets of the primers 
used and their sequences. 
 
2.7.5 Q-PCR reaction 
Power SYBR Green PCR Master Mix (Invitrogen) was used for Q-PCR. Each cDNA sample 
was run in triplicate. Hprt was used as the endogenous control gene, as all the Q-PCR reactions 
were completed over two days the plates were designed so that two genes were tested per plate, 
with Hprt only on one of the plates. The same machine, batch of nuclease-free water, primers 
and Power SYBR Green Master Mix was used to limit variation. Reactions using Ptgs2 primers 
required a different Tm (62°C), thus were run on a separate plate with Hprt repeated, but at Tm 
62°C. The Q-PCR mix was made up of 12.5 µl Power SYBR Green, 1 µl forward primer, 1 µl 
reverse primer, 6.5 µl nuclease free water and 3 µl cDNA and added to a MicroAmp Optical 96-
well reaction plate (Applied Biosystems). Control samples of Q-PCR mix containing no cDNA, 
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or no RT samples were included in triplicate for each gene. The plate was loaded onto an 
Applied Biosystems 7300 real-time PCR machine and the Q-PCR reaction run. The reaction 
cycles were 2 min at 50°C, 10 min at 95°C, 15 sec at 95°C repeated 40 times, then 1 min at 
60°C.  
 
2.7.6 Q-PCR data analysis 
Raw Ct values were used to calculate average Ct values and the standard deviation. Values for 
each gene tested were normalized to Hprt values for the same sample. This was done to try to 
avoid differences due to different quantities of cDNA in the samples. The values were then 
analysed to get the relative quantity (RQ) of mRNA transcripts for the genes of interest in BAL, 
lung and LdLN samples compared to blood neutrophil samples. To do this, the ΔΔCt values 
were calculated using one of the blood samples as a calibrator (sample 2 was used as it had most 
consistently the smallest standard deviation), then subtracting each samples ΔCt value from this. 
The fold change, or RQ was then calculated; RQ= 2- ΔΔCt. 
 
2.8 Immunohistochemistry 
2.8.1 Tissue preparation and frozen sectioning 
Lung draining lymph nodes were removed and placed in RPMI 2% FCS on ice. Using a 
dissecting microscope any pieces of fat or connective tissue were carefully removed, with care 
taken not to damage the LdLN. The tissue was then fixed by incubation in PBS 4% 
paraformaldehyde (PFA) at room temperature for 10 min, in the dark if the tissue contained 
fluorescent protein. Tissues were transferred to PBS 30% sucrose and incubated for at least 4 
hours at 4°C, then in PBS 60% sucrose at 4°C overnight. The tissues were then embedded in 
optimal cutting temperature medium (OCT, Tissue-Tek, Sakura Finetek) on dry ice, wrapped in 
foil, then stored at -80°C. Optimal cutting temperature medium embedded tissue was sectioned 
using a cryostat. Six micrometer sections were cut and collected onto poly-L-lysine coated 
microscope slides. Sections were dried overnight, in the dark if necessary, then stored at -20°C. 
 
2.8.2 Immunofluorescent staining of frozen tissue 
Lung draining lymph node sections on poly-L-lysine coated microscope slides were removed 
from -20°C and brought to room temperature on the bench. If fluorescent protein was present 
the sections were kept in the dark thought the protocol. A circle was drawn around each section 
using a wax ImmEdge pen (Vector Laboratories), the sections were then hydrated and washed 
in PBS. Each wash step involved the slides being submerged in PBS for 15 min in total, with 
   
 68 
changes of PBS ever 5 min. The sections were incubated in a blocking buffer of PBS 5% serum, 
at room temperature for 5 min. This was to prevent non-specific antibody staining. The serum 
of the host the secondary antibody was raised in was used; this was usually goat serum (Sigma). 
After blocking, sections were incubated in the primary antibody mix, made up in blocking 
buffer for 1 hour at room temperature. The slides were then washed. If needed, a further 
incubation with a secondary antibody was performed for 1 hour at room temperature. The slides 
were then washed and residual PBS removed using a tissue. A drop (approximately 10 µl per 
slide) of ProLong Gold (Invitrogen) was added to each section, then a No 1.5 glass coverslip 
(Fisher) mounted on top. The slides were incubated overnight at 4°C. The next day the slides 
were sealed using nail varnish. Stained slides were stored at 4°C. Images were processed using 
Volocity software (PerkinElmer). Tables 2.2 and 2.3 lists all antibodies used in frozen section 
staining. 
 
2.8.3 Confocal microscopy 
Immunofluorescent stained sections were imaged using the Zeiss LSM 710 confocal 
microscope on an Axio Observer.Z1 invert, and Zen software (Zeiss). The microscope had 5 
lasers, 7 laser lines; 405, 458, 488, 514, 561, 594 and 633 nm. Positioning of the sample and 
area of interest was done using the 20x objective; image acquisition was performed using the 
40x oil objective. In most experiments 4 laser lines were used and acquired individually, these 
were the 405, 488, 594 and 633 nm lines. Tile scans were performed to image the whole tissue. 
Images were processed using Volocity software. 
 
2.9 Multiphoton explant imaging 
2.9.1 Explant tissue preparation 
The LdLN was removed and placed into warm (approximately 37°C) RPMI medium (medium 
contained no supplements). The fat and connective tissue was then removed from the LdLN 
using a dissecting microscope using ceramic coated forceps (Fine Scientific Tools), care was 
taken not to cause damage. The LdLN was placed in a No1.5 glass bottom petri dish (35 mm 
diameter, 10 mm glass diameter, MatTek) containing RPMI medium and a glass cover slip 
placed on top. The cover slip stopped the LdLN moving and helped reduce evaporation of the 
medium.  
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2.9.2 Multiphoton microscopy 
The LdLN was imaged using the Chameleon pulsed Ti:Sa infrared multiphoton laser (Coherent) 
on a Zeiss 780 LSM, Axio Odserver.Z1 invert microscope, with 4 external non-descanned 
detectors (3 Gallium Arsenide (GsAs) PMTs) and Zen software (Zeiss). The microscope was 
fitted with a light tight incubation chamber set to 37°C. The 40x water dipping objective was 
used in every explant imaging experiment. The scan area imaged was 353.6 µm x 353.6 µm, 
frame size 512 x 512, averaging; 2, Z intervals of 3 µm, Z depth 18-30 µm. Images were 
acquired every 8-10 seconds, each imaging period was approximately 20-40 min, each LdLN 
was imaged for approximately 4 hours in total, until all of the LdLN had been covered. Table 
2.7 lists all videos from explant imaging referred to in this thesis. 
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Table 2.7: List of explant imaging videos. 
  
Time Point 
(hours) 
Intranasal treatment Description 
Scale 
(µm) 
Video 1 6 HK unlabelled S. pneumoniae 
Video shows all Z 
planes merged together. 
9 
Video 2 0 None 
 
130 
Video 3 19 PBS 
 
25 
Video 4 2 
HK CTV labelled  
S. pneumoniae  
28 
Video 5 6 HK PKH26 labelled S. pneumoniae 
 
25 
Video 6 12 HK PKH26 labelled S. pneumoniae 
 
27 
Video 7 24 
HK CTV labelled  
S. pneumoniae  
27 
Video 8 48 
HK CTV labelled  
S. pneumoniae  
31 
Video 9 72 
HK CTV labelled  
S. pneumoniae  
31 
Video 10 24 
HK CTV labelled  
S. pneumoniae 
Neutrophil interacting 
with macrophages. 
18 
Video 11 12 HK PKH26 labelled S. pneumoniae Transient swarm. 14 
Video 12 6 
HK CTV labelled  
S. pneumoniae 
Persistent swarm. 31 
Video 13 6 HK PKH26 labelled S. pneumoniae Persistent swarm. 16 
Video 14 12 HK unlabelled S. pneumoniae No inhibitor. 33 
Video 15 12 HK unlabelled S. pneumoniae 10 µM Shionogi-12. 33 
Video 16 6 108 CFU live S. pneumoniae  No inhibitor. 33 
Video 17 6 108 CFU live S. pneumoniae 10 µM IC87114. 33 
Video 18 15 HK unlabelled S. pneumoniae No inhibitor. 33 
Video 19 15 HK unlabelled S. pneumoniae 10 µM LY223982. 33 
Video 20 13 HK PKH26 labelled S. pneumoniae No inhibitor. 33 
Video 21 13 HK PKH26 labelled S. pneumoniae 10 µM FTY720. 33 
Video 22 6 HK unlabelled S. pneumoniae No inhibitor. 33 
Video 23 6 HK unlabelled S. pneumoniae 10 µM GSK143. 33 
Video 24 12 HK unlabelled S. pneumoniae No mAb. 33 
Video 25 12 HK unlabelled S. pneumoniae 15 µg/ml M1/70. 33 
Video 26 6 HK unlabelled S. pneumoniae 
LdLN from B6.CD11c 
Cre x B6.Rosa26 
mT/mG F1 mouse. 
33 
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2.9.3 Investigating signalling pathways involved in neutrophil dynamics 
Compounds and blocking antibodies to pathways involved in neutrophil migration were added 
to the explant culture medium. First the LdLN was imaged for 1 hour in RPMI medium, with 
images acquired from both medullary and subcapsular sinus regions of the LdLN. This provided 
a ‘baseline’ of neutrophil velocity and behaviors. The LN was then incubated at 37°C for 30 
min in 1 ml of RPMI medium containing a compound or blocking antibody. The LdLN was 
then imaged in RPMI containing the compound of interest. The LdLN was imaged until the 
entire LN had been covered. Compounds used in explant imaging are found in Table 2.8.  
 
Table 2.8: Chemical compounds. 
Name Description MW Supplier Reference 
FTY720 S1PR1,3-5 agonist 343.9 Caymen Chemical Adachi et al160 
Shionogi-12 PI3Kγ inhibitor 492.6 GSK Patent WO2010/125799 
GSK143 Syk inhibitor 342.4 GSK Liddle et al161 
IC87114 PI3Kδ inhibitor 397.4 Klaus Okkenhaug  Sadhu et al162 
LY223982 BLT1 antagonist 502.6 Caymen Chemical Gapinski et al163 
S1P Phospholipid 379.47 Sigma   
 
To test that compound was penetrating the LN samples were sent to GSK for liquid 
chromatography-tandem mass spectrometry analysis (LS-MS/MS). Lung draining lymph nodes 
were removed from mice that had received intranasal S. pneumoniae, 12 hour infection. The fat 
was trimmed off and the LdLN incubated in RPMI medium containing either 10 µM GSK G or 
IC87114, for 1 hour at 37°C. The LdLN was then removed from the medium, washed in PBS 
and weighed. Finally the LdLN was frozen at -20°C and sent to GSK (Stevenage) for LS-MS 
analysis. The media the LNs were incubated in was also frozen and sent for analysis. The results 
indicate that compounds could indeed penetrate the LN, both GSK143 and IC87114 were found 
in the LN tissue. Thus this methodology could be employed in ex vivo explant imaging. 
 
Table 2.9: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) results. 
Compound Nominal incubation Measured media LN concentration Ratio (LN:Media) concentration (μM) concentration (μM) 
IC87114 10 8.2 9.75* 1.15* 
GSK143 10 5.86 81.7* 14* 
*n=2 
 
2.9.4 Image analysis 
Videos were analysed using Volocity software. Individual neutrophils were manually tracked, 
for each neutrophil the centroid point was estimated and used for tracking. Neutrophils were 
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only tracked when they were distinguishable from other GFP+ cells and other neutrophils. In 
each video as many neutrophils as possible were tracked, in videos with large numbers of 
neutrophils a minimum of 20 were tracked. 
 
2.10 Cell culture 
The human osteosarcoma cell line U2OS, expressing GFP-tagged S1PR1 was used to 
investigate S1PR1 internalisation in response to S1P and FTY720. The cell line was provided 
by GSK. Twenty thousand cells in 300 µl complete DMEM (containing 10% FCS, glutamine 
and penicillin and streptomycin) were added to each well of an 8 well, glass bottom (No 1.5) 
chamber slide (Fisher). The cells were then incubated for 48 hours at 37°C, 5% CO2. The media 
was removed, cells washed with PBS, and 300 µl DMEM containing no FCS was added to each 
well. The cells were then incubated at 37°C, 5% CO2 for a further 2 hours. This time allowed 
S1PR1 to be re-expressed at the cell surface. Foetal calf serum contains S1P; binding of S1P to 
S1PRs causes their internalisation. Thus to ensure S1PR1 was at the cell surface a period of 
serum starvation, that was not detrimental to the cell, was required. The media was then 
replaced with 300 µl DMEM (no FCS) containing 10 µM S1P (Sigma), 10 µM FTY720 
(Caymen Chemical) or 1:100 dilution of acidified DMSO (5% 1M HCl; vehicle control). Cells 
were incubated for 1 hour, 37°C, 5% CO2. The media was then removed and replaced with 20  
µl of warm PBS containing 1:2000 dilution of CellMask Deep Red (Invitrogen) and incubated 
for 5 min at 37°C, 5% CO2. The PBS was removed and replaced with warm PFA 4% and 
incubated for 10 min at 37°C, 5% CO2. The cells were then washed three times with PBS and 
incubated with PBS containing 1:5000 dilution of DAPI (Invitrogen) for 5 min at room 
temperature. The DAPI was removed; cells washed three times, then 300 µl PBS left in the 
wells. The cells were imaged using the Zeiss LSM 710 confocal microscope. 
 
2.11 CD11c+ cell depletion using diphtheria toxin 
In B6.CD11c Cre x B6.Rosa26 iDTR F1 mice, cells that express CD11c also express the 
primate diphtheria toxin receptor (DTR). Mice are insensitive to diphtheria toxin (DTx), 
however cells that express the primate receptor are highly sensitive and are thus depleted when 
DTx is administered159. One hundred nanograms of DTx (Sigma) in sterile PBS was 
administered intraperitoneal injections (i.p), control mice received sterile PBS only. In 
experiments using this model, mice received one dose of DTx, after 36 hours they were infected 
with S. pneumoniae (or PBS as a control), 12 hours later they were culled and tissues analysed 
by flow cytometry and immunohistochemistry. 
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2.12 Antibody mediated neutrophil depletion 
In order to investigate neutrophil function antibody mediated depletion of neutrophils was 
performed using the Ly6G specific mAb, clone 1A8 (Bioxcel). Pilot experiments were 
completed to establish the correct does of antibody and time course of neutrophil depletion. 
Figure 2.4 shows an example of one pilot experiment. One mouse received 500 µg 1A8 i.p, 
another received 500 µg 1A8 i.p and 200 µg intranasal (i.n), and a control mouse received an 
isotype control mAb, 2A3, i.p. After 24 hours blood and lungs were removed and processed for 
flow cytometry as described in section 2.5. Figure 2.4 (A) shows that when analysing 
neutrophils using the surface marker Gr1 (neutrophils are Gr1 high), indeed after 1A8 mAb 
treatment neutrophils were depleted when compared to control 2A3 mAb treatment. However 
when looking at CD11b expression, neutrophils were visible by their distinct SS profile, Figure 
2.4 (B). These neutrophils had reduced Gr1 expression. Gating on these cells revealed that 
indeed neutrophils weren’t depleted; their percentage in 1A8 treated mice, in the blood and 
lungs, was not very different from 2A3 treated mice. In all pilot experiments neutrophil 
depletion was not achieved, thus experiments investigating neutrophil function by depletion of 
these cells were not conducted.  
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Figure 2.4: Neutrophil depletion was not achieved using the Ly6G specific 1A8 clone 
monoclonal antibody. 
Mice received either 500 µg of isotype control (rat IgG2b) mAb i.p, or 500 µg anti-Ly6G (1A8) 
mAb i.p, or 500 µg of 1A8 mAb i.p and 200 µg 1A8 intranasal. After 24 hours blood and lungs 
were taken, processed and analysed by flow cytometry. (A) Flow plots gated on CD11b+ cells. 
(B) Flow plots gated on all live cells, neutrophils could be identified by their expression of 
CD11b and SS (red boxes). 1A8 treatment did not deplete neutrophils but reduced their Gr1 
expression. n=1, representative of 5 experiments. 
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2.13 Statistics 
The software GraphPad Prism (GraphPad) was used for statistical analysis. The Kolmogorov-
Smirnov test was used to test for a normal distribution. The Mann Whitney U test and Kruskal 
Wallis test, with Dunns post-hoc test were used to test for significance. No parametric tests 
were used due to either or a combination of; lack of normality, small sample size or uneven 
sample size. Data plotted on graphs have bars showing mean values and error bars showing 
standard error of the mean (SEM). 
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Chapter 3: Characterisation of neutrophils in the lung 
draining lymph node following acute pulmonary infection 
with Streptococcus pneumoniae 
3.1 Neutrophils in secondary lymphoid organs 
The role of neutrophils in modulating immune responses in secondary lymphoid organs is 
controversial. However, several recent publications provide evidence that neutrophils can traffic 
to the spleen and lymph nodes and contribute to adaptive immune responses. 
 
3.1.1 B-helper neutrophils in the spleen 
In the human, rhesus macaques and mouse, spleen B-helper (BH) neutrophils have been 
described. Under homeostatic conditions neutrophils enter the spleen in response to microbial 
antigens that have been filtered from the blood after translocation from mucosal surfaces. This 
is not a classical inflammation driven process. Toll-like receptor signalling in splenic sinusoid 
endothelial cells (SEC) induces their production of IL-10 and neutrophil chemoattractants. 
When neutrophils cross the SEC wall this reprograms circulating neutrophils to become BH 
neutrophils. Granulocyte macrophage colony-stimulating factor produced by splenic ILC3 cells 
is also involved in BH neutrophil differentiation and activation164. These neutrophils localize to 
the splenic peri-marginal zone where they are close to marginal zone (MZ) B cells. B-helper 
neutrophils form NETs that interact with MZ B cells, they also produce BAFF, APRIL and IL-
21 that induce MZ B cell somatic hypermutation, class-switch recombination, plasma cell 
differentiation and thus production of IgM, IgG and IgA. In addition to their MZ B cell 
activating capability they mediate T cell suppression in the spleen. Therefore BH neutrophils 
potentiate extra-follicular B cell responses to TI antigens, and suppress follicular B cell TD 
responses thus minimizing inflammation165. 
 
3.1.2 Bacterial infection induced neutrophil recruitment to the tissue draining 
lymph node 
Intradermal inoculation of Mycobacterium bovis bacille Calmette-Guérin (BCG) into the ear 
induces rapid migration of neutrophils to the dLN. Neutrophils are found as early as 4 hours, 
however after 24 hours they are no longer observed. Neutrophils localise in the SS and carry 
BCG. It is likely that the neutrophils migrate through the lymphatics, as neutrophils carrying 
BCG are observed in lymphatic vessels in the ear166. Similar neutrophil trafficking kinetics are 
found in other skin infections. Subcutaneous injection of P. aeruginosa in the footpad induces 
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rapid migration of neutrophils to the draining popliteal LN. Neutrophils are observed as early as 
4 hours and intravital imaging reveals that they form dynamic swarms33,139. However, 
interestingly subcutaneous injection of Salmonella typhimurium in the footpad does not induce 
neutrophil migration to the dLN139. Thus some bacterial infections induce rapid migration of 
neutrophils to the dLN. Neutrophils are involved in early antigen transport to the dLN.  
 
3.1.3 Parasitic infection induced neutrophil recruitment to the tissue draining 
lymph node 
Parasitic infection induces similar LN neutrophil trafficking and behaviour as bacterial 
infections. Both skin (ear) and oral infection with T. gondii induces neutrophil recruitment to 
the dLNs where they localise in the SS. In the skin, dLN neutrophils are observed early; 1-5 
hours after infection. Application of intravital microscopy shows that neutrophils form swarms. 
The swarms are either transient with less than 150 neutrophils rapidly migrating to the centre 
then dispersing, or persistent, involving more than 300 neutrophils recruited to the swarm, but 
not leaving it36. Skin (ear) inoculation with the nematode N. brasiliensis induces neutrophil 
migration to the dLN within 18 hours where neutrophils are located in the medulla, however no 
neutrophils are observed at 24 or 48 hours post infection. This migration is dependent on 
CCL2167. 
 
3.1.4 Chronic inflammation induced neutrophil recruitment to the tissue 
draining lymph node 
In colitis, myeloid cells, including neutrophils accumulate in the gut where they contribute to 
tissue damage and disruption of the gut epithelia. In a model of bacterial driven T cell induced 
colitis, under non-colitic conditions; CD4+CD45RBlow T cells transferred into recombination-
activating gene (RAG) deficient mice, there are very few neutrophils in the draining mesenteric 
LN. During colitis induced by transfer of CD4+CD45RBhigh T cells into RAG deficient mice, 
there is a significant influx of neutrophils into mesenteric lymph nodes168. Interestingly these 
neutrophils, as well as colon neutrophils, express MHC II and ICAM-1, however blood and 
spleen neutrophils do not168. This disease model is thought to be driven by segmented 
filamentous bacteria in an IL-17 mediated process. IL-17 is a potent recruitment factor for 
neutrophils.  
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3.1.5 Vaccine and adjuvant induced neutrophil recruitment to the tissue draining 
lymph node 
Multiple studies have demonstrated that immunisation results in neutrophil migration to the 
dLN. Immunisation with hen egg white lysozyme (HEL) in CFA into the footpad induces 
neutrophils to migrate to the dLN within 15 min, numbers peak after 2 hours and by 24 hours 
neutrophils are no longer found in the dLN. The neutrophils are found in the paracortical sinus 
and superficial cortex, similar to bacterial and parasitic infection169. In the same model, from the 
same group it was found that following this first acute influx of neutrophils, after 3 days of 
HEL/CFA immunisation a second wave of neutrophils arrive in the dLN. This second wave of 
neutrophils is more robust, greatly increased numbers are recruited and they persist until 18 
days post-immunisation, they also localise to a different area; the cortex and medulla. The first 
wave of recruitment is dependent on prostaglandin-endoperoxide synthase (PTGS, also known 
as cyclooxygenase; COX-1 and -2) production of prostanoids, but not GPCR signalling, wave 
two depends on both prostanoids and GPCR signalling170.  
 
In a model of immunisation using an emulsion of OVA in CFA, one immunisation alone did not 
induce a robust recruitment of neutrophils, 3 doses of OVA/CFA over 30 days, followed by 
challenge with OVA labelled with fluorescein isothiocyanate (FITC) at day 40 was required to 
induce neutrophil influx into the dLN (popliteal). Like in the BCG infection, neutrophils carry 
antigen; OVA-FITC, to the dLN171. Complete Freund’s adjuvant alone, during the priming 
immunisation can also induce neutrophil-dLN migration. As with bacterial infection, 
neutrophils accumulation is rapid, peaking at 6 hours post injection. In this model it was found 
that CCR7 is important for neutrophil-dLN migration; CCR7 knockout mice have reduced 
numbers of neutrophils infiltrating the dLN172.  
 
Other adjuvants aside from CFA also induce neutrophil migration to the tissue dLN. In 
combination with the adjuvant MF59 (oil-in-water emulsion) OVA induces rapid migration of 
neutrophils to the dLN, peaking at 3 hours and falling to near baseline levels at 17 hours. This is 
again an example of rapid neutrophil recruitment from tissues to LNs. Neutrophils are also 
found in the dLN carrying both the antigen and the adjuvant. However, interestingly this rapid 
recruitment is not observed using aluminium adjuvants (alum) in combination with OVA173. In 
unpublished data from our lab and others, it has also been found that alum does not induce 
neutrophil recruitment to tissue dLNs.  
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3.1.6 Neutrophil function in the tissue draining lymph node 
Taken together, the studies outlined above all provide evidence that during inflammation 
neutrophils traffic to tissue dLNs and actively transport antigen to the dLN. This migration is 
often rapid, temporally and spatially separate from dendritic cells, with their localisation being 
in the LN sinuses rather than the paracortex of the lymph node. In cases where LN neutrophil 
influx is persistent, this might result from persistence of inflammation, in the case of colitis, or 
persistence of TLR stimulation in the case of HEL/CFA immunisation. There could be 
persistent antigen/adjuvant complex deposition in the injection site causing continued neutrophil 
recruitment, activation and subsequent trafficking to the dLN. However neutrophil-dLN 
migration is stimulus specific, S. typhimurium that induces systemic intracellular infection and 
the adjuvant alum do not induce their migration to the dLN. Alum, unlike CFA or MPL, does 
not activate TLRs174. Consistent with a role for TLRs in the process was the finding that in mice 
deficient of MyD88 adapter protein, a key component of TLR signalling and subsequent NF-κB 
activation, neutrophil recruitment to the dLN is significantly impaired36. 
 
Although there is some consensus across infection/inflammation models about recruitment 
kinetics, ability to transport antigen to the dLN, and their localisation in the LN, there has been 
no clear role found for neutrophils. Thus far only two studies have provided evidence for two 
potential functions of neutrophils in tissue dLNs. During immunisation with HEL/CFA 
neutrophils are proposed to be responsible for early T cell retention, in an S1P independent 
process. It is proposed that neutrophil derived thromboxane A2 limits the magnitude of the T 
cell response in the dLN, but also prevents T cell spread to distal LNs170. In a P. aeruginosa 
skin infection model, neutrophil depletion results in higher LN bacterial CFUs and also blood 
bacterial CFU. This indicates that neutrophils are involved in pathogen clearance in the dLN, 
thus preventing systemic spread139. However the neutrophil depletion would have also affected 
pathogen clearance from inflamed tissue by neutrophils, this effect was not investigated. 
Therefore the increased dLN and systemic bacterial spread could be partly due to failure to 
control the infection in the tissue, and not solely due to the absence of neutrophils in the dLN.36 
 
3.1.7 Neutrophil heterogeneity  
Various studies have identified neutrophils with different phenotypes in a range of settings, for 
example MHC II+ ICAM-1+ neutrophils in the colitic colon and ICAM-1+ rTEM neutrophils in 
I-R injury. Other studies have detailed distinct neutrophil subsets; B-helper neutrophils in the 
spleen. There is some discussion as to whether bona fide subsets of neutrophils exist, or if they 
represent different activation profiles of neutrophils resulting from their specific tissue location 
and their surrounding cytokine milieu175. 
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Infection of mice with N. brasiliensis third-stage larvae (L3) involves migration of the larvae 
from the skin to the lungs, then entry into the small intestine. The lung is an important site 
where the immune system interacts with the parasite larvae. Neutrophils recruited to the lung 
following L3 inoculation are found to polarize to a distinct, type 2 gene expression profile, 
characterized by increased gene expression of IL13, IL33, Igf1, Retnla and Chi3l3. These are 
termed ‘N2’ alternatively activated neutrophils, in line the with M2 macrophages. However 
inoculation through the same route with LPS polarized type 1 gene expression in lung 
neutrophils; Il6 and Il12b are up-regulated in these ‘N1’ classically activated neutrophils. 
Compared to neutrophils from naïve mice, N. brasiliensis and LPS stimulated neutrophils 
similarly upregulate 153 genes, Nos2 and Tnf being amongst the most upregulated genes. 
However, LPS stimulated neutrophils up-regulate 1,315 distinct genes, and N. brasiliensis 
neutrophils up-regulate 218 distinct genes. In addition to gene transcription differences, the 
neutrophils have different nuclear morphology; N. brasiliensis stimulated have band shaped 
nuclei, whereas LPS stimulated have classic lobed nuclei.  
 
This phenotypic polarization is also observed in tumour models. Using two different tumor 
types and two different injection sites; flank and orthotopic, in three different mouse strains, 
tumor associated neutrophils polarise into N1 ‘anti-tumor’ and N2 ‘pro-tumor’ phenotypes. The 
cytokine transforming growth factor β (TGFβ) is responsible for this skew and favors N2 
polarisation. As seen in the parasite infection, these different neutrophil phenotypes are also 
associated with distinct nuclear morphologies; N1 cells have hyper-segmented nuclei, however 
N2 cells have ring-shaped nuclei, similar, but not the same to band-shaped nuclei176. Thus, as 
seen in macrophage activation neutrophils can also polarize their response depending on the 
specific stimulus63.  
 
3.2 Summary 
Neutrophils are capable of migrating to tissue draining secondary lymphoid organs. A clear 
function for them has yet to be found, however the current literature suggests that their role is 
stimulus and context dependent, rather than cell intrinsic. In various infection and inflammation 
models neutrophils have been found to have varying phenotypes including the expression of 
ICAM-1, MHC II and CD11c in some settings. Polarization to N1 or N2 phenotypes, 
characterised by distinct gene expression profiles and cytokine production has also been 
documented, however these phenotypes are highly stimulus and location dependent.  
 
We hypothesised that in an acute pulmonary infection with the bacteria S. pneumoniae 
neutrophils would migrate to the LdLN where they have an important role in early events in the 
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initiation of immune responses. In addition to this neutrophils in the LdLN would be 
phenotypically different to lung and blood neutrophils, reflecting the change in their function; 
from pathogen clearance to a role in immune response modulation. The aim of this chapter was 
to investigate neutrophil recruitment to the LdLN following pulmonary infection with S. 
pneumoniae. 
  
3.3 Aims 
• Characterise the kinetics of neutrophil recruitment to the mediastinal LdLN. 
• Establish the anatomical location of neutrophils within the LdLN. 
• Compare LdLN neutrophils to circulating blood, lung and airway neutrophils using both 
surface phenotype and gene expression profile. 
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3.4 Results 
3.4.1 Pulmonary infection with S. pneumoniae induced neutrophil recruitment to 
the LdLN  
To investigate neutrophil recruitment to the LdLN in mice approximately 108 CFU S. 
pneumoniae or PBS (control) was delivered i.n. Exact CFU dose was determined using BHI 
agar plates, in all experiments between 107 - 108 CFU were administered. Lung dLN were then 
removed, digested and analysed by flow cytometry. To identify neutrophils a gating strategy 
was identified that permitted selective quantification of neutrophils but did not include other 
myeloid populations such as dendritic cells, macrophages and monocytes in the mediastinal LN 
(Figure 3.1). This grating strategy was then applied in all other tissues investigated in 
subsequent experiments. Following doublet exclusion live cells were gated on by excluding 
DAPI positive cells. The cells were then distinguished from cellular debris based on their FS 
and SS profiles. To identify myeloid lineages CD11b+ (high) cells were gated on, then the Ly6C 
fluorescence intensity of these cells was plotted against the Ly6G fluorescence intensity. 
Neutrophils were identified as being Ly6Cint and Ly6G+ (Figure 3.1 A). In naïve, PBS treated 
mice only a small Ly6C- and Ly6G- population of cells was visible, with a few rare neutrophils 
observed. In the inflamed LdLN a population of neutrophils was clearly visible, as well as a 
population of Ly6Chi Ly6G- cells. Cell sorting of the Ly6Cint Ly6G+ population, followed by 
Giemsa staining confirmed that these cells were neutrophils, as demonstrated by the 
characteristic lobed nuclear morphology. The Ly6Chi Ly6G- cells resembled monocytes due to 
their expression of Ly6C, CX3CR1, F4/80, also low MHC II and CD11c expression177-179, 
indicating they had not yet differentiated into dendritic cells. Thus using this gating strategy we 
could quantify and isolate different myeloid populations in tissue dLNs post infection with S. 
pneumoniae. 
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Figure 3.1: Pulmonary infection with S. pneumoniae induced neutrophil recruitment to 
the LdLN 
(A) Representative plots showing the flow cytometry gating strategy. Neutrophils were 
identified as CD11b+ Ly6Cint Ly6G+ cells. Very few neutrophils were found in LdLN of mice 
that received PBS i.n. Neutrophils were found in the LdLN at 12 hours of pulmonary S. 
pneumoniae infection. (B) Sorted CD11b+ Ly6Cint Ly6G+ cells had lobed nuclear morphology. 
(C) Histogram overlays of Ly6Cint Ly6G+ neutrophils (red) and Ly6C+ Ly6G- inflammatory 
monocytes (blue).  
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3.4.2 Formation of neutrophil:monocyte pairs 
One surprising observation was the presence of very specific cell doublets as shown by doublet 
exclusion (Figure 3.2). In the top panel a very tight single pulse width gate is set leading to very 
clear Ly6Chi Ly6G- (monocyte) and Ly6Cint Ly6G+ (neutrophil) populations. However, if the 
gate set for doublet exclusion was not tight enough a population of Ly6Chi Ly6G+ cells was 
observed. This was also seen in the lung, BAL fluid and to a lesser extent in the blood. These 
cells arose from the small population identified by an arrow in the bottom left plot in Figure 3.2. 
These cells were sorted, then an aliquot run on the flow cytometer for a post sort purity test 
(Figure 3.3 A). Two populations were observed when pulse width was plotted against FS; single 
cells and doublets. The single cells were a near 1:1 ratio of neutrophils to monocytes. No Ly6Chi 
Ly6G+ cells were found. Ly6Chi Ly6G+ events fell in the higher pulse width gate and were 
doublets. The sorted Ly6Chi Ly6G+ cells were Giemsa stained and clear neutrophil monocyte 
pairs were observed (Figure 3.3 B). Approximately 50% of the pairs remained intact after cell 
sorting and therefore must have been tightly bound to each other. 
 
As a result of this observation when investigating monocytes and neutrophils strict doublet 
exclusion was utilized in all experiments. It is however interesting that neutrophils and 
monocytes formed such tight interactions, interactions that survived tissue digestion, multiple 
rounds of cell resuspension and finally passing through a cell sorter. This could be simply down 
to cells attaching together during tissue processing. Alternatively these interactions could have 
been formed in vivo, for example as part of the process of efferocytosis by which apoptotic cells 
are phagocytosed. The images acquired from Giemsa staining are low quality so it is not clear, 
however in the synapse between the two cells S. pneumoniae was found in some of the pairs. 
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Figure 3.2: CD11b+ Ly6Chi Ly6G+ cells in the LdLN following pulmonary S. pneumoniae 
infection. 
Top row; tight pulse width gate (red). Bottom row; larger pulse width gate (red). Using the 
larger pulse width gate resulted in the appearance of a Ly6Chi Ly6G+cell population, arising 
from the population marked by the yellow arrow. 12 hour S. pneumoniae infection, 
representative plots of all flow cytometry experiments. 
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Figure 3.3: CD11b+ Ly6Chi Ly6G+ cells were neutrophil-monocyte doublets. 
 (A) Post sort flow cytometric analysis of CD11b+ Ly6C+ Ly6G+ cells sorted from the lung at 12 
hours of pulmonary S. pneumoniae infection. CD11b+ Ly6C+ Ly6G+ cells were doublets of 
Ly6Cint Ly6G+ neutrophils and Ly6C+ Ly6G- monocytes. (B) Sorted CD11b+ Ly6C+ Ly6G+ 
doublets from the lung, BAL and LdLN stained with Giemsa. The doublets were pairs of 
neutrophils and monocytes. 
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3.4.3 Pulmonary infection with S. pneumoniae induced early neutrophil 
recruitment to the LdLN 
Following identification of neutrophils in the LdLN during pulmonary S. pneumoniae infection 
the kinetics of neutrophil recruitment to the LdLN was investigated. Mice were infected at -72, -
48, -24, -12, -6, and -2 hours with the same batch of S. pneumoniae culture. At time zero LdLNs 
were collected, digested and neutrophil numbers were analysed by flow cytometry using 
AccuCheck counting beads. Figure 3.4 (A) shows an early peak of neutrophil recruitment. 
Neutrophils were observed as early as 2 hours post infection, with numbers peaking at 6-12 
hours. By 24 hours neutrophil numbers had reduced back down, they stayed low at 48 and 72 
hours, however they didn’t reduce back down to baseline levels seen in naïve mice (time zero). 
This early peak of neutrophil recruitment preceded the influx of other MHC IIhi cells. Figure 3.4 
(B) shows that influx of MHC II+ CD11c+ cells occurs at 24 hours, when the peak of neutrophil 
recruitment had fallen. Thus neutrophils were recruited early to the LdLN in pulmonary S. 
pneumoniae infection, preceding the influx of other responding immune cells. 
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Figure 3.4: Pulmonary infection with S. pneumonie induced early neutrophil recruitment 
to the LdLN. 
 (A) Total neutrophil numbers in the LdLN at 0, 2, 6, 12, 24, 48 and 72 hours post pulmonary S. 
pneumoniae infection. Gated on CD11b+ Ly6Cint Ly6G+ cells, pooled data from three 
experiments, n= 3-8. (B) Total CD11c+ CD11b+/lo cell numbers in the LdLN. Gated on MHC II+ 
cells. Neutrophil numbers peaked early, preceding the influx of responding MHC II+ cells. 
Pooled data from two experiments, n= 3-5. Bars represent mean + SEM, * P<0.05, ** P<0.01 
*** P<0.001 (Kruskal-Wallis test with Dunn's post hoc test). 
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3.4.4 Investigating neutrophil localisation within the LdLN following pulmonary 
infection with S. pneumoniae 
In the highly organized structure of the LN, cellular location can in part determine function 
through localized cytokine and chemokine gradients, and other cell types sharing the niche. 
Thus frozen sections of LdLNs were stained to identify where neutrophils were situated. The 
surface markers Ly6G; neutrophils, lymphatic vessel endothelial hyaluronan receptor 1 (Lyve-
1); lymphatic vessels and PNAd (MECA-79); HEVs, were used to identify these cell 
populations. 
 
In the naïve LdLN (Figure 3.5 A), as observed in flow cytometry samples, very few neutrophils 
were observed. The few that were found were located within or near HEVs. This could indicate 
that these cells were not in the LdLN tissue, but rather in vessels, moving through the LN 
microvasculature. In LdLN from mice taken at 6 hours of pulmonary S. pneumoniae infection 
neutrophils were found mainly in lymphatic regions of the LdLN, with some in HEVs (Figure 
3.5 B). The neutrophils were not in the cortex of the LN in the T cell zone, or in areas were the 
B cell follicles are located (Figure 3.6). This was representative of 12 and 24 hours of infection. 
Thus this area of the LN was further investigated.  
 
Analysis of the sections from infected LdLN (Figure 3.7 A) showed that neutrophils were found 
to populate the lymphatic areas which contained CD169+ macrophages with a round 
morphology. Staining on a serial section revealed that the CD169+ macrophages were also 
SIGN-R1+, neutrophils were closely located to these cells. Figure 3.7 (C) and (D) show that 
these round CD169+ macrophages were indeed SIGN-R1+ and F4/80+ MSM. Thus neutrophils 
were found exclusively in lymphatic areas of the LdLN, densely populating the medullary sinus, 
in close proximity to MSMs. 
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Figure 3.5: Neutrophils localised to the lymphatic sinus in the LdLN following pulmonary 
infection with S. pneumoniae. 
Immunohistochemistry of frozen sections stained for lymphatics (lyve-1; red), HEVs 
(MECA79; green) and neutrophils (ly6G; white). (A) In naïve LdLN few neutrophils were 
found. Scale bars; A i= 70µm, A ii and iii= 35 µm. (B) At 6 hours of infection neutrophils in the 
LdLN were found in lymphatic areas. Scale bars; B i= 60 µm and B ii= 70 µm. 
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Figure 3.6: Neutrophils localised to the lymphatic sinus and not the T cell zone in the 
LdLN following pulmonary infection with S. pneumoniae. 
Immunohistochemistry of a frozen section from the LdLN of a B6.hCD2-DsRed.B mouse. In 
this mouse strain T cells express the fluorescent protein DsRed (blue in the image). The section 
was stained for lymphatics (lyve-1; red) and neutrophils (Ly6G; white). At 6 hours of infection 
neutrophils in the LdLN were found in lymphatic areas, not in T cell areas or areas where B cell 
follicles are located. Scale bar= 70 µm.  
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Figure 3.7: Neutrophils in the LdLN were located in close vicinity to medullary sinus 
macrophages following pulmonary infection with S. pneumoniae 
Immunohistochemistry of frozen sections stained for lymphatics (Lyve-1; red), neutrophils 
(Ly6G; white) and LN macrophages (CD169; green). (A) At 12 hours of infection neutrophils 
were located in lymphatic areas close to CD169+ macrophages. Scale bar= 42 µm. These 
macrophages were SIGN-R1+ (B) and had a rounder morphology than other CD169+ 
macrophages thus were MSMs. Scale bar= 24 µm. MSM were CD169+ SIGN-R1+ (C) and 
F4/80+ (D), SSMs were SIGN-R1- F4/80- with dendrite-like structures. Scale bars C= 70 µm, D= 
47 µm. 
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3.4.5 Neutrophils in the circulation, lung, alveolar space and LdLN had different 
activation states during pulmonary infection with S. pneumoniae 
The phenotype and activation state of neutrophils in the LdLN was next investigated with the 
aim of identifying if these cells resembled neutrophils in the circulation or lung. Circulating 
blood, lung tissue, airway (from BAL fluid) and LdLN neutrophils were compared at 12 hours 
of S. pneumoniae infection. This time point was selected as it is when neutrophil numbers 
peaked in the LdLN. Flow cytometry and Q-PCR was used to investigate the following markers 
of neutrophil activation; CD11b, ICAM-1, ROS production, Tnf and Ifng gene expression. Lung 
dLN neutrophils had the highest mean (median) fluorescence intensity (MFI) for CD11b, almost 
3.5 times higher than blood neutrophils, and over 1.5 times higher than lung and BAL fluid 
neutrophils (Figure 3.8 A). Few ICAM-1+ neutrophils were found in the blood (5% ± 0.3 SEM 
were ICAM-1+), however a high percentage of lung (90% ± 2), BAL (86% ± 2) and LdLN 
neutrophils (75% ± 2) were ICAM-1+. When looking at ICAM-1 MFI, BAL fluid and Lung 
neutrophils had the highest MFI whereas LdLN neutrophils had an approximately 3 fold lower 
MFI (Figure 3.8 B). Reactive oxygen species production was assessed by flow cytometry using 
DHR 123. As compared to the blood (14% ± 1), a high percentage of lung (71% ± 2), BAL 
(84% ± 3) and LdLN (67% ± 4) neutrophils were positive for ROS. The highest percentage of 
ROS+ neutrophils were found in the BAL fluid, these also had the highest MFI. Similar 
percentages of ROS+ neutrophils were found in the Lung and LdLN, these cells also had similar 
ROS MFI (Figure 3.8 C). 
 
Neutrophils were sorted from the blood, lung, BAL fluid and LdLN of mice at 12 hours of S. 
pneumoniae infection. Three separate experiments to sort neutrophils were performed, with 5-
10 mice pooled for each experiment. The same gating strategy was employed as in flow 
cytometry experiments, RNA was extracted from these cells and Q-PCR performed. The 
relative quantity (RQ) of mRNA in blood, lung, BAL and LdLN neutrophils was calculated. 
One of the blood replicate samples was used as the calibrator, thus the RQ of all other samples 
was calculated relative to the mRNA in that sample. 
 
Neutrophils in the BAL fluid had the highest amount of Tnf mRNA. Lung and LdLN showed 
similar levels of Tnf expression, higher than blood, however approximately half that of BAL 
neutrophils (Figure 3.8 D). Ifng mRNA was also most highly expressed in BAL neutrophils. 
Lung neutrophils had less Ifng mRNA than BAL neutrophils, but 2-fold more that LdLN 
neutrophils. Lung dLN neutrophils had 2-fold more Ifng mRNA than blood neutrophils (Figure 
3.8 D). Thus, neutrophils in the circulation, lung tissue, airways and LdLN showed distinct 
activation states based on expression of known markers of neutrophil priming and activation.  
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Figure 3.8: Neutrophils in the circulation, lung and LdLN had different activation states 
during pulmonary infection with S. pneumoniae. 
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Figure 3.8: Neutrophils in the circulation, lung and LdLN had different activation states 
during pulmonary infection with S. pneumoniae. 
Quantification of flow cytometry plots gated on Ly6Cint Ly6G+ cells. (A) LdLN neutrophils had 
a higher MFI of CD11b. (B i) Gated on CD11b+ Ly6Cint Ly6G+ cells, gating strategy to identify 
ICAM-1+ neutrophils. Quantification of flow cytometry plots; neutrophils in the Lung, BAL 
fluid and LdLN expressed ICAM-1 (B ii). (B iii) Total lung and BAL fluid neutrophils had a 
higher ICAM-1 MFI than LdLN neutrophils. (C i) Gated on CD11b+ Ly6Cint Ly6G+ cells, 
gating strategy to identify ROS in neutrophils. (C ii) Fewer neutrophils in the blood, lung and 
LdLN made ROS as compared to BAL neutrophils. (C iii) Gated on total neutrophils. Q-PCR 
analysis of sorted CD11b+ Ly6Cint Ly6G+ cells. Graphs show quantification of gene expression 
relative to blood neutrophils. BAL fluid neutrophils expressed more mRNA for Tnf (D) and Ifng 
(E). 12 hour S. pneumoniae infection. (A) and (B) n= 4. (C) n=3. (D) and (E) n=3. Bars 
represent mean + SEM, * P<0.05 and ** P<0.01 (Kruskal-Wallis test with Dunn's post hoc test). 
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3.4.6 Gene transcription analysis of neutrophils in the circulation, lung tissue, 
alveolar space and LdLN during infection with S. pneumoniae 
In addition to Tnf and Ifng mRNA expression investigated in Figure 3.8, other genes involved in 
activation and neutrophil function were investigated by Q-PCR to further characterise the 
differences between neutrophils in the circulation, lung and LdLN. Quantitative PCR was 
performed to assess mRNA expression of Nos2 to investigate the induction of iNOS synthesis. 
Figure 3.9 (A) shows that all populations of neutrophils expressed Nos2 mRNA, however BAL 
neutrophils had the highest level. 
 
In a HEL/CFA vaccine model LN neutrophils are found to produce high levels of prostanoids, 
in particular thromboxane A2, thus suppressing T cell responses. The enzymes COX-2 and 
COX-1 are responsible for prostanoid synthesis. In inflammation COX-2 is induced and is the 
dominant enzyme in prostanoid synthesis180. The gene Ptgs2 encodes COX-2, thus Ptgs2 
transcription was investigated to see if neutrophils in this infection model were having a similar 
role. As observed in Figure 3.9 (B), lung and LdLN neutrophils had high Ptgs2 mRNA 
expression as compared to blood, but also BAL neutrophils, with the highest level in lung tissue 
neutrophils.  
 
Mmp9, S100a8 and S100a9 are three key, highly expressed neutrophil genes that encode 
abundant granular (MMP9) and cytoplasmic (S100A8 and S100A9) proteins. Their expression 
was analysed to see if there was variation at the different sites. Interestingly the blood 
neutrophils showed the highest expression of Mmp9 mRNA (Figure 3.9 C). Blood neutrophils 
also showed the highest level of expression of both S100a8 and S100a9 mRNA. BAL and 
LdLN neutrophils showed slightly higher expression than lung neutrophils (Figure 3.9 D and 
E).  
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Figure 3.9: Gene transcription analysis of neutrophils in the circulation, lung tissue, 
alveolar space and LdLN during infection with S. pneumoniae. 
Q-PCR analysis of sorted CD11b+ Ly6Cint Ly6G+ cells. Graphs show quantification of gene 
expression relative to blood neutrophils. BAL fluid neutrophils had more mRNA for Nos2 (A). 
Lung tissue and LdLN neutrophils had high expression of Ptgs2 mRNA (B). Blood neutrophils 
had more mRNA for Mmp9 (C), S100a8 (D) and S100a9 (E). n=3. Bar represents mean + SEM, 
* P<0.05 and (Kruskal-Wallis test with Dunn's post hoc test). 
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3.4.7 Neutrophil antigen presenting cell marker expression in the LdLN during 
pulmonary infection with S. pneumoniae 
The characterization of neutrophil activation state revealed that LdLN neutrophils resembled 
lung neutrophils and were in an intermediate activation state. However there had been no clear 
phenotypes that separated lung from LdLN neutrophils, therefore this was investigated further. 
In various in vivo and in vitro models it has been shown that neutrophils are capable of antigen 
presentation and T cell activation67,168,181-183. The high expression of ICAM-1 would aid stable T 
cell interactions with CD11a184, thus neutrophil MHC II and CD11c expression was investigated 
to see if they had taken on an antigen presenting cell phenotype. In the blood (0.1% ± 0.03), 
lung (0.7% ± 0.1) and BAL (0.1% ± 0.02) there were few MHC II positive cells, however in the 
LdLN 10% (± 3) of neutrophils expressed MHC II (Figure 3.10 A ii). When looking at the 
neutrophil populations at each site, the LdLN population as a whole showed a shift to higher 
MHC II MFI (Figure 3.10 A iii). As with MHC II expression, a small population of neutrophils, 
6% (± 1.3) expressed CD11c (Figure 3.10 B ii) and as a population LdLN neutrophils show a 
shift to higher CD11c MFI (Figure 3.10 B iii). Thus a subset of neutrophils had taken on antigen 
presenting cell phenotype. 
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Figure 3.10: A subset of neutrophils in the LdLN express antigen presenting cell markers 
during pulmonary infection with S. pneumoniae. 
Gated on CD11b+ Ly6Cint Ly6G+ cells, gating strategy to identify MHC II+ neutrophils (A i). (A 
ii) quantification of flow cytometry plots; a small population of neutrophils in the LdLN 
expressed MHC II. (A ii) Gated on total neutrophils. LdLN neutrophils had a higher MFI of 
MHC II. (B i) gated on CD11b+ Ly6Cint Ly6G+ cells, gating strategy to identify CD11c+ 
neutrophils. (B ii) quantification of flow cytometry plots; small population of neutrophils in the 
LdLN expressed CD11c. (B iii) Gated on total neutrophils. LdLN neutrophils had a higher MFI 
of CD11c. 12 hour S. pneumoniae infection. n=4. Bars represent mean + SEM, * P<0.05 and ** 
P<0.01 (Kruskal-Wallis test with Dunn's post hoc test). 
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3.4.8 Neutrophils in the LdLN were not specialised for B helper functions during 
infection with S. pneumoniae 
B-helper neutrophils in the spleen have been described that make B cell survival and activation 
factors including BAFF and APRIL. They induce activation and antibody production by 
marginal zone B cells165. Figures 3.5-7 showed that neutrophils were located in the LN medulla 
after pulmonary S. pneumoniae infection, this location is a known niche for plasma B cells. 
Gene expression of Tnfsf13, encoding APRIL and Tnfsf13b, encoding BAFF was analysed to 
see if neutrophils in the LdLN had potential for a B cell helper function. Expression of Tnfsf13 
was lowest in LdLN neutrophils. The same was found for Tnfsf13b. Expression of mRNA for 
all these genes in lung, BAL and LdLN neutrophils was never above that detected in blood 
neutrophils (Figure 3.11). Thus LdLN neutrophils had not upregulated gene transcription of B 
cell activating factors. 
 
Figure 3.11: Neutrophils in the LdLN were not specialised for B helper function during 
infection with S. pneumoniae. 
Q-PCR analysis of sorted CD11b+ Ly6Cint Ly6G+ cells. Graphs show quantification of gene 
expression relative to blood neutrophils for Tnfsf13 (A) and Tnfsf13b (B). n=3, bars represent 
mean + SEM. 
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3.5 Summary of results 
• Pulmonary S. pneumoniae infection induces neutrophil migration to the LdLN.  
• Lung dLN neutrophil recruitment is rapid, peaking at 6-12 hours and falling at 24 hours.  
• Neutrophils populate lymphatic areas of the LdLN. 
• Neutrophils densely populate the medullary sinus in areas when MSM are found.  
• Lung dLN neutrophils are in an intermediate activation state resembling lung tissue 
neutrophils. Blood neutrophils are in an inactivated state, BAL fluid neutrophils are 
highly activated. 
• Lung dLN and lung neutrophils express high levels of Ptgs2 mRNA, however no other 
clear marker was found to distinguish LdLN neutrophils from lung neutrophils. 
• A small percentage of LdLN neutrophils express CD11c and MHC II. 
• Neutrophils in the LdLN following acute pulmonary S. pneumoniae infection are not 
specialised for B helper activity.  
 
3.6 Discussion 
3.6.1 Neutrophil involvement in early immune response events in the lung 
draining lymph node following pulmonary S. pneumoniae infection  
The rapid migration of neutrophils to the LdLN indicates they may have a role in very early 
immune response events in the lymph node. Lymphatic endothelial cells that line the medullary 
sinus are key in modulating lymphocyte egress118. The positioning of neutrophils within this 
area may indicate that they have a role in regulating early exit from the LN during 
inflammation. It has been proposed that neutrophil derived thromboxane A2 is a non-specific 
mechanism for early (less than 24 hour) T cell retention in the LN170. In this model Ptgs2 is 
highly induced in these cells thus this data could support this, however neutrophil prostaglandin 
or thromboxane production was not confirmed. Alternatively neutrophils could be modulating 
early events in the expansion of the lymphatic endothelial cell network. Lymph node 
hypertrophy is an important process during an immune response, involving expansion of the 
HEV and lymphatic vessel network. Neutrophils have been reported to be involved in 
angiogenesis; neutrophil derived MMP9 aids vascularization in tissues during inflammations185. 
It also has a role in lymphangiogenesis through extracellular remodeling increasing VEGF-A 
bioavailability, additionally neutrophils are found to secrete VEGF-D186. We found that LdLN 
neutrophils also express MMP9, and thus it would be interesting to determine if neutrophils 
express VEGF-C and VEGF-D which are known to drive lymphangiogenesis187, and if MMP9 
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expression by neutrophils has an important role in the rapid ECM remodeling that occurs in 
LNs during an immune response. 
 
3.6.2 Neutrophils in the circulation, lung, airways and LdLN have different 
activation states 
Phenotypic analysis finds that circulating blood neutrophils represent a ‘quiescent’ state. Few 
blood neutrophils were ICAM-1+ or ROS+ and they had the lowest CD11b expression. Gene 
transcription for Tnf and Ifng was not increased to the level of lung, BAL and LdLN 
neutrophils, however Mmp9 and S100a8/9 gene was the highest in these cells. Matrix 
metallopeptidase 9 is a gelatinase enzyme that cleaves collagen in the basement membrane188 
and has been shown to be an important proinflammatory mediator, produced by neutrophils to 
facilitate their migration to inflammatory sites including the bladder and lung. In the bladder 
MMP9 is essential for neutrophils get through the basement membrane in order to cross the 
uroepithelium189. In influenza infection MMP9 is produced in large amounts by lung tissue 
neutrophils, and is also important for neutrophil migration into the lung188. Thus it was expected 
that gene expression was going to be highest in lung neutrophils, in order to aid their interstitial 
migration and crossing of the pulmonary epithelia into the alveolar space. However this was not 
the case, circulating blood neutrophils had the highest MMP9 gene transcription. Although not 
to the levels expected, the gene was still expressed in lung neutrophils, thus it could indeed be 
having a role in neutrophil infiltration; however it is possible that MMP9 may not have such an 
important role in S. pneumoniae infection, as compared to influenza infection. Alternatively at 
12 hours of infection, as investigated here, transcription may be turned down to favor 
transcription of other inflammatory genes in lung, airway and LdLN neutrophils. Matrix 
metallopeptidase 9 gene expression may be temporally regulated in neutrophils; alternatively 
pre-produced MMP9 is released without the need for new synthesis. 
 
S100A8/9 have been reported to be important in neutrophil migration, it was not expected that 
blood neutrophils would have the highest gene expression for S100A8/9, it was expected that 
S100A8/9 may be involved in interstitial migration of lung neutrophils. In human neutrophils it 
is reported that S100A9 binding to pertussis toxin-sensitive receptors induces increased affinity 
of CD11b190, and increases their adherence to fibrinogen191. Additionally it is found that both 
S100A8 and S100A9 induce activation of human endothelial cells; increased chemokine and 
adhesion molecule expression, and deceased junction molecule expression, thus loosening 
endothelial cell junctions192. Thus perhaps in this mouse bacterial infection model S100A8 and 
S100A9 are having the same effect and having a greater role in neutrophil TEM, acting on both 
the neutrophils and the endothelium, as opposed to interstitial migration in the lung or LdLN. 
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Once transmigrated these cells may down-regulate S100A8/9 expression to favor other 
inflammatory gene transcription, and use pre-made S100A8/9 cytoplasmic stores. 
 
Lung tissue neutrophils were in an intermediate ‘activation’ state, between that of quiescent 
blood and highly activated BAL neutrophils. CD11b expression was high, 90% (± 2) of the 
neutrophils were ICAM-1+, and 71% (± 2) were ROS+. Gene expression of Tnf had increased 48 
(± 12) fold as compared to blood neutrophils; Ifng mRNA expression has also increased. In 
contrast, Nos2 transcription levels were not increased. Transcription of Ptgs2 had been 
significantly induced in lung tissue neutrophils, with a 53 (± 18) fold induction over blood 
neutrophils. Ptgs2 encodes COX-2 that is induced in inflammation. Cyclooxygenase 2 catalyses 
the first step in synthesis of five prostaglandins (PG); PGE2, PGD2, PGF2α , PGI2 and 
thromboxane A2. Prostaglandin E2 is the main PG active in the mouse lung, due to expression 
of PGE2 receptors 2 and 4 (EP2 and EP4), and it has highly anti-inflammatory effects on lung 
myeloid cells. During efferocytosis (ingestion of apoptotic cells by macrophages) in the lung 
PGE2 is generated, acting via EP2, it inhibits the recruitment of neutrophils to the lung. When 
combined with pulmonary S. pneumoniae infection this leads to impairment of clearance of the 
bacteria193. Prostaglandin E2-EP2 signalling in neutrophils inhibits chemotaxis, ROS generation, 
LTB4 release and aggregation194. In the intestine, during acute T. gondii infection, inflammatory 
monocytes regulate neutrophil activation through PGE2, preventing neutrophil mediated gut 
pathology195. Therefore in the lung tissue neutrophils, high Ptgs2 expression could indicate that 
these intermediately activated neutrophils are also acting to prevent excessive neutrophil 
infiltration and activation that could drive lung pathology.  
 
LdLN neutrophils showed a similar intermediate phenotype to lung neutrophils. CD11b 
expression was high, just 75% (± 2) were ICAM-1+ and 67% (± 4) were ROS+. As with lung 
neutrophils, Tnf gene expression had been increased to a comparable level, however Ifng 
transcription was not as high. Nos2 expression had not been increased over blood neutrophil 
level. Similarly to lung neutrophils Ptgs2 expression had been induced, however not to as high 
levels. The elevated expression of Ptgs2 could indicate that these cells are also mediating anti-
inflammatory effects. The intermediate state of LdLN neutrophils indicates that they may not be 
destructive in the LdLN; they are not activated to the level of airway neutrophils. Activation to 
that level could inhibit the adaptive immune response through inhibiting normal T cell - DC 
interactions by destruction of the collagen matrix secreted by FRCs in the paracortex of the LN.  
 Although not directly addressed or demonstrated, the similar phenotype of lung tissue and 
LdLN neutrophils, along with the positioning of LdLN neutrophils in mainly lymphatic areas 
indicates that these cells could have migrated from the lung through the lymphatics, similar to 
how DCs migrate to the LN. Prostaglandin E2-EP2/EP4 signalling induces CCR7 expression on 
monocyte-derived DCs and is thought to be essential for the migratory capacity of human DC, 
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thus it would be interesting if the high Ptgs2 in lung and LdLN neutrophils correlates with 
induced CCR7 on LdLN neutrophils, allowing their entry into lymphatics and subsequent 
migration to the LN194. 
 
Broncioalveolar lavage fluid (airway) neutrophils showed an activated phenotype. These cells 
had high ICAM-1 expression, and the highest expression of ROS. They also expressed 
significantly more Tnf mRNA that blood neutrophils, and nearly double the amount detected in 
lung and LdLN neutrophils. In addition to this they the highest level of Ifng mRNA and a two 
fold increase in Nos2 mRNA expression, as compared to the other neutrophil populations. 
Reactive oxygen species are generated rapidly as an anti-microbial defense, however NO 
production is slower and requires iNOS transcription and translation52, thus airway neutrophils 
were further along in the cascade of activation than lung and LdLN neutrophils. Nitric oxide has 
been shown to be pro-apoptotic in inflammatory cells including neutrophils196. The higher 
expression of iNOS (Nos2) mRNA could indicate that neutrophil apoptosis is being induced in 
the airway neutrophils. This is an important process to control inflammation and has been 
shown to have an essential role in macrophages during S. pneumoniae infection; high levels of 
NO induce macrophage apoptosis. Dysregulation of NO production causes a decrease in 
bacterial killing and induction of macrophage necrosis rather than apoptosis197. 
 
Tumor necrosis factor α stimulates endothelial cell activation, which in turn stimulates 
neutrophil transmigration and activation, including ROS production52. Both TNFα and IFNγ 
activate iNOS transcription52. Nitric Oxide produced by iNOS is thought to be important for 
pulmonary neutrophil infiltration, potentially by vasodilation of capillaries198. Thus the 
expression of TNFα, IFNγ and iNOS by BAL neutrophils indicates that, alongside bacterial 
killing, these cells were recruiting and activating more neutrophils. Neutrophils in the airways 
had not highly induced Ptgs2 like lung and LdLN neutrophils. This could further indicate that 
these neutrophils are highly activated and solely polarized to generate inflammation to directly 
kill bacteria, not to promote anti-inflammatory responses.  
 
Lung and LdLN neutrophils were in an intermediate state between that of ‘quiescent’ blood 
neutrophils and activated alveolar neutrophils. During transmigration of the endothelium 
neutrophils become primed, once in the tissue they fully activate. There is no clear definition of 
the process of neutrophil priming, or the phenotype of primed neutrophils, thus it is difficult to 
conclude if lung and LdLN neutrophils were ‘primed’ or ‘activated’. However, due to the high 
percentage of ROS+ cells observed without ex vivo stimulation of the neutrophils, perhaps the 
lung and LdLN neutrophils were beyond priming and were activated, with alveolar neutrophils 
in a highly activated state.  
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Using in vivo inflammation models it is challenging to capture ‘primed’ neutrophils. At an 
inflammatory site, many inflammatory mediators are released from a variety of hematopoietic 
and non-hematopoietic cells. Thus the neutrophils may experience “priming” agents within 
seconds, or even at the same time as binding the activation agent. The majority of the work 
characterising neutrophil priming has been performed in vitro. In vitro it is possible to 
sequentially add these mediators, for example TNFα followed by fMLP44, however this is 
unlikely to occur in vivo during an inflammatory immune response. 
 
3.6.3 ICAM-1 expression on neutrophils 
In the lung, airways and LdLN neutrophils were found to express high levels of ICAM-1. Thus 
activated neutrophils expressed ICAM-1. This is consistent with what has been found in human 
lung neutrophils; BAL fluid neutrophils from both normal healthy individuals and sarcoidosis 
patients express ICAM1, however blood neutrophils from either patient groups do not express 
it199. The same is seen for neutrophils from the colitic colon67. ICAM-1 is expressed on many 
cell types, its up-regulation is a signature event in tissue inflammation. Tumor necrosis factor α, 
IL-1β and IFNγ, all neutrophil activating cytokines, all are known to up-regulate ICAM-1200. 
Thus it is perhaps not surprising that activated neutrophils were expressing ICAM-1. Clearance 
of neutrophils by tissue macrophages during an immune response is an important mechanism of 
controlling neutrophil release from the bone marrow and for inflammation resolution. ICAM-1 
is a ligand for CD11b, thus perhaps ICAM-1 on neutrophils helps mediate macrophage uptake 
of neutrophils through CD11b. 
 
Expression of ICAM-1 protein on neutrophil membrane may be modulated by many factors 
other than transcription. Neutrophil arrest, crawling and transendothelial migration is dependent 
on neutrophil CD11b-endothelial cell ICAM-1 interaction. Thus perhaps during the process of 
transendothelial migration neutrophils rip ICAM-1 off the surface of endothelial cells, leaving it 
bound to CD11b on their surface, and thus making them positive for ICAM-1 when analysed by 
flow cytometry. This process is known as trogocytosis, or trans-endocytosis. It occurs between 
APCs and lymphocytes at the immune synapse, the lymphocyte extracts APC surface 
molecules201,202. However this process involves endocytosis and degradation of acquired 
molecules. Thus with such high percentages of neutrophils positive for ICAM-1, at high MFI, it 
seems unlikely that neutrophils are ripping ICAM-1 from other cells. Q-PCR analysis of ICAM-
1 gene transcription would demonstrate if neutrophils really are making ICAM-1, or acquiring 
it. 
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3.6.4 Clues to neutrophil function in the LdLN following acute pulmonary S. 
pneumoniae infection 
The data presented in this chapter sheds light on neutrophil phenotype within LdLN and hints at 
their function. Neutrophils were activated, producing ROS, thus they could represent another 
line of defense in the LN, killing bacteria that enter the LN. This has been proposed as an 
essential step for preventing systemic spread of bacteria139. Indeed they were situated in close 
proximity to SIGN-R1+ macrophages that are known to be important for uptake of S. 
pneumoniae in the spleen203. Thus neutrophils could be acting in addition to these macrophages 
to clear S. pneumoniae from the lymph fluid, or indeed modulating tissue resident macrophage 
function. 
  
Neutrophils may also function further to bacterial clearance in the LdLN and be involved in 
early T cell activation. CD11c and MHC II expression was detected on small percentages of 
neutrophils; these molecules are hallmarks of APCs. Thus some LdLN neutrophils may be 
developing professional APC function. This has been demonstrated in other infection and 
inflammatory models. In chronic colitis MHC II is expressed highly on neutrophils in the colon, 
and to lower levels on neutrophils in the mesenteric LN. However in this model CD11c 
expression was not detected. In vitro these MHC II+ neutrophils are indeed able to present 
antigens to T cells67. ICAM-1 was also expressed by neutrophils. This was also observed on 
neutrophils in the mesenteric LN and colon of a colitic mouse model, however not on blood 
neutrophils168, similar to results seen in this project. On DCs ICAM-1 binds CD11a on T cells 
co-stimulating T cell activation and stabilizing the immune synapse184. DCs also skew the 
differentiation of TH subsets through cytokine secretion. Lung dLN neutrophils were found to 
express Ifng mRNA, thus could have a role in TH1 differentiation. It would be interesting to 
investigate if the MHC II+ neutrophils were also producing IFNγ. 
 
The location of LN neutrophils in the lymphatic sinus and that less than 10% of neutrophils 
were CD11c or MHC II positive however indicates that a T cell activation role may be unlikely 
as T cell activation occurs in the LN paracortex. Alternatively LdLN neutrophils could be 
having a contact-independent inhibitory effect on T cells; ROS production, Nos2 and Ptgs2 
gene expression are consistent with this. Reactive oxygen species production by T cells 
themselves modulates T cell proliferation, however bystander neutrophils have also found to 
have the same effect204. Nitric oxide produced by iNOS in macrophages and mesenchymal stem 
cells also has a suppressive role on T cell proliferation205,206. Finally prostanoids are anti-
inflammatory, significantly neutrophil thromboxane A2 is found to be suppressive of T cell 
activation170. 
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Expression of APRIL and BAFF mRNA in LdLN neutrophils did not differ from expression in 
blood neutrophils, it was indeed lower. This suggests that, unlike in the spleen, LdLN 
neutrophils may not function as ‘B-helper’ cells. This could be due to the difference in the 
location. B-helper splenic neutrophils were involved in MZ B cell activation to TI antigens, 
however in the LN B cells predominantly respond to TD antigen. Alternatively the difference 
could be attributed to the fact that the mice had never previously been exposed to S. 
pneumoniae, so there were unlikely to be a pool of plasma cells in the medulla. Thus 
neutrophils in the LdLN medulla, early in infection, may not be functioning to provide B cell 
survival factors to plasma cells.  
 
3.6.5 Investigating neutrophil function in the lymph node 
The data presented in this chapter provides an in depth characterization of neutrophil 
recruitment, location and phenotype in the LdLN following pulmonary S. pneumoniae infection. 
It also starts to dissect whether LdLN neutrophils resemble circulating, lung tissue or alveolar 
neutrophils, or another phenotype entirely. This has not been done before in this infection model 
or, to date, in another model. Lacking in this work is the identification of a function for LdLN 
neutrophils. Hypotheses for neutrophil function can be drawn from gene expression analysis, 
however there has been no demonstration of protein production, for example cytokine detection 
by flow cytometry or enzyme-linked immunosorbant assay (ELISA), thus no direct conclusions 
on neutrophil function can been made.  
 
Many studies investigating the function of neutrophils use the anti-Ly6G, clone 1A8, antibody 
to deplete neutrophils and then look for changes in immune responses in the absence of 
neutrophils, thus indicating neutrophil function. This was not done in this study. As described in 
Chapter 2.12, preliminary experiments were carried out to deplete neutrophils using the 1A8 
antibody however neutrophil depletion was not achieved. Thus no functional experiments using 
neutrophil depletion were conducted, as neutrophil depletion could not be confirmed. The lack 
of depletion may be down to the antibody used being defective, or too low dose administered, 
however a comparable, if not higher dose to that in other studies was used; 500 µg. Antibody 
protein concentration of the stock was confirmed using a nano-drop spectrophotometer to 
ensure correct dosing. Alternatively the antibody may not actually cause neutrophil depletion, 
rather block neutrophil migration out of the blood207,208. However this phenomenon was 
observed using a 100-fold lower dose of 5 µg. 
 
A study aimed to prove that neutrophils contribute to chronic oviduct pathology following 
chlamydial infection. To do this 1A8 depletion of neutrophils was utilized, using doses of 300 
µg 1A8 given i.p. Depletion of Ly6Ghi neutrophils from the circulation was confirmed, however 
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there was no effect on disease pathology, indeed there were comparable levels of TNFα, IL-6 
and IL-1β in tissue homogenates. This was not expected due to previous results and other 
studies all pointing to neutrophils as having a major role in pathology. Further investigation 
revealed a robust infiltration of Gr1low immature neutrophils in the oviduct, taking the place of 
Ly6Ghi neutrophils in their absence209. The same was observed in attempts to deplete 
neutrophils in this thesis. Treatment with 1A8 resulted in the disappearance of Gr1hi cells but 
the appearance of an equivalent percentage of Gr1int cells. Perhaps depleted mature neutrophils 
were rapidly replaced by immature neutrophils, as opposed to a down-regulation of Gr1 in 
response to 1A8 binding. Cell sorting, followed by Giemsa staining would answer this question. 
Mature and immature neutrophils can be distinguished by their nuclei; mature cells have 
segmented nuclei, whereas immature cells have ring-shaped, band nuclei210. 
 
 It is very difficult with existing technologies to selectively target LdLN neutrophils without 
disturbing the balance of the immune response in the draining tissue. Any method would also 
affect lung neutrophils, with most methods likely affecting neutrophil trafficking to the lung. 
Neutrophils have been observed in the LN in several different types of infection (bacterial, viral 
and parasitic), but also immunization models, however no clear, agreed, function has been 
found for them. The difficulty in targeting LN neutrophils alone could be the reason for this. 
 
3.7 Conclusion 
In line with the hypothesis neutrophils were indeed found to migrate to the tissue dLN during 
acute pulmonary infection with S. pneumoniae. This was very rapid and neutrophils in the 
LdLN showed an altered, less activated phenotype to airway neutrophils in the BAL fluid. 
Interestingly lung tissue neutrophils shared this phenotype. However a role for neutrophils in 
the LdLN was not elucidated. The dense population of neutrophils found in the LN lymphatic 
sinus was very interesting. The lymphatics sit below the capsule of the LN, making this area 
easy to image by real-time microscopy. Thus to further the in-depth analysis of neutrophils in 
the LdLN, the dynamics and migration mechanisms of neutrophils was investigated using 4D 
multi-photon microscopy of LdLN explants.  
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Chapter 4: Investigating neutrophil dynamics and 
migration mechanisms in the lung draining lymph node 
4.1 Molecular mechanisms of leukocyte migration 
Neutrophils and indeed all leukocytes migrate as single cells using ‘amoeboid’ cell migration. 
This form of migration is similar to that used by the amoeba Dictyostelium discoideum. Cells 
can assume many different shapes, immobile leukocytes are rounded (Figure 4.1 a), however 
during migration they polarise and develop a leading edge (lamellipod), mid-body and uropod; 
the trailing edge of the cell (Figure 4.1 b). Amoeboid cell migration is very fast, with 
neutrophils found to move up to 30 µm/min; this enables rapid scanning of the extracellular 
environment. It is also weakly adhesive, strong focal adhesions to the tissue are not required, 
thus avoiding tissue destruction211.  
 
 
Figure 4.1: Amoeboid cell polarisation and migration. 
Diagrams of the molecular components and processes involved in amoeboid cell polarisation 
and subsequent migration. Diagram (a) depicts the shape change from an immobile, rounded 
cell, to a highly polarised migrating cell (b) with a leading edge, mid-body and uropod. 
Diagrams (c), (d) and (e) show the subcellular molecular machinery involved in maintaining 
cell polarisation and driving forward migration. From Friedl and Weigelin, 2008211. 
  
At the leading edge dynamic ruffling of the cell membrane and short-lived protrusions, 
pseudopodia, are generated by rapid generation of networks of actin filaments. Various 
receptors at the leading edge include Fc receptors (FcR), chemokine receptors and β2 integrins. 
These make the leading edge of the cell highly sensitive to receptor engagement and thus signal 
transduction and phagocytosis. The mid-body is immobile and contains the cell nucleus. This 
region is essential in maintaining the front-rear axis by creating a stiff core through actinmyosin 
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filaments, preventing lateral protrusion formation. The uropod contains microtubules and 
mitochondria; it has various adhesion molecules at the surface and forms the adhesive and 
contractive rear of the cell. The uropod forms cell-ECM and cell-cell interactions211. The 
underlying mechanism of amoeboid cell migration involves actin polymerisation at the leading 
edge, pushing the cell forwards, followed by actinmyosin contraction at the rear, releasing the 
cell.  
 
Cell polarisation is induced in response to a wide range of extracellular signals including; 
cytokines, chemokines, lipids, alarmins, formyl peptides and complement factors. Leukocytes 
integrate these signals into intracellular signalling cascades and as a result shape change, cell 
polarisation and cell migration occurs. Cell polarisation, followed by directed migration towards 
a soluble gradient of chemokine is termed chemotaxis. However cells can also polarise and 
migrate in homogenous fields of soluble chemokines, without a gradient, this is called 
chemokinesis. Directed migration along a surface in response to a surface-bound chemokine 
gradient is called haptotaxis, whereas non-directed migration is haptokinesis212.  
 
G-protein coupled receptors, coupling to Gαi G proteins signal through PI3K to mediate cell 
migration and polarisation. Class I PI3Ks are heterodimeric proteins that consist of a catalytic 
and a regulatory subunit. Class IA PI3Ks are PI3Kα, β and δ, they are characterised by having a 
p85 regulatory subunit that binds the p110α, β and δ catalytic subunit. There is only one 
member of class IB PI3K; PI3Kγ. This is also a heterodimer, and consists of a regulatory 
subunit p101 or p84 that binds the catalytic subunit p110γ. Class I PI3Ks are mainly involved in 
receptor tyrosine kinase signalling, however class IB PI3Kγ is mainly activated by GPCRs. 
Thus PI3Kγ, that is mainly restricted to hematopoietic cells, is involved in cell migration. 
However there is evidence that the hematopoietic restricted class IA PI3Kδ also has a role in 
immune cell migration213. The Gβγ subunit of Gαi coupled GPCRs directly binds to the catalytic 
p110γ domain of PI3Kγ, recruiting it to the cell membrane where it becomes activated. The 
p110γ domain of the active kinase binds the membrane lipid phosphatidylinositol-3,4-
bisphosphate (PIP2) and also adenosine triphosphate (ATP). A phosphate is transferred from 
ATP to PIP2, phosphorylating it to generate phosphatidylinositol 3,4,5-triphosphate (PIP3) at 
the leading edge of the neutrophil. The serine-threonine kinase Akt (also known as protein 
kinase B) binds PIP3 inducing Akt activation; Akt is then able to activate Rac, a member of the 
Rho family of small GTPases211. Rac, and also the small GTPase Cdc42 activate WASP family 
verprolin-homologous protein (WAVE/Scar) and the actin-related protein 2/3 (ARP2/3) 
complex. WAVE is an actin binding protein that generates actin filaments (F-actin) and ARP2/3 
causes the sideways branching of F-actin. Rac is important for membrane protrusion and cell 
movement; in contrast Cdc42 is important in directional sensing. Without Rac cells do not 
move, however without Cdc42 cells are still able to move, but their migration is random and 
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they are no longer able to sense chemotactic gradients214,215. Other pathways, independent of 
PI3Kγ, also induce Rac dependent actin filament generation. Accumulation of PIP3 at the 
leading edge ultimately leads to local Rac activation, F-actin generation and pushing forward of 
the plasma membrane (Figure 1.2 c)211. 
 
In the mid-body, and also the uropod the GTPase RhoA works to generate stiffness to limit 
lateral protrusion formation. RhoA activates Rho-associated protein kinase (ROCK) that 
phosphorylates the cytoskeletal motor protein myosin II, increasing its activity214. Myosin II 
cross-links and contracts F-actin. This generates a rigid core to the cell and pushes the nucleus 
forwards. Alongside actinmyosin stiffness controlling the mid-body and uropod, the 
phosphatase and tensin homolog (PTEN) works to dephosphorylate PIP3 and the kinases PI3Kγ 
and Akt, thus preventing protrusion formation211. 
 
Integrins are also involved in amoeboid cell migration, however they are not always essential, in 
non-adhesive environments leukocytes can migrate in an integrin-independent manner. Integrins 
form dynamic, weakly-adhesive nascent adhesions and focal contacts with the ECM. The actin-
binding proteins talin and vinculin link the cytoplasmic domain of integrins to intracellular 
actinmyosin fliaments216. Contraction of the actin filaments by myosin II causes retrograde 
pulling on the integrins, pushing the cell forward217. These nascent adhesions rapidly turn over 
at the leading edge and allow the fast traction of these cells across the ECM. Integrins activate 
the spleen tyrosine kinase (Syk), which is found to associate with CD18 at the leading edge; 
Syk is involved in maintaining the leading edge and thus cell polarity during chemotaxis. In 
vitro, Syk deficient neutrophils form multiple lamellipodia and when migrating on immobilised 
fibrinogen show defective migration towards fMLP in comparison to wild type 
neutrophils218,219. 
 
4.2 Leukocyte migration is environment dependent 
Since the early use of D. discoideum, DCs have been used as a model of amoeboid cell 
migration in vitro, ex vivo and in vivo. Work has found that these cells can rapidly adapt to the 
extracellular environment and switch migration mechanisms. When moving from adhesive to 
non-adhesive surfaces in vitro they switch from integrin-dependent to integrin-independent 
migration allowing maintenance of cell speed and amoeboid migration220. In vitro assays using 
3D collagen (type I) gels or 2D assays where cells migrate on surfaces coated with integrin 
ligands for example, reveal that leukocyte migration is context dependent. In 3D collagen gels 
migration is integrin-independent, relying only on actin polymerisation driving the cell through 
the collagen network. This has been demonstrated using T cells with blocked integrin function, 
or B cells, neutrophils and DCs depleted of all integrins217. However in 2D leukocytes migration 
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is integrin-dependent. Integrin mediated adhesion is required for migration; macrophages and 
DCs depleted of integrins can’t adhere to ligand-coated 2D tissue culture dishes and thus can’t 
migrate212,217. 
 
In vitro assays however do not reflect the true physiological environments leukocytes migrate in 
in vivo. Explant imaging and intravital microscopy studies have been essential in providing 
insight into immune cell migration in vivo. The interstitial space of mouse skin is dense with 
extracellular matrix, type I collagen is the major constituent of this. Collagen I forms a thick 
mesh with other extracellular matrix components, as well as blood vessels, lymphatics, fat cells, 
nerves and muscle fibres. In this environment neutrophil and DC migration is integrin 
independent; DCs depleted of all integrins and neutrophils lacking β2 integrins migrate at similar 
speeds and directionality as wild-type neutrophils in the same tissue33,217. 
 
The process of TEM in extravasation from the circulation can be seen as a 2D process. 
Neutrophils must firmly adhere to the vessel wall to resist the sheer flow of the blood. They 
must then crawl along the lumen to find a suitable exit point to cross the endothelial cell layer. 
In this context neutrophil migration is integrin-dependent, neutrophils depleted of all integrins, 
or deficient in β2 integrins only can’t perform TEM, and thus can’t infiltrate tissues28,217. Unlike 
the interstitial space of non-lymphoid organs, lymphoid organs are densely packed with 
lymphocytes and stromal cells, with little accessible ECM. In this setting DC migration within 
the LN was integrin-independent; DCs lacking all integrins migrate with comparable speed and 
dynamics to wild-type DCs217. Dendritic cell migration to LNs is also shown be integrin-
independent, but dependent on the chemokine receptor CCR7217. T cell migration within the LN 
is also highly dependent on chemokine receptor signalling and actin-myosin dynamics221. 
However, integrins do have a role in their migration; blocking T cell CD11a reduces their 
velocity in the paracortex222. Interestingly in the medulla integrins have a key role in T cell 
migration and dynamics, T cell CD11a mediates adhesion dependent migration on the 
lymphatic endothelium, preventing their early exit from the LN, allowing them to re-enter and 
scan the para-cortex223.  
 
4.3 Investigating leukocyte migration  
To investigate live cellular migration, in real time, ex vivo or in vivo, microscopy has been used 
in combination with fluorescent reporter mice where DNA encoding fluorescent proteins is 
inserted into the genome of animals including zebrafish and mice, allowing visualisation of 
particular cell types, often depending on the expression of a gene of interest, or a gene unique to 
that cell type. In order to investigate neutrophils in tissues, lineage specific fluorescent reporter 
mice have been used. The work in this thesis has utilized B6.LysM Cre mice that have the Cre 
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recombinase gene inserted into the translational start site of the lysozyme M gene. Lysozyme M 
is expressed by monocytes, macrophages and neutrophils156. B6.Rosa26 mT/mG mice are 
double fluorescent reporter mice. The mT/mG cassette consists of the membrane targeted 
tdTomato (mT) gene and a transcriptional stop sequence in between two loxP sites and 
downstream of the Rosa26 promoter. Distal to the last loxP site is the membrane targeted EGFP 
(mG) gene. The cassette is in the Rosa26 locus on chromosome 6, this locus is a ubiquitously 
expressed, thus all cells contain the mT/mG cassette. B6.Rosa26 mT/mG mice express 
tdTomato fluorescent protein in all cells, however upon Cre excision, Cre+ cells express GFP. 
Thus crossing B6.LysM Cre mice with B6.Rosa26 mT/mG mice generates B6.LysM Cre x 
B6.Rosa26 mT/mG F1 progeny that have GFP+ monocytes, macrophages and neutrophils157. 
This approach has been used in a number of studies to understand myeloid lineage cellular 
dynamics. 
 
To understand what receptors, molecules and signalling pathways are involved in driving 
cellular migration blocking antibodies, receptor agonist and antagonist compounds, as well as 
small molecule inhibitor compounds can be utilized. Thus to investigate what receptors and 
pathways could be involved in neutrophil migration within the LdLN this strategy was utilized, 
focusing on key chemotactic effectors such as PI3Kγ and δ, LTB4 and the role of integrins and 
Syk signalling in cellular behaviour.  
 
4.4 Summary 
Leukocytes are capable of rapidly adapting their migratory mechanisms to their environment, 
allowing their efficient migration. Neutrophil extravasation can be seen as a 2D process that is 
highly dependent upon integrins. However in the ECM-rich environment of the non-lymphoid 
interstitium their migration is integrin independent. The LN is a 3D structure, tightly packed 
with cells and no ECM to negotiate, thus we hypothesis that the mechanisms driving neutrophil 
migration will be tissue specific rather than cell intrinsic; migration mechanisms of neutrophils 
in the LN will differ from those required for peripheral tissue infiltration and migration. Thus 
we aim to determine the molecular mechanisms regulating neutrophil dynamics in tissue dLNs. 
 
4.5 Aims 
• Investigate ex vivo, in real time, neutrophil dynamics and behavior in the LdLN in an 
explant system. 
• Understand the molecular mechanisms controlling neutrophil migration within the 
LdLN. 
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4.6 Results 
4.6.1 Tracking neutrophils using GFP B6.LysM Cre x B6.Rosa26 mT/mG F1 
mice 
Flow cytometry experiments revealed that at the peak of neutrophil recruitment inflammatory 
monocytes were also found in the LdLN (Figure 3.1). Thus neutrophils and inflammatory 
monocytes were analysed in B6.LysM Cre x B6.Rosa26 mT/mG F1 mice to determine if the 
different cell types could be distinguished. In these mice, in the blood 89.5% (± 1.38) of 
neutrophils were GFP+, similarly in the spleen 87.7% (± 1.18) were GFP+ (Figure 4.2). There 
were significantly fewer GFP+ monocytes; in the spleen 28.2% (± 2.53) were GFP+, whilst in 
the blood only 16.1% (± 2.0) were GFP+. Analysis of the GFP+ cells revealed that neutrophils 
had a significantly higher MFI for GFP. Thus neutrophils could be distinguished from 
monocytes based on GFP expression and fluorescence intensity in B6.LysM Cre x 
B6.Rosa26mT/mG F1 mice. In addition to GFP expression, when imaging the cells ex vivo in 
the LdLN explant, the characteristic neutrophil lobed nuclear morphology was visible, thus 
neutrophils were distinguished on this basis (Chapter 4.6.2). These fluorescent reporter mice 
were therefore suitable for use to image neutrophil dynamics in LNs using multiphoton 
microscopy. 
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Figure 4.2: Neutrophils were distinguished from monocytes in B6.LysM Cre x B6.Rosa26 
mT/mG F1 mice by GFP expression. 
Quantification of flow cytometry plots gated on CD11b+ cells. Percentage of GFP+ neutrophils 
(Ly6Cint Ly6G+) and inflammatory monocytes (Ly6C+ Ly6G-) in the blood (A i) and spleen (B 
i) of B6.LysM Cre x B6.Rosa26 mT/mG F1 mice after 24 hour S. pneumoniae infection. GFP 
MFI of GFP+ neutrophils and inflammatory monocytes in the blood (A ii) and spleen (B ii). 
Compared to monocytes, more neutrophils were GFP+, of the GFP+ neutrophils and monocytes, 
neutrophils had a higher GFP MFI and thus were distinguishable from monocytes. n=5, bars 
represent mean + SEM, * P<0.05 and ** P<0.01 (Mann-Whitney U test). 
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4.6.2 Visualising neutrophil dynamics in the lung draining lymph node using ex 
vivo explant imaging  
To visualize neutrophil dynamics in the LdLN explant imaging was used, in combination with 
multiphoton laser scanning microscopy. Mice received intranasal administered heat inactivated 
S. pneumoniae, were sacrificed then the LdLN removed and placed into warmed RPMI culture 
medium that contained no supplements. Under a dissecting microscope any fat or connective 
tissue was removed from around the LdLN. This was done as quickly as possible, and as 
carefully as possible to cause as little damage or stress to the LdLN as possible. The LdLN was 
then placed in a glass bottom dish (No 1.5 glass, MatTek) containing approximately 75 µl of 
RPMI (supplement free) that was warmed to 37°C. A glass cover slip was then placed over the 
LdLN, this was done to ensure the LdLN stayed in place and to limit evaporation of the RPMI 
around the LdLN. Extra RPMI was then added at the edges of the dish as an extra measure to 
limit evaporation of media surrounding the LdLN. The dish was then placed on the microscope 
stage, the microscope had a light tight incubator fitted that kept the chamber at 37°C, thus the 
LdLN was kept at 37°C. The LdLN was then imaged using the multiphoton laser. A summary 
of the explant culture system used is shown in Figure 4.3 (A). A typical single image from a 4D 
time lapse sequence is shown in Figure 4.3 (B i). The collagen of the LdLN capsule was 
visualized by second-harmonic generation. LysM- cells were identified by tdTomato expression. 
Vasculature in the LdLN had high tdTomato expression; however other cells, particularly 
haematopoietic cells, had lower expression. LysM+ GFP+ cells, of various morphologies, were 
clearly visible. Large immotile GFP+ cells had morphologies similar to SSM and MSM. The 
only highly motile GFP+ cells were bright for GFP and had visible lobed nuclear morphology 
(Figure 4.3 B ii), thus these cells were classified as neutrophils and in quantification were 
tracked specifically on these criteria. The software Volocity was used to track these cells; 
arrows in Figure 4.3 (B i) indicate three representative neutrophils that were tracked using this 
software. Figure 4.3 (B iii) shows a graph of the tracks of these neutrophils. The tracks were 
plotted from an arbitrary starting position of zero. Cell tracking showed that neutrophils were 
highly dynamic in X, Y and Z planes. Serial stills of a GFP+ neutrophil found in Video 1 
demonstrates how dynamic the shape of neutrophils was, enabling them to rapidly navigate the 
tightly packed LN microenvironment (Figure 4.4, Video 1). Neutrophils showed classic 
amoeboid cell morphology with a distinct leading edge (lamellipod) and tail (uropod) when 
migrating in the LdLN. 
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Figure 4.3: Explant imaging was used to visualise neutrophil dynamics in the LdLN in 3D, 
in real time.  
(A) Diagram of explant imaging set up. Arrow indicates direction of multiphoton laser. (B i) 
B6.LysM Cre x B6.Rosa26 mT/mG F1 mice were used to visualise neutrophils in the LdLN. 
Collagen LdLN capsule (blue) was visualised by second-harmonic generation. LysM- 
tdTomato+ cells (red), LysM+ GFP+ cells (green). Large immotile GFP+ cells had morphologies 
similar to SSM and MSM. Motile GFP+ cells were neutrophils. Scale bar= 25 µm. (B ii) 
Neutrophil migration was quantified by cell tracking using Volocity software (PerkinElmer). 
Cell tracks from neutrophils identified by arrows in (B i). (B iii) The characteristic lobed nuclei 
of neutrophils is easily identified in motile GFP+ cells. Scale bar= 4.2 µm. 
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Figure 4.4: Neutrophil cell shape was highly dynamic during migration in the LdLN. 
Sequential stills from video 1 showing the migration of one GFP+ neutrophil. Explant imaging 
of the LdLN from a B6.LysM Cre x B6.Rosa26 mT/mG F1 mouse after 6 hours of pulmonary S. 
pneumoniae infection. Scale bar= 4.2 µm. 
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4.6.3 Dynamic neutrophil migration in the lung draining lymph node following 
pulmonary S. pneumoniae infection  
Very few migrating GFP+ neutrophils were found in naïve mice (Figure 4.5 stills from videos 2-
9). Video 2 shows a LdLN from a naïve mouse, and video 3 shows a LdLN from a mouse that 
received intranasal PBS and was sacrificed after 19 hours. The videos are representative of the 
whole LdLN. In contrast after 2, 6, 12, 24, 48 and 72 (videos 4-9) of pulmonary S. pneumoniae 
infection highly motile neutrophils were observed below the capsule of the LdLN. Videos 6 and 
10 show the close interactions of neutrophils and large sessile GFP+ cells, likely to be MSMs. In 
each experiment Z stack videos were collected covering all areas of the LdLN that were 
imageable. The LdLN was turned over in the dish after one side was imaged to image the other 
side. Each area was imaged for 30-40 min, covering a Z depth of 21-33 µm, photobleaching of 
the tdTomato occurred during imaging; however this was useful to identify areas that had 
already been imaged so as not to image an area twice. There was no observed effect of imaging 
on neutrophil dynamics or behavior. Each video was analysed using Volocity software and 
neutrophil migration quantified. Figure 4.6 shows the quantification of neutrophil velocity. 
Neutrophils were highly dynamic, moving at an average velocity of 15.5 (± 0.16) µm/min. At 6 
and 12 hours neutrophils had a greater velocity than at other time points investigated; average 
neutrophil velocity was 16.6 (± 0.38) µm/min at 6 and 16.6 (± 0.28) µm/min at 12 hours. 
Interestingly this corresponded to the time when neutrophil numbers peaked in the LdLN 
(Figure 4.6 B). 
 
It has previously been found that neutrophils form swarms in LNs during parasite and bacterial 
infection33,36. In the LdLN following S. pneumoniae infection, neutrophils were also observed to 
form swarms. Neutrophils formed transient swarms, involving small numbers of cells coming 
together for a few minutes, but dispersing. They were also observed forming persistent swarms, 
where neutrophils where continuously recruited to the swarm. These swarms did not disperse 
during the length of imaging, and were still there when the same area was reimaged later in the 
experiment (Figure 4.7, videos 11-13). It was likely that cell death was occurring in the 
persistent swarms, bubbling of the membrane GFP was observed which could have been 
neutrophils undergoing apoptosis, or perhaps NETosis. Neutrophils were tracked moving 
towards swarms, from the same LdLN in areas were swarms were not present these cells were 
also tracked. The presence of a swarm altered the migration of neutrophils, in the presence of a 
swarm there was a mild, but significant increase in neutrophil velocity, however there was a 
profound increase in meandering index (Figure 4.8). Meandering index is a measure of 
directionality and thus swarming alters the directionality of the cells, causing them to travel in 
straighter tracks, towards the swarm. 
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Figure 4.5: Neutrophil migration was dynamic in the LdLN following pulmonary S. 
pneumoniae infection. 
Representative stills from explant imaging videos of the LdLN from B6.LysM Cre x B6.Rosa26 
mT/mG F1 mice; (A) naïve, (B) PBS control, (C) 2 hour, (D) 6 hour, (E) 12 hour, (F) 24 hour, 
(G) 48 hour and (H) 72 hour pulmonary S. pneumoniae infection. Scale bars; A= 130 µm, B and 
D= 25 µm, C and F= 27 µm, E= 28 µm, G and H= 32µm. The corresponding videos are 2-9. S. 
pneumoniae was heat inactivated and labeled with either CTV or PKH26. In the stills both the 
GFP+ sessile macrophages and motile neutrophils are shown. In the videos the distincion 
betweent he two populations is clear due to the motility of the neutrophils. 
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Figure 4.6: Neutrophils in the LdLN were highly dynamic following pulmonary S. 
pneumoniae infection. 
Quantification of neutrophil velocity (A) in the LdLN at 2-72 hours of pulmonary S. 
pneumoniae infection. n=3, red bars represent mean ± SEM, * P<0.05, ** P<0.01 *** P<0.001 
(Kruskal-Wallis test with Dunn's post hoc test). Neutrophils had the highest velocity when their 
numbers were highest in the LdLN. (B) Is Figure 3.4 (A); total neutrophil numbers in the LdLN 
following pulmonary S. pneumoniae infection. 
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Figure 4.7: Neutrophils formed swarms in the LdLN following pulmonary S. pneumoniae 
infection. 
Sequential stills from explant imaging videos of the LdLN from B6.LysM Cre x B6.Rosa26 
mT/mG F1 mice. Top; a transient swarm at 12 hours of infection. Scale bar= 14 µm. Middle and 
bottom; persistent swarms at 6 hours of infection. Scale bars, middle= 31 µm, bottom= 16 µm. 
The corresponding videos are 11-13.  
  
   
 123 
 
Figure 4.8: The effect of swarming on neutrophil migration. 
Quantification of neutrophil velocity and meandering index in the LdLN at 6 hours of 
pulmonary S. pneumoniae infection in the presence and absence of swarms. Neutrophils 
migrating in the presence of a swarm had increased velocity and meandering index. n=3, red 
bars represent mean ± SEM, * P<0.05 and *** P<0.001 (Mann-Whitney U test).  
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4.6.4 Role of phosphoinositide 3-kinase γ in neutrophil migration in the lung 
draining lymph node  
The explant culture set-up allowed addition of compounds and antibodies to the culture to 
directly target cells in the LdLN. Thus blocking agents of signalling pathways known to be 
important in regulating neutrophil migration were added to evaluate if these pathways were 
involved in neutrophil migration within the complex 3D structure of the LdLN. G-protein 
coupled receptor signalling through PI3Kγ is a major signalling pathway driving neutrophil 
migration211. Thus a selective inhibitor of PI3Kγ; Shionogi-12, was used to assess the 
contribution GPCR and PI3Kγ signalling in neutrophil migration within the LdLN following 
pulmonary S. pneumoniae infection. The inhibitor works by binding to the p110γ catalytic 
subunit of PI3Kγ in the ATP binding pocket, thus inhibiting binding of ATP and the 
accumulation of PIP3 at the leading edge. This mechanism is not unique to this inhibitor, all 
kinase inhibitors work in this way. The compound was made by, and provided by GSK 
(Stevenage), it was originally designed and synthesised by Shionogi & Co, Ltd, in Japan, 
example number 12 in patent WO2010/125799. The IC50 of an inhibitor compound is the 
concentration that inhibits the response by 50%. This value is used to determine potency or 
selectivity for a target. The IC50 of Shionogi-12 for PI3Kγ inhibition is 0.003 µM, whereas the 
IC50 values for PI3Kα, PI3Kβ and PI3Kδ are 15.9, 1 and 1.26 µM (unpublished data from 
GSK). Thus Shionogi-12 is highly selective for PI3Kγ. 
 
The LdLN was first explant imaged as described in Chapter 2.9 and Figure 4.3, images were 
collected for approximately one hour. Two videos were acquired, one from each side of the 
LdLN corresponding to the medullary sinus and the subcapsular sinus. This gave a ‘baseline’ 
for neutrophil migration in the absence of the inhibitor. The LdLN was then placed in 1ml of 
warmed RPMI containing 10 µM Shionogi-12 and incubated at 37 °C, in the dark, for 30 
minutes. Following the incubation period the LdLN was explant imaged in RPMI containing 10 
µM Shionogi-12. As with previous explant imaging experiments, Z stack videos were collected 
covering all areas of the LdLN that were imageable. Neutrophil migration was quantified using 
Volocity software. This methodology was employed for all compounds tested. Neutrophil tracks 
in X and Y dimensions were plotted from a starting position of zero, the corresponding videos 
are 14 and 15 (Figure 4.9 A). PI3Kγ inhibition clearly inhibited neutrophil migration, with most 
neutrophils not moving far from their original starting position. PI3Kγ inhibition had a profound 
effect on neutrophil velocity, reducing it by 47.8% (Figure 4.9 B). The same effect was 
observed on neutrophil meandering index, with a reduction of 48% (Figure 4.9 C). Thus PI3Kγ 
inhibition severely impaired both the velocity of neutrophils but also their random 
directionality. 
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Figure 4.9: Investigating the effect of PI3 Kinase γ inhibition on neutrophil migration in 
the LdLN following pulmonary S. pneumoniae infection. 
Explant imaging of the LdLN from B6.LysM Cre x B6.Rosa26 mT/mG F1 mice after 6-12 
hours of pulmonary S. pneumoniae infection. Neutrophil tracks in X and Y planes, starting 
position set to zero, before (A i) and after (A ii) addition of 10 µM PI3Kγ inhibitor Shionogi-12. 
Quantification of neutrophil velocity (B) and meandering index (C) before and after the addition 
of 10 µM Shionogi-12. PI3Kγ inhibition impaired neutrophil migration in the LdLN. Pooled 
data from three experiments, n=3, red bars represent mean ± SEM, *** P<0.001 (Mann-
Whitney U test).   
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4.6.5 Role of phosphoinositide 3-kinase δ in neutrophil migration in the lung 
draining lymph node  
The in vivo role of PI3Kδ signalling in cell migration is not as clear as it is for PI3Kγ. PI3Kδ 
does not couple to GPCRs like PI3Kγ, but binds tyrosine-kinase linked receptors. In NK cells 
and B cells, PI3Kδ signalling has been shown to be involved in chemotaxis and activated 
downstream of selected chemokine receptors224,225. Production of ROS in response to 
stimulation of human neutrophils with fMLP, is inhibited by PI3Kδ inhibition44. The fMLP 
receptor FPR is a GPCR. Thus PI3Kδ may be involved in chemokine receptor signalling, 
however how it fits in the signalling cascade is not clear. To investigate the role of PI3Kδ 
signalling in neutrophil migration in the LdLN the specific inhibitor IC87114162 was utilized. 
IC87114 binds the p110δ catalytic domain binding pocket, inhibiting ATP binding. The IC50 of 
IC87114 for PI3Kδ inhibition is 0.5 µM, whereas the IC50 values for PI3Kα, PI3Kβ and PI3Kγ 
are >100, 75 and 29 µM. Thus IC87114 is highly selective to PI3Kδ. In vitro it is selective at a 
concentration range of 0.3-10 µM162. Like PI3Kγ, PI3Kδ inhibition impairs neutrophil migration 
(Figure 4.10 A). The corresponding videos are 16 and 17. The velocity (Figure 4.10 B) and 
meandering index (Figure 4.10 C) of neutrophils was significantly impaired by PI3Kδ 
inhibition, with a 37.8% and 39% reduction in velocity and meandering index respectively. This 
was significantly less than that observed for PI3Kγ. 
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Figure 4.10: Investigating the effect of PI3 Kinase δ inhibition on neutrophil migration in 
the LdLN following pulmonary S. pneumoniae infection. 
Explant imaging of the LdLN from B6.LysM Cre x B6.Rosa26 mT/mG F1 mice after 6 hours of 
pulmonary S. pneumoniae infection. Neutrophil tracks in X and Y planes, starting position set to 
zero, before (A i) and after (A ii) addition of 10 µM PI3Kδ inhibitor IC87114. Quantification of 
neutrophil velocity (B) and meandering index (C) before and after the addition of 10 µM 
IC87114. PI3Kδ inhibition impaired neutrophil migration in the LdLN. Pooled data from three 
experiments, n=3, red bars represent mean ± SEM, *** P<0.001 (Mann-Whitney U test).  
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4.6.6 Role of leukotriene B4 in neutrophil migration in the lung draining lymph 
node  
Leukotriene B4 is a potent chemoattractant of neutrophils, acting on the GPCR BLT1. It has 
been described as a ‘relay signal’, produced by neutrophils themselves, stimulating their own 
migration in an autocrine and paracrine mannor34 in vitro. In vivo LTB4 is involved in initial 
neutrophil recruitment to inflammatory sites226,227. It was also demonstrated to be involved in 
neutrophil swarm formation33 recruiting neutrophils to the swarm. Thus the BLT1 antagonist 
LY223982163 was used to inhibit LTB4 signalling and investigate the role of LTB4 in neutrophil 
migration in the LdLN. Similar to PI3Kγ inhibition, BLT1 antagonism impaired neutrophil 
migration (Figure 4.11 A). The corresponding videos are 18 and 19. The velocity (Figure 4.11 
B) and meandering index (Figure 4.11 C) of neutrophils was significantly impaired by BLT1 
antagonism, velocity was reduced by 35.5% and meandering index by 36.7%. Thus the 
inhibition observed using the PI3Kγ inhibitor may be in part due to inhibition of LTB4 
signalling through BLT1.  
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Figure 4.11: Investigating the effect of LTB4 receptor BLT1 inhibition on neutrophil 
migration in the LdLN following pulmonary S. pneumoniae infection. 
Explant imaging of the LdLN from B6.LysM Cre x B6.Rosa26 mT/mG F1 mice after 6-12 
hours of pulmonary S. pneumoniae infection. Neutrophil tracks in X and Y planes, starting 
position set to zero, before (A i) and after (A ii) addition of 10 µM BLT1 antagonist LY223982. 
Quantification of neutrophil velocity (B) and meandering index (C) before and after the addition 
of 10µM LY223982. BLT1 antagonism impaired neutrophil migration in the LdLN. Pooled data 
from three experiments, n=3, red bars represent mean ± SEM, *** P<0.001 (Mann-Whitney U 
test). 
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4.6.7 Role of sphingosine-1-phosphate in neutrophil migration in the lung 
draining lymph node  
Sphingosine-1-phosphate signalling through S1PR1 has an essential role in controlling T cell 
egress from the LN. S1P receptors are GPCRs, neutrophils express S1PR4, which couples to 
Gαi228. Neutrophils were located in the LdLN in the lymphatic sinus, densely populating the 
medulla (Figure 3.5-7). This region has the highest concentration of S1P, produced by 
lymphatic endothelial cells117. The effect of S1P signalling directly on neutrophils and how it 
affects their migration is not known. However, due to the location of these cells and the effect 
of PI3Kγ inhibition on neutrophil migration, the effect of S1PR inhibition on neutrophil 
migration was investigated. The S1PR1,3-5 agonist FTY720 was used. FTY720 binding induces 
internalization of S1PRs and thus the cells are unresponsive to S1P. Incubation of a cell line 
expressing GFP-tagged S1PR1 with 10 µM FTY720 showed that receptor internalization was 
induced, this was comparable to receptor internalization induced by the receptor ligand S1P 
(Figure 4.12). FTY720 has a high affinity for S1PR4, thus this dose was deemed sufficient to 
induce internalization of S1PR4. Incubation of the LdLN in 10 µM FTY720 impaired neutrophil 
migration (Figure 4.13 A). The corresponding videos are videos 20 and 21. The velocity and 
meandering index of LdLN neutrophils was impaired (Figure 4.13 B and C), however not to the 
extent of PI3K inhibition. Velocity was reduced by 16.5% as compared to 47.8% by PI3Kγ, 
meandering index was reduced by 25.1%, but PI3Kγ inhibition caused a 48% reduction. 
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Figure 4.12: 10 µM FTY720 induced S1P receptor internalisation. 
The U20S S1PR1-GFP cell line was cultured with serum free DMEM, with either acidified 
DMSO, 1:100, as a vehicle control (top panel), 10µM S1P (middle) or 10 µM FTY720 (bottom) 
added for 1 hour. The cells had GFP tagged S1PR1 receptors (green), the plasma membrane 
was stained with CellMask DeepRed and the nuclei with DAPI (blue). 10 µM FTY720 was 
sufficient to induce receptor internalisation, and thus insensitivity to S1P. 
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Figure 4.13: Investigating the effect of S1P receptor inhibition on neutrophil migration in 
the LdLN following pulmonary S. pneumoniae infection. 
Explant imaging of the LdLN from B6.LysM Cre x B6.Rosa26 mT/mG F1 mice after 6-12 
hours of pulmonary S. pneumoniae infection. Neutrophil tracks in X and Y planes, starting 
position set to zero, before (A i) and after (A ii) addition of 10 µM S1PR1,3-5 agonist FTY720. 
Quantification of neutrophil velocity (B) and meandering index (C) before and after the addition 
of 10 µM FTY720. FTY720 inhibition impaired neutrophil migration within the LdLN. Pooled 
data from 3 experiments, n=3, red bars represent mean ± SEM, * P<0.05 and *** P<0.001 
(Mann-Whitney U test).  
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4.6.8 Role of spleen tyrosine kinase in neutrophil migration in the lung draining 
lymph node  
Analysis of mechanisms involved in neutrophil migration in the LdLN found that migration was 
largely chemotactic, mediated by GPCR and PI3K signalling (Figures 4.9-11,13). However 
integrin mediated migration is also known to be a key mechanism for neutrophil migration, 
particularly on 2D surfaces such as vessel walls. Dendritic cell migration in a 3D interstitial 
environment and LNs is reliant on chemokines, however not integrins. T cells utilize both 
integrin dependent and independent migratory mechanisms in the LN, depending on their 
location; in the medulla they utilize integrin mediated migration. Thus it was investigated if 
neutrophil migration in the LdLN was independent or dependent on integrin signalling.  
 
One the signalling molecule required for integrin mediated signalling is Syk which is activated 
by multiple integrins in neutrophils, including the β1, β2 and β3 families. Thus GSK provided a 
highly selective Syk specific inhibitor161 (referred to as GSK143) to assess the contribution of 
Syk signalling in neutrophil LdLN migration. This inhibitor works by binding to the ATP 
binding pocket, preventing access to ATP. GSK143 is highly selective for Syk over other 
protein kinases, of note the IC50 value of GSK143 for Syk is 30 nM, but 18.9 µM for Zeta-
chain-associated protein kinase 70 (ZAP-70), the other member of the Syk kinase family161. Syk 
inhibition did inhibit neutrophil migration (Figure 4.14 A, videos 22 and 23); there was a 
significant reduction in neutrophil velocity (Figure 4.14 B) and meandering index (Figure 4.14 
C), however this impairment was not as marked as the effect observed during PI3Kγ, PI3Kδ or 
LTB4 inhibition. Velocity was only decreased by 15% and meandering index by 14.4%, 
consistent with a role for integrins in neutrophil migration in the LdLN. 
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Figure 4.14: Investigating the effect of Syk inhibition on neutrophil migration in the LdLN 
following pulmonary S. pneumoniae infection. 
Explant imaging of the LdLN from B6.LysM Cre x B6.Rosa26 mT/mG F1 mice after 6-12 
hours of pulmonary S. pneumoniae infection. Neutrophil tracks in X and Y planes, starting 
position set to zero, before (A i) and after (A ii) addition of 10 µM Syk inhibitor GSK143. 
Quantification of neutrophil velocity (B) and meandering index (C) before and after the addition 
of 10 µM GSK143. Syk inhibition had a minor negative effect on neutrophil migration in the 
LdLN Pooled data from three experiments, n=3, red bars represent mean ± SEM, * P<0.05 and 
*** P<0.001 (Mann-Whitney U test).  
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4.6.9 Role of CD11b in neutrophil migration in the lung draining lymph node  
Based on the analysis of Syk inhibition, the role of integrin-mediated neutrophil migration was 
investigated by blocking CD11b on the cell surface, using a known inhibitory antibody clone 
M1/70. CD11b is known to be key in neutrophil migration in vitro and in vivo during 
extravasation, however not in 3D environments. To ensure sufficient antibody was being used 
to target neutrophils, and that the antibody could penetrate the LdLN explant and bind 
neutrophil CD11b; the experiment in Figure 4.15 was performed. LdLN were incubated in the 
same way as they would be for explant imaging; placed in warmed RPMI containing 15 µg/ml 
purified anti-CD11b M1/70 (a rat antibody) and incubated at 37 °C for 45 min. The LdLN were 
then digested and single cell suspension prepared. The cell suspension was first incubated with 
a goat anti-rat secondary antibody to detect the rat anti-CD11b mAb. This incubation was in the 
presence of 5% goat serum to block non-specific binding of the secondary antibody. The cells 
were then washed three times to remove the secondary antibody. Finally the cells were stained 
for neutrophil markers using anti-Gr1 and Ly6C rat antibodies. To ensure no residual secondary 
antibody was binding the anti-Gr1 and Ly6C antibodies an excess of rat IgG was added to the 
staining mix, also an anti-CD4 rat antibody was included. CD4 T cells are not known to express 
CD11b, thus if CD4+ T cells co-stained with the secondary antibody this would be an indication 
of residual secondary antibody binding to the rat antibodies in the second staining step. Analysis 
of LdLN neutrophils showed that 15 µg/ml CD11b was sufficient to bind 98.4% (± 0.7) of the 
neutrophils in the LdLN (Figure 4.15). A low percentage of CD4 T cells co-stained for the 
secondary antibody (4% ± 0.19), thus residual secondary antibody binding was not a problem. 
Incubation of an explanted LdLN with anti-CD11b antibody successfully bound neutrophil 
CD11b, thus blocking neutrophil CD11b. In explant imaging experiments, blockade of CD11b 
reduced both the velocity and meandering index of neutrophils in the LdLN (Figure 4.16 A-C, 
videos 24 and 25), effects were strongest on the meandering index. 
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Figure 4.15: Confirmation of ex vivo anti-CD11b monoclonal antibody clone M1/70 
binding. 
A whole LdLN was incubated with 15 µg/ml purified anti-CD11b mAb M1/70 in RPMI 
medium for 45 mins at 37 °C. The percentage of neutrophils labeled with anti-CD11b was 
assessed by flow cytometry using a goat anti-rat secondary Ab. CD4 T cells were also stained as 
a control for non-specific binding on the anti-rat secondary antibody. Nearly all neutrophils 
were labeled with goat anti-rat secondary Ab. 12 hour, heat inactivated S. pneumoniae, 
representative of one experiment, n=3, bars represent mean + SEM.  
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Figure 4.16: Investigating the effect of CD11b blockade on neutrophil migration in the 
LdLN following pulmonary S. pneumoniae infection. 
Explant imaging of the LdLN from B6.LysM Cre x B6.Rosa26 mT/mG F1 mice after 12 hours 
of pulmonary S. pneumoniae infection. Neutrophil tracks in X and Y planes, starting position 
set to zero, before (A i) and after (A ii) addition of 15 µg/ml purified anti-CD11b mAb M1/70. 
Quantification of neutrophil velocity (B) and meandering index (C) before and after the addition 
of 15 µg/ml M1/70. CD11b blockade had a minor effect on neutrophil velocity, but a bigger 
negative effect on neutrophil directionality in the LdLN. Pooled data from two experiments, 
n=2, red bars represent mean ± SEM. 
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4.7 Summary of results 
• Explant imaging the LdLN was used successfully to investigate neutrophil dynamics in 
the LdLN ex vivo. 
• Neutrophils are highly motile in the LdLN following pulmonary S. pneumoniae infection, 
moving at an average velocity of 15.5 ± 0.16 µm/min. 
• Neutrophils for dynamic swarms. 
• Addition of compounds or blocking antibodies to the explant culture medium can be used 
to investigate pathways involved in neutrophil migration in the LdLN. 
• Neutrophil migration in the LdLN is mainly integrin independent involving PI3K 
signalling, with a minor role for integrin signalling. 
 
Table 4.1 Analysis of mechanisms involved in neutrophil migration within the LdLN 
 
Effect on neutrophil migration 
Compound Mechanism Velocity Meandering index 
Shionogi-12 PI3Kγ inhibition ê48% ê48% 
IC87114 PI3Kδ inhibition ê38% ê39% 
LY223982 BLT1 antagonist ê35% ê37% 
FTY720 S1PR1,3-5 agonist ê17% ê25% 
GSK143 Syk inhibition ê15% ê14% 
M1/70 mAb CD11b blockade ê11% ê39% 
 
4.8 Discussion 
4.8.1 Dynamic neutrophil migration in the lung draining lymph node 
Neutrophil location and phenotype within the LdLN was described in Chapter 3. Using an 
explant imaging system, in combination with fluorescent reporter mice and multiphoton laser 
scanning microscopy, neutrophil dynamics and migration in the LdLN has been investigated in 
this chapter. Neutrophils were found to be highly dynamic in the sinus region of the LN, 
moving below the collagen capsule. Neutrophils were only observed shallow in the LdLN, no 
neutrophils were found deeper in the cortex of the LdLN. This was in line with 
immunohistochemistry results in Chapter three using frozen section staining. Neutrophils 
showed classic amoeboid cell morphology with a distinct lamellipod and uropod when 
migrating in the LdLN. The lobed nucleus was also clear. This was important as in B6.LysM 
Cre x B6.Rosa26 mT/mG F1 mice monocytes and macrophages are also GFP+. Thus being able 
to identify the nuclear morphology reinforces that it was neutrophils that were the highly motile 
GFP+ cells. In the literature it is accepted that during inflammation in the lung ‘stiffening’ of 
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neutrophils is a part of neutrophil activation. This aids in sequestering these cells in the fine 
capillary beds within the lung. In this chapter neutrophils seen in the LdLN did not have a 
‘rigid’ shape. The neutrophil cell shape was highly dynamic, allowing it to move through the 
densely packed LN microenvironment and sense local chemokine gradients. Thus, in agreement 
with the phenotypic analysis in Chapter three, LdLN neutrophil may not be fully activated, 
allowing them to move freely within the LdLN. 
 
Neutrophils were observed to be highly dynamic, moving at an average speed of 15.5 µm/min. 
Neutrophils were moving at a greater velocity at 6 and 12 hours post pulmonary S. pneumoniae 
infection. This was in line with when their numbers peaked in the lymph node. Thus perhaps 
this enhancement in speed was due to factors made by the neutrophils themselves; more 
neutrophils, lead to more released factors, resulting in increased neutrophil velocity. These 
factors could have been chemoattractants, for example LTB4, this is known to be produced by 
neutrophils to enhance recruitment of other neutrophils. This data supports the hypothesis that 
how cells move is location dependent rather than cell type specific. 
 
4.8.2 Ex vivo explant imaging 
A caveat must be considered when analyzing neutrophil speed and behavior in this explant 
system. Great care was taken to excise the LdLN, and remove fat, causing as little damage or 
disturbance to the LdLN as possible. However, this process would have undoubtedly caused 
sterile injury. The multiphoton laser may have added to this effect. However no tissue damage 
or cell was observed during 4-5 hours of imaging. Sterile injury can induce DAMP production 
and subsequent inflammatory mediator release, which may activate the neutrophils further 
causing them to migrate faster. Intravital microscopy could have been a better method, however 
the surgery required would have also generated sterile injury, also the LdLN is not easily 
assessable without disturbing the heart and lungs. In addition, to examine neutrophil migration 
in the LdLN in vivo using the compounds used here would have been impossible. Blocking 
PI3K, LTB4 or Syk would have prevented neutrophil extravasation and recruitment to the lung 
and LdLN. For this same reason using mice with gene deficient neutrophils, for example 
neutrophils lacking integrins, would not have been possible. In the explant system neutrophils 
were already in the LdLN, thus by adding the compound or blocking antibody to the explant 
culture medium, pathways involved in neutrophil migration could be investigated. Despite the 
caveats to this system it provides meaningful methodology to understand molecular 
mechanisms driving neutrophil migration and behaviors in lymph nodes. 
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4.8.3 Molecular mechanisms involved in neutrophil dynamics in the lung 
draining lymph node: Phosphoinositide 3-kinase γ 
The PI3Kγ signalling pathway was key for neutrophil migration within the LdLN, inhibition of 
this pathway impaired both the velocity and directional migration of neutrophils. 
Phosphoinositide 3-kinase γ is activated by GPCR signalling; therefore neutrophil migration 
was highly dependent on GPCR signalling. In the brain it was found that CXCL10 aids CD8 T 
cells to locate T. gondii parasites by aiding a generalised Levy walk strategy as opposed to 
Brownian walks229. The generalized Levy walk involves short spurts of movement followed by 
scanning of the environment for a target, then another spurt of movement. Brownian migration 
is random cell migration. Thus perhaps in the LN chemokine signalling supports more directed 
neutrophil migration similar to a levy walk, however inhibition of this signalling causes 
neutrophil migration to become more random, like Brownian walking. Mathematical analysis of 
the raw data would address this question; however that was not done in this project. 
 
Phosphoinositide 3-kinase γ inhibition did not fully inhibit neutrophil migration; it reduced 
neutrophil velocity by 48%. This indicates that neutrophil migration in the LdLN is not entirely 
dependent on PI3Kγ and other signalling pathways are also being utilised. The total reduction in 
neutrophil velocity/meandering index was an average of all the neutrophils tracked, however 
neutrophils did not respond homogeneously to PI3Kγ inhibition; some cells did not move at all 
and were stuck to one position, however others were still able to migrate, all be it at a reduced 
velocity, with more meandering tracks taken, whilst other cells looked uninhibited and moved 
as normal. This could reflect differences in chemokine receptor levels and/or chemokine 
receptor types on individual cells. Different cells may be responding to varying local chemokine 
gradients, or ‘prioritising’ different chemokines. Indeed PI3Kγ signalling is dispensable in 
chemotaxis to the ‘end-point’ chemoattractant fMLP, which instead relies on p38 MAPK29,30. 
Thus some cells in the LdLN may be migrating in a p38 MAPK dependent as opposed to PI3Kγ 
dependent manner. Additionally it is possible that neutrophils have an inherent migratory 
capacity that is independent of exogenous cues, and does not require integrin interactions in 
order to undergo amoeboid type migration. 
 
4.8.4 Molecular mechanisms involved in neutrophil dynamics in the lung 
draining lymph node: Phosphoinositide 3-kinase δ 
Phosphoinositide 3-kinase δ inhibition using IC87114 also resulted in inhibition of neutrophil 
chemotaxis. This result is both interesting and puzzling. The role of PI3Kδ signalling in 
neutrophil migration is not clear from the literature, additionally the signalling pathways it is 
downstream of are unclear. It has been reported to be involved in integrin signalling, 
   
 141 
downstream of Syk, and is important for neutrophil TEM. However it has also been 
demonstrated to have a role in chemokine signalling and chemotaxis. Due to the minor effect of 
Syk inhibition and major effect of PI3Kγ inhibition, the effect of PI3Kδ inhibition on neutrophil 
migration in the LdLN would indicate that PI3Kδ is involved in GPCR signalling and not 
integrin signalling. PI3Kγ is also involved in integrin outside-in signalling for activation of 
integrins, however, as with PI3Kδ, the minor effect of Syk inhibition and major effect of PI3Kγ 
indicates that it is GPCR signalling that PI3Kγ is involved in in LdLN neutrophil migration. 
It is important to note that whilst interpretating the results from experiments using IC87114 
there may have been an additional partial inhibition of PI3Kγ due to a narrow window of 
selectivity for PI3Kδ over PI3Kγ. The IC87114 IC50 value for PI3Kγ is 29 µM, thus at the 
concentration used; 10 µM, there may have been some inhibition of PI3Kγ. However the 
calculation of IC87115 IC50 values was performed using purified PI3Ks in a kinase assay. This 
assay involves incubating recombinant PI3K proteins with PIP2, ATP and IC87114, and 
measuring the amount of PIP3 produced compared to samples without any inhibitor. This assay 
is very different to the ex vivo tissue explant system used here. Thus an off target effect on 
PI3Kγ may not be great. 
 
4.8.5 Molecular mechanisms involved in neutrophil dynamics in the lung 
draining lymph node: Leukotriene B4 
Leukotriene B4 receptor BLT1 inhibition resulted in an impairment of neutrophil chemotaxis. 
Thus in the LN neutrophils are moving towards LTB4, which is produced by neutrophils 
themselves227. The inhibition of neutrophil migration was not as great as PI3Kγ inhibition, thus 
neutrophils must be responding to other chemokines as well as LTB4, demonstrating the 
redundancy of neutrophil chemoattractants. However, a titration of the BLT1 antagonist was not 
performed although the levels of inhibitor used in these experiments was the same as that used 
historically in the literature. Thus it is possible that a higher concentration of the antagonist 
could produce a larger effect on neutrophil migration. Experiments blocking other major 
neutrophil chemokine receptors, for example CXCR2 could provide evidence as to which other 
chemokines the neutrophils are responding to in the LdLN. 
 
4.8.6 Molecular mechanisms involved in neutrophil dynamics in the lung 
draining lymph node: Sphingosine-1-phosphate 
Sphingosine-1-phosphate signalling is crucial for T cell egress from the LN, desensitization of 
S1PR1 by FTY720 blocks T cell egress. This occurs in areas of the LN where neutrophils 
populate. Neutrophils express S1PR4, a S1P receptor, thus due to the effect of PI3Kγ inhibition 
and that neutrophils are located in areas of high LN S1P concentration; the role of S1PR4 was 
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investigated. Indeed, FTY720, which binds S1PR4, caused inhibition of neutrophil migration, 
however not to the level of PI3Kγ, PI3Kδ or LTB4 inhibition. Thus S1P signalling has a role in 
neutrophil migration, but secondary to that of PI3Kγ, PI3Kδ and LTB4. 
Little is known of the role of S1P and S1PR4 on neutrophils. In mice that lack S1P lyase, the 
enzyme that is responsible for breaking down S1P, there is neutrophilia in the blood. This is 
attributed to a disruption in the IL-23/IL-17/G-CSF neutrophil homeostasis feedback loop due 
to the inability of neutrophils to infiltrate tissues in these mice, and thus elevated IL-23 mRNA, 
and serum IL-17 and G-CSF. Mice deficient in both S1P lyase and S1PR4 showed a partial 
reduction in neutrophilia, however this could not be attributed to a direct effect on neutrophils 
or restoration of the ability of neutrophil to infiltrate tissues230. The effect of S1P on neutrophil 
migration could be indirect, involving an intermediate cell type, for example lymphatic 
endothelial cells, that in turn release factors effecting neutrophils. Indeed studies have found 
that S1P acting on other cell types, for example airway smooth muscle cells231 and lung 
endothelial cells232 induces the production of chemokines by these cells that induce neutrophil 
migration.233 
 
4.8.7 Molecular mechanisms involved in neutrophil dynamics in the lung 
draining lymph node: Spleen tyrosine kinase and CD11b 
Spleen tyrosine kinase signalling was found to have a role in neutrophil migration, however 
blocking Syk did not cause as great impairment on neutrophil migration as seen with PI3Kγ 
blockage; a 14% decrease in velocity and meandering index as compared to a 47% decrease. 
This result indicated integrin signalling may have been having an effect on neutrophil 
migration. Thus to investigate further antibody mediated blockage of the αMβ2 integrin (CD11b) 
was investigated. CD11b blockade produced a larger inhibitory effect on neutrophil migration 
than Syk inhibition. This might indicate that Syk is not heavily involved in integrin-mediated 
migration where-by integrins form adhesions with extracellular ligands, linking the intracellular 
actin filaments to the extracellular environment to generate force and forwards locomotion. 
However the result with CD11b blockade may be flawed. In areas where large GFP+ 
macrophages were observed, neutrophil migration did not look as previously observed. 
Neutrophils appeared to be stuck to the macrophages, the interaction did not look similar to 
interactions between neutrophils and macrophages in the absence of the M1/70 antibody. 
Macrophages in the LdLN could be binding the Fc region of the M1/70 antibody, thus hindering 
neutrophil migration. This possibility could be eliminated through using Fab or Fab2 fragments, 
however this was not done. Alternatively, the presence of the antibody alone could hinder 
neutrophil migration. Neutrophils express high levels of CD11b, thus large amounts of the 
M1/70 antibody would bind the surface of the neutrophils. This coating of large protein 
molecules could modify the migratory capacity of these cells.  
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4.8.8 Neutrophil migration within the lung draining lymph node is dependent on 
chemokines and integrins 
In summary, explant imaging experiments combined with inhibitor compounds reveal that 
neutrophil migration in the LdLN is mainly chemokine-GPCR driven, with a small role for 
integrins. Chemokines and integrins may work in synergy, driving optimum neutrophil 
migration. This could be explained by the medulla microenvironment where neutrophils were 
found to densly populate. Neutrophil migration within the ECM rich environment of the skin is 
integrin independent, migration is dependent on chemokines and ‘squeezing’ of cells through 
the dense collagen meshwork found in tissue33,217. Whilst migration of neutrophils within the 
LN was mainly chemokine driven, the lack of dense collagen fibers may mean that neutrophils 
also need help from integrins to move through the medullary sinus, this could involve binding 
integrin ligands on stromal cells or lymphatic endothelial cells. Indeed this is true for T cells; 
their migration in the paracortex is mainly chemotactic, however is not integrin independent. 
However their adhesive migration on lymphatic endothelial cells in the medulla is dependent on 
CD11a-ICAM-1 interaction, and is important for their retention in the LN223. Although the 
underlying stromal networks and ECM of the cortex and B cell follicles has been studied in 
detail, far less is known about the networks and ECM composition of the medullary sinus. 
 
4.9 Conclusion 
In conclusion, neutrophils are highly dynamic and motile in the LdLN, form swarms and closely 
interacting with macrophages. Neutrophil migration is mainly chemokine driven involving 
PI3K signalling, with LTB4 having an important role. Integrin signalling through Syk has a 
minor role in neutrophil migration within the LdLN. Chapters 3 and 4 have characterized 
neutrophils within the LdLN, however the factors driving their recruitment to the LdLN has not 
been addressed. Chapter 5 investigates the recruitment of neutrophils to the LdLN following 
pulmonary S. pneumoniae infection. 
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Chapter 5: Investigating neutrophil recruitment to the 
lung draining lymph node 
5.1 Neutrophil recruitment to tissue draining lymph nodes 
The factors involved in driving trafficking of neutrophils from an infection site to the dLN have 
not been well investigated. In a model of footpad inoculation with P. aeroguinosa, neutrophil 
recruitment to the dLN (popliteal LN) is mediated by SSMs through their production of IL-1β. 
In mice depleted of macrophages by clodronate liposomes, and also IL-1R deficient mice, 
neutrophil recruitment to the dLN during P. aeroguinosa infection is greatly reduced139. The 
most detailed study of neutrophil LN homing has found that following OVA challenge in the 
footpad of mice immunized with OVA/CFA, neutrophils enter the dLN from both the blood, 
through HEVs, and the lymph through lymphatic vessels234. This occurs rapidly, large numbers 
of neutrophils are found in the dLN at 6 hours post-OVA challenge. Entry through HEVs 
requires the selectins L-selectin and PSGL1 and integrins CD11b and CD11a. These integrins, 
but not the selectins are also required for neutrophil dLN entry through lymphatics. The 
chemokine receptor CXCR4 and S1P receptor S1PR4 are required for entry through both the 
HEVs and lymphatics. Indeed treatment of OVA/CFA immunised mice with FTY720 before 
CFA challenge markedly inhibited neutrophil migration to the dLN234.  
 
5.2 Summary 
Little is known of the exact mechanisms by which neutrophils are recruited to dLNs. Previous 
studies have found a role for SSMs through production of IL-1β139. In Chapter 3.4.4 neutrophils 
were found to be located in the LdLN strictly in lymphatic areas, thus it is plausible that SSM 
could also be having a role in neutrophil recruitment to the LdLN during pulmonary S. 
pneumoniae infection. Lymphatic endothelial cells are known to be a key source of S1P in the 
LN, in Chapter 4.6.7 it was found that FTY720 desensitisation of S1PR1,3-5 inhibited 
neutrophil motility in the LdLN. Thus the finding that FTY720 inhibited neutrophil migration to 
the dLN234 supports the hypothesis that S1P may have a role in neutrophil recruitment to and 
retention in the LdLN. 
 
5.3 Aims 
• Investigate the role of LN SSM in recruitment of neutrophils to the LdLN. 
• Investigate the role of S1P signalling in neutrophil recruitment to and retention in 
the LdLN. 
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5.4 Results 
5.4.1 Investigating the role of subcapsular macrophages on neutrophil 
recruitment to the lung draining lymph node following pulmonary S. 
pneumoniae infection 
The role of SSM in recruitment of neutrophils to the LdLN during pulmonary S. pneumoniae 
was investigated by depleting this macrophage population. In order to deplete SSM DTx 
mediated depletion was used. Subcapsular sinus macrophages express CD11c, thus B6.CD11c 
Cre x B6.Rosa26 iDTR F1 mice were used, this is a methodology that has been employed in 
other studies108. In these mice once CD11c expression is turned on Cre recombinase is 
expressed and made. Cre recognizes loxP sites either side of a ‘stop’ site upstream of the gene 
for the DTR, thus CD11c+ cells express the DTR and are susceptible to DTx. This excision is 
irreversible. If the cell stops expressing CD11c it will still express the DTR. Figure 5.1 shows 
that, compared to PBS treated mice, 48 hours after i.p injection with 100 ng of DTx CD11c cells 
were absent from the LdLN and CD169+ SSM were depleted, however CD169+ MSM were not. 
Thus SSM could be depleted using DTx mediated depletion.  
 
To investigate neutrophil recruitment in these mice one group received PBS as a control, and 
another group received 100 ng DTx i.p. After 36 hours half of each grouped received i.n PBS 
and the other i.n S. pneumoniae. Following 12 hours of infection the mice were culled and 
neutrophil recruitment to the LdLN analysed by flow cytometry. Figure 5.2 shows that in i.p 
PBS treated mice, upon infection there was a significant recruitment of neutrophils to the LdLN. 
However, in DTx treated mice the number of neutrophils recruited during infection was much 
lower. Thus CD11c+ cell depletion reduced the number of neutrophils recruited to the LdLN. 
The BAL fluid and lungs of these mice were also investigated. It was found that, like in the 
LdLN, DTx mediated CD11c cell depletion caused a reduction in the number of neutrophils 
recruited following infection (Figure 5.3). Thus CD11c+ cells were important for neutrophil 
recruitment to the lungs during pulmonary S. pneumoniae infection. 
 
In Chapter 3.4.7 (Figure 3.10) it was shown that a small percentage of neutrophils in the LdLN 
express CD11c, thus this was further investigated using B6.Rosa26 mT/mG mice crossed with 
B6.CD11c Cre mice to generate B6.CD11c Cre x B6.Rosa26 mT/mG F1 mice. In these mice, 
any cell that was CD11c+, or importantly had ever expressed CD11c, was GFP+. The blood and 
LdLN of these mice were analysed by flow cytometry. Figure 5.4 shows that, surprisingly on 
average 44% (± 12) of blood neutrophils were GFP+. Interestingly three distinct populations 
were observed; GFP-, GFPint and a distinct population of GFPhi neutrophils. Six hour pulmonary 
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S. pneumoniae infection did not significantly alter the percentage of GFP+ neutrophils. In the 
LdLN similar percentages were also observed. In control LdLN from mice receiving i.n PBS, of 
the small numbers of neutrophils found, indeed 46% (± 9) were GFP+, similar to blood 
neutrophils. Following infection this percentage increased to 66% (± 1.6) in the LdLN. 
Interestingly in the LdLN only the GFP- and GFPhi populations of neutrophils were observed. 
 
In chapter 3.4.7 (Figure 3.10); it was also found that a small percentage of neutrophils express 
MHC II in the LdLN. Thus MHC expression on the GFP- and GFP+ neutrophils was 
investigated. There was a clear cut difference found, GFP- had very low expression of MHC II, 
GFP+ also had low expression of MHC II, however this was three fold higher than the 
expression on GFP- cells (Figure 5.5). Thus CD11c expression on neutrophils correlated with 
expression of MHC II. 
 
These mice were also investigated by explant imaging, 6 hours after pulmonary S. pneumoniae 
infection. Figure 5.6 (A) shows a still from video 26, (B) and (C) are Z stack, 3D images taken 
at higher resolution. Motile GFP+ cells were observed that had the same dynamics as 
neutrophils in Chapter 4 explant imaging experiments. These GFP+ cells had distinct lobed 
nuclear morphology, thus were neutrophils. Most interestingly in the LdLN there were many 
different populations of GFP+ cells with various morphologies. Many of the vessels, as 
highlighted by high TdTomato expression, were lined with long, thin GFP+ cells. Thus CD11c 
was expressed by a wide range of cells in the LdLN, including neutrophils. 
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Figure 5.1: Subcapsular macrophage depletion following DT treatment of B6.CD11c Cre x 
B6.Rosa26 iDTR F1 mice. 
Immunohistochemistry of frozen sections of LdLN from B6.CD11c Cre x B6.Rosa26 iDTR F1 
mice. Sections were stained for CD169 (green) and CD11c (red). Mice received 100 ng DTx or 
100 µl PBS i.p, after 48 hours LdLN removed. Scale bars = 130 µm. DTx treatment depleted 
CD11c+ cells and also SSM, but not MSMs. 
  
CD11c CD169 
PBS DT 
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Figure 5.2: CD11c depletion resulted in a reduction of the number of neutrophils 
migrating to the LdLN. 
B6.CD11c Cre x B6.Rosa26 iDTR F1 mice received 100 ng DT or 100 µl PBS i.p, after 48 
hours half of each treatment group received intranasal S. pneumoniae and the other half 
intranasal PBS. At 12 hours of infection LdLN were removed and neutrophil numbers analysed 
by flow cytometry. CD11c depleted mice had fewer neutrophils recruited to the LdLN. n= 3-4, 
bars represent mean + SEM, * P<0.05 (Kruskal-Wallis test with Dunn's post hoc test). 
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Figure 5.3: CD11c depletion resulted in a reduction in the number of neutrophils recruited 
to the lung. 
B6.CD11c Cre x B6.Rosa26 iDTR F1 mice received 100 ng DT or 100 µl PBS i.p, after 36 
hours half of each treatment group received intranasal S. pneumoniae and the other half 
intranasal PBS. At 12 hours of infection BAL was performed and lungs removed, neutrophil 
numbers were analysed by flow cytometry. CD11c depleted mice had fewer neutrophils in the 
BAL fluid and lung tissue. n=2-3, bars represent mean + SEM. 
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Figure 5.4: GFP expression on neutrophils in B6.CD11c Cre x B6.Rosa26 mT/mG F1 mice. 
(A) Representative flow plots from B6.CD11c Cre x B6.Rosa26 mT/mG F1 mice following 
intranasal PBS or 6 hour S. pneumoniae infection. Gated on CD11b+ Ly6Cint Ly6G+ cells. (B) 
Quantification of the number of GFP+ neutrophils in the blood and LdLN. A high percentage of 
neutrophils in the blood and LdLN are GFP+. n= 3, bars represent mean + SEM, representative. 
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Figure 5.5: MHC II expression on neutrophils from B6.CD11c Cre x B6.Rosa26 mT/mG 
F1 mice. 
(A) Histogram overlays showing MHC II expression on GFP+ and GFP- neutrophils in 
B6.CD11c Cre x B6.Rosa26 mT/mG F1 mice following intranasal PBS or 6 hour S. 
pneumoniae infection. Blood GFP+ neutrophils (PBS treated); dark green dotted line, blood 
GFP- neutrophils (PBS treated); dark red dotted line, blood GFP+ neutrophils (S. pneumoniae 
infected); dark green solid line, blood GFP- neutrophils (S. pneumoniae infected); dark red solid 
line, LdLN GFP+ neutrophils (S. pneumoniae infected); bright green solid line and LdLN GFP- 
neutrophils (S. pneumoniae infected); bright solid red line. LdLN neutrophils from PBS treated 
mice not shown due to low numbers. (B) Quantification of MHC II MFI. The GFP+ neutrophils 
had the highest MHC II MFI, in both the blood and LdLN. n= 3, bars represent mean + SEM. 
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Figure 5.6: CD11c expression in the LdLN following pulmonary infection with S. 
pneumoniae.  
(A) Still from explant imaging video of a LdLN from a B6.CD11c Cre x B6.Rosa26 mT/mG F1 
mouse at 6 hours of infection. (B) and (C), Z stack image of the same LdLN at two different Z 
depths. Arrows identify motile GFP+ cells with neutrophil cell morphology and nuclear 
morphology. Many cell types of various morphology were GFP+. Scale bars; left= 51 µm X, 16 
µm Z, middle and right= 33 µm X, 11 µm Y.  
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5.4.2 Investigating the role of S1P signalling in neutrophil recruitment to, and 
retention in the lung draining lymph node 
In Chapter 4.6.7 (Figure 4.13) it was found that FTY720 inhibited neutrophil migration within 
the LdLN. The exact mechanism of this inhibition was not clear; neutrophils only express 
S1PR4 highly234, however there is sparse literature on the effect of S1P-S1PR4 signalling on 
neutrophils themselves. Additionally, there is very little literature on S1PR4 signalling in 
general, the studies that have been done do not present clear functions specifically of S1PR4 
signalling. The bulk of the literature on S1P signalling is on S1P-S1PR1 signalling and its 
function in regulating cell migration, in particular T cell egress from the LN. Due to the results 
in chapter 4.6.7 it was investigated if S1P signalling had an effect on neutrophil migration to, or 
retention in the LdLN by using FTY720. 
 
Mice were treated with either 1 mg/kg FTY720 i.p, or PBS only as a vehicle control. After 12 
hours all mice received i.n inoculation with S. pneumoniae. At 12 hours post infection (24 hours 
post FTY720 dose) blood, lungs and LdLN were removed and analysed by flow cytometry. 
Figure 5.7 (A) confirms that FTY720 was effective and induced lymphopenia in the blood, also 
a mild reduction in neutrophil numbers (Figure 5.7 B). In the lungs there was a small, but not 
significant reduction in neutrophil numbers in the lung (Figure 5.7 C), whereas in the LdLN 
there was a small, but not significant, increase in neutrophils (Figure 5.7 D). Thus FTY720 
(S1PR1,3-5 agonist) treatment had no significant effect in neutrophil migration to or retention in 
the lung and LdLN during 12 hour pulmonary S. pneumoniae infection. 
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Figure 5.7: FTY720 treatment had no effect on neutrophil recruitment to the LdLN 
following pulmonary infection with S. pneumoniae. 
Mice were treated with either PBS or 1 mg/kg FTY720 i.p, after 12 hours both groups were 
infected intranasal with S. pneumoniae. At 12 hours of infection blood, lungs and LdLNs 
removed and neutrophil numbers analysed by flow cytometry. (A) Number of T cells (gated on 
TCR β+ cells) and (B) neutrophils per ml of blood. (C) Total number of neutrophils in the lung, 
and (D) LdLN. A reduction of T cells in the blood confirmed that FTY720 was effective, 
however it had little effect on neutrophil numbers in the blood, or their recruitment to the lung 
or LdLN. (A) n= 3, (B-D) n= 4, bars represent mean + SEM.  
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5.4.3 Summary of results: 
• CD11c cells are involved in neutrophil recruitment to the lungs during pulmonary S. 
pneumoniae infection. 
• A large percentage of neutrophils (44%) expressed CD11c during their life time. 
• CD11c expression on neutrophils correlated with MHC II expression. 
• S1P signalling had no role in neutrophil recruitment to or retention in the LdLN. 
 
5.5 Discussion 
5.5.1 CD11c cell mediated recruitment of neutrophils to the lung during S. 
pneumoniae infection 
CD11c cells were found to be key in neutrophil recruitment to the lungs. This was perhaps 
mainly due to alveolar macrophage and lung DC depletion, these cells are known to recruit 
neutrophils to the lung during infection and inflammation86,88. These cells are CD11c positive235 
and thus would have been depleted, however this was not assessed. Interestingly alveolar 
macrophage depletion during S. pneumoniae infection was found to result in increased 
neutrophil influx into the lung, the opposite of what was observed here236,237. Thus perhaps more 
complex processes were going on in the lungs, or mouse as a whole, in response to the DTx 
treatment. 
 
The experiments did not address neutrophil recruitment to the LdLN. Neutrophil migration to 
the lung was inhibited and thus it is difficult to draw conclusions about recruitment to the 
LdLN. However when looking at DTx treated mice alone, there was indeed neutrophil 
recruitment to the LdLN when compared to uninfected mice. Thus it is possible that recruitment 
of neutrophils to the LdLN was intact, however there were fewer neutrophils in the lung to 
migrate there. To address if SSM have a role in neutrophil recruitment to the LdLN without 
affecting alveolar macrophages or DC populations CD169-DTR mice could be used. This 
however would also deplete MSM. 
 
The use of B6.CD11c Cre x B6.Rosa26 mT/mG F1 demonstrated that many cells in the LdLN 
express CD11c, including neutrophils. CD11c expression was not limited to DCs. Indeed during 
S. pneumoniae infection there was an increase in GFP+ CD11c+ neutrophils. This supports 
phenotypic analysis performed in Chapter 3.4.7 using antibody staining, and links MHC II and 
CD11c co-expression by neutrophils. It also shows that these surface molecules are upregulated 
by neutrophils in response to infection. 
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This reporter mouse also demonstrated an issue with the B6.CD11c Cre x B6.Rosa26 iDTR F1 
mouse strain. In the LdLN of these mice (also the blood) there were many GFP positive cells of 
different morphologies, suggesting various cell populations express CD11c at some point. In the 
B6.CD11c Cre x B6.Rosa26 iDTR F1 these cells would be depleted. This could cause a 
significant disturbance to the structure and homeostasis of the LdLN. Thus in experiments 
comparing DTx treated mice to PBS treated mice a like-for-like comparison was not being 
made. The disturbance to LN structure due to DTx treatment could alter immune cell entry and 
exit. Indeed large thin GFP+ cells were observed lining LN vessels, thus their depletion could 
damage vessel integrity. In addition the DTx induced cell death would have caused DAMP 
release and sterile inflammation. Thus when comparing PBS treated mice to DTx treated mice, 
the DTx treated mice are already in an inflamed state and not at homeostasis. 
 
5.5.2 Sphingosine-1-phosphate receptor signalling and neutrophil recruitment to 
the LdLN 
In the LdLN it was found that FTY720 treatment had a minor effect on neutrophil migration 
within the LN, however no effect on neutrophil recruitment to the LdLN, thus S1PR signalling 
didn’t have a role in neutrophil recruitment to the LdLN during acute pulmonary S. pneumoniae 
infection. This is contrary to recent results that found that the same dose of FTY720 inhibited 
neutrophil recruitment to the tissue draining, popliteal LN234. However this work was performed 
using a very different model to that used in this thesis. In that study an immunization model was 
used; mice received OVA/CFA immunization, 3 doses over 30 days, followed by OVA 
challenge in the footpad. Popliteal LNs were analysed for neutrophil recruitment 6 hours after 
the OVA challenge. FTY720 was administered i.p. 2 hours before the OVA. In the majority of 
experiments neutrophils in the dLN analysed in the study were adoptively transferred bone 
marrow neutrophils. Bone marrow neutrophils were first stimulated in vitro with OVA/anti-
OVA ICs, then differentially labeled depending on the injection route. The differently labeled 
cells were injected either in the footpad or intravenously. The dLN were then analysed 90 min 
later for these transferred populations to assess trafficking of neutrophils through the lymphatics 
(footpad injected neutrophils) versus HEVs (intravenous injected neutrophils). It is likely that 
bone marrow neutrophils are phenotypically different to peripheral neutrophils. In addition to 
this, in this study the neutrophils trafficking through HEVs were pre-activated, whereas work in 
chapter 3 of this thesis has demonstrated that circulating neutrophils are in a quiescent state 
during a localized tissue infection. Further to this BALB/c mice were used, work in this thesis 
has been entirely performed on the B6 background. Thus the differences in results are likely to 
be due to differences in the experimental models, with perhaps a difference due to the BALB/c 
versus B6 background. Differences in neutrophil function have been observed in models of L. 
major infection238, however the differences seen here are more likely to be due to the different 
inflammatory models. 
   
 157 
 
5.6 Conclusion 
In summary, the role of SSM in neutrophil recruitment to the LdLN is not clear, however S1P 
signalling does not have a role in neutrophil recruitment to the LdLN, thus the mechanisms 
involved in neutrophil recruitment to the LdLN during pulmonary S. pneumonaie infection 
remain elusive. 
 
The involvement of the chemokine receptor CCR7 and its ligands CCL19 and CCL21 was not 
investigated. One previous study had found that in CCR7 deficient mice, following footpad 
injection of CFA neutrophils failed to migrate to the dLN unlike in wild type mice172. 
Preliminary experiments using mice homozygous for a naturally occurring paucity of lymph 
node T cell (plt/plt) mutation239 that results in a deficiency in CCL19 and CCL21 in secondary 
lymphoid organs240, were performed to investigate if neutrophil migration to the LdLN was 
inhibited during S. pneumoniae infection. However these results did not provide consistent 
results. These mice have major defects in DC and T cell recruitment to, and positioning in 
LNs241, thus as with the CD11c depletion experiments in section 5.4.1, any defect in neutrophil 
recruitment to the LdLN could not be concluded to be directly due to the neutrophils 
themselves. Thus experiments using these mice were not pursued further. 
 
The technical problems involved in dissecting mechanisms involved in neutrophil recruitment 
to the LdLN are the same as those identified in Chapter 3 when investigating the function of 
neutrophils in the LdLN. It is not possible to specifically target neutrophils in the LdLN or 
migration to the LdLN without impacting lung neutrophils or neutrophil recruitment to the lung. 
Thus any conclusions drawn cannot be solely related to LdLN neutrophils. 
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Chapter 6: Discussion 
Neutrophils are potent first-line effector cells for the immune system, rapidly infiltrating tissues 
from the blood and killing pathogens through powerful mechanisms including phagocytosis, 
degranulation, NETosis and release of inflammatory factors. However more recently 
neutrophils have been shown to have many other roles including helping B cells through the 
production of survival factors, containing pathogens within the draining LN, modulating 
lymphocyte recirculation, macrophage polarisation, DC activation and NK cell function.  
 
In this thesis we aimed to test the hypothesis that neutrophil behaviors, gene expression profiles 
and migration mechanisms are dictated by the localized microenvironment rather than being cell 
type intrinsic. By investigating neutrophils in the LdLN following acute pulmonary S. 
pneumoniae infection we aimed to test this hypothesis using flow cytometry, 
immunohistochemistry, Q-PCR and 4D multiphoton explant imaging. The use of these 
techniques together allowed a deep analysis of neutrophil phenotype, both on the transcriptional 
and surface protein expression level, recruitment kinetics, location and migration mechanisms 
within the LdLN.  
 
6.1 Summary of findings 
6.1.1 Early recruitment to the lung draining lymph node following pulmonary S. 
pneumoniae infection 
The model organism S. pneumoniae was used to investigate neutrophil dynamics in an acute 
inflammatory response, specifically determining the dynamics of neutrophil trafficking to the 
tissue dLN. Following pulmonary infection with S. pneumoniae neutrophils were found in the 
mediastinal LdLN as early as 2 hours following infection, with numbers peaking at 6 to 12 
hours. This early recruitment preceded the recruitment of other migratory antigen presenting 
cells including dendritic cells, macrophages and infiltrating monocytes. Neutrophil numbers in 
the LdLN were rapidly reduced 24 hours post infection and stayed at a low level at 48 and 72 
hours, however the absolute numbers of neutrophils did not completely reduce back to levels 
seen in naïve mice during this time period. Neutrophils were located shallow in the LdLN, 
below the collagen-rich capsule in lymphatic areas, but not in the cortex or paracortex of the 
LN. They densely populated areas containing MSM which have a key role in control of 
pathogen and antigen uptake in the medullary region of the lymph node. 
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6.1.2 Lung draining lymph node neutrophils resembled lung tissue neutrophils 
The phenotype of neutrophils in the LdLN was investigated using gene expression and flow 
cytometry to determine if they differed from blood, lung tissue or airway neutrophils, and also 
to gain information on their possible function. Surface protein expression and gene expression 
revealed that blood neutrophils were in a quiescent state, with low expression of markers that 
indicate neutrophil activation; ICAM-1, ROS, Tnfa, Ifng and Nos2. Airway neutrophils 
collected in BAL fluid were highly activated, with high expression of CD11b, ICAM-1, ROS 
and up regulation of Tnfa, Ifng and Nos2. Lung tissue neutrophils had high expression of 
CD11b, ICAM-1, ROS, and had up regulated Tnfa, Ifng, however not to the level of BAL 
neutrophils. They had not up regulated Nos2. Interestingly they had high up regulation of Ptgs2. 
Lung dLN neutrophils had a similar phenotype to lung tissue neutrophils; high expression of 
CD11b, ICAM-1, ROS and had up regulation of Tnfa and Ifng, but not Nos2. Like lung tissue 
neutrophils, LdLN also had a high induction of Ptgs2. Lung and LdLN neutrophils were not in a 
quiescent state like blood neutrophils and had high expression of activation markers, thus were 
activated, however not to the level of BAL neutrophils as indicated by Tnfa, Ifng and Nos2 
relative expression. Cell surface antibody staining and CD11c Cre reporter mice revealed that a 
small population of LdLN neutrophils expressed MHC II and CD11c on their surface. Using the 
CD11c gene expression fluorescent reporter mouse it was found that CD11c expression 
correlated with MHC II expression. 
 
6.1.3 Both phosphoinositide 3-kinase and integrin signalling control neutrophil 
migration in the lung draining lymph node 
An ex vivo explant system was set up using fluorescent reporter mice and multiphoton laser 
scanning microscopy to visualise and thus investigate neutrophil dynamics within the LdLN 
following pulmonary S. pneumoniae infection. Neutrophils were found to be highly motile, 
moving in a classic ‘amoeboid’ manner. Swarms of neutrophils were observed, both persistent 
and transient swarms. Neutrophil migration to a swarm was highly directional as compared to 
neutrophil migration in areas without swarms. Small molecule inhibitors, and blocking antibody 
were used to investigate mechanisms involved in neutrophil migration within the LdLN. 
Inhibiting PI3Kγ, PI3Kδ and Syk function, blocking LTB4 and S1P receptor binding and 
blocking the integrin CD11b all had an inhibitory effect of neutrophil migration; both the 
velocity and the directionality of the cells. However PI3Kγ and LTB4 inhibition had the most 
profound inhibitory effect indicating that PI3Kγ signalling is highly utilised by migrating 
neutrophils, possibly largely by activation of the LTB4 receptor BLT1. It was of interest that 
PI3Kδ, a molecule that does not directly couple to chemokine receptors, also appeared to have a 
role in regulating migration. Integrin signalling did not have as large a role as PI3Kγ signalling 
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in controlling neutrophil migration, however neutrophil migration within the LdLN was not 
entirely integrin-independent. Thus neutrophils utilise a number of mechanisms including both 
chemokine and integrin signalling to navigate the LdLN, specifically the medullary sinus niche. 
 
6.1.4 Mechanism of neutrophil trafficking to the lung draining lymph node 
following pulmonary S. pneumoniae infection 
In order to investigate neutrophil recruitment to the LdLN, and the role of SSMs in this process 
these cells were depleted using DTx mediated deletion of CD11c+ cells. Deletion of SSM was 
successful and it was found that neutrophil recruitment to the LdLN was reduced following this 
treatment. However the role of other CD11c+ cells, for example DCs and alveolar macrophages, 
in this process cannot be ignored as they would have also been depleted. Neutrophil recruitment 
to the lung and airways was also acutely inhibited, thus it can’t be concluded that SSM or 
indeed CD11c+ cells are involved in the specific recruitment of neutrophils to the LdLN. 
 
In the explant imaging studies it was found that inhibition of S1P receptors 1, 3, 4 and 5 by 
FTY720 had a negative effect on neutrophil migration. Due this result, and the location of 
neutrophils in areas of lymphatic vasculature; a source of S1P, it was investigated if FTY720 
treatment had any effect on neutrophil trafficking to, or retention in the LdLN. Results showed 
no significant difference in neutrophil numbers in the LdLN following FTY720 treatment, thus 
in this setting of acute pulmonary S. pneumoniae infection, S1P is not involved in the 
recruitment or retention of neutrophils in the LdLN. 
 
Collectively this work has found that in response to pulmonary S. pneumoniae infection, within 
6-12 hours neutrophils are capable of migrating to the tissue dLN, the site of the adaptive 
immune response to the infection. Due to the phenotype of these cells it is likely that they have 
come from the lung, via the lymphatics, however this has not been directly demonstrated. This 
indicates that neutrophils do not respond in a homogeneous manner, for example, fully activate, 
locate and destroy the invading pathogen. Some are capable of resisting the chemotactic draw to 
the infection site and are able to traffic away from the lung to the dLN. Those that do are not 
fully activated to the levels of cells at the infection site and have turned up transcription and 
expression of other effector molecules that are associated with modulation of other immune 
cells, rather than pathogen killing mechanisms. 
 
Neutrophil recruitment to the LN is transient, and their location is highly restricted to lymphatic 
areas. This indicates that neutrophils are acting in a specific manner, potentially in the initiation 
of immune responses in the LN, however unfortunately their function was not uncovered in this 
work. Through ex vivo live imaging, it has been found though that in the dense cellular 3D 
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environment of a secondary lymphoid organ neutrophils migrate in a largely chemokine driven 
manner with a small role for integrins. This is different to the entirely integrin-dependent 
migration seen at the 2D post-capillary vessel wall during TEM, or to integrin-independent 
migration of neutrophils in the 3D, collagen rich ECM of the interstitial space. 
 
6.2 Conclusion 
The results presented in this thesis support the evolving view of the neutrophil as a complex cell 
type that has multiple functional profiles and mechanisms of migration. Lung dLN neutrophils 
showed an intermediate activation state, rather than a highly activated phenotype as found in the 
alveolar space, the location of the infection. Intermediately activated alveolar neutrophils may 
fail to fully fight the infection, and highly activated neutrophils in the LdLN may cause 
destruction of the tissue architecture, resulting in disruption of functional immune response 
generation. Thus to avoid this neutrophils have tuned their activation state and phenotype to 
their location and function at that site. Unfortunately the function of neutrophils in the LdLN 
remains to be found. 
 
In addition to phenotype and functional tuning neutrophils adapt their migrational mechanisms 
according to their location. In the vasculature migration and adherence to the endothelial cell 
surface is absolutely integrin dependent, however in the ECM rich interstitial space migration is 
integrin independent, rather driven by chemokines and actin polarization, pushing the cell 
through the mesh of collagen fibres in the ECM. However in the cell dense LdLN, in the 
medullary sinus that is lined by lymphatic endothelial cells, neutrophils employ both integrin 
independent and dependent migrational mechanisms. They are likely to utilise ICAM-1 on 
lymphatic endothelial cells and LN macrophages, and respond to cytokines and 
chemoattractants produced by these cells and other neutrophils.  
 
In conclusion, collectively results in this thesis support the hypothesis that neutrophil phenotype 
and function is not wholly cell intrinsic, it is dictated by the local microenvironment. 
 
6.3 Outstanding questions and future directions 
6.3.1  Neutrophils in the lung draining lymph node at 24 to 72 hours following 
pulmonary S. pneumoniae infection 
As discussed, neutrophils showed a transient wave of early recruitment to the LdLN. However it 
was not clear if the neutrophils stayed and died in the LdLN, or egressed through the 
lymphatics. Were the low numbers seen at 24-72 hours residual neutrophils from the early wave 
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of recruitment, or were they fresh neutrophils that had been recruited at later time points? A way 
to address this could be to do more in-depth analysis of apoptosis in these cells using Annexin 
V and Propidium Iodide (PI) staining. If there is a difference in the percentage of cells that are 
apoptotic between early and later time points, for example more apoptotic cells at later time 
points, this could indicate that the neutrophils are not freshly recruited. The phenotype of 
neutrophils in the LdLN at later time points was not investigated, mainly due to the small 
numbers found. However it would be interesting to see if at these time points a larger 
percentage of these cells are CD11c+ and MHC II+. Are the persistent, or later recruited 
neutrophils polarised to an immune-modulatory phenotype involved in promoting or inhibiting 
immune response generation in the dLN? 
 
6.3.2 Neutrophil function in the lung draining lymph node following pulmonary 
S. pneumoniae 
The technical difficulties identified in targeting LdLN neutrophils specifically meant that a 
function for neutrophils at this site was not found, however phenotypic analysis did provide 
clues, for example the acquisition of APC markers by some LdLN neutrophils. The markers and 
genes investigated in chapter 3 were selected based on the literature of studies investigating 
neutrophil function, and also analysis of microarray data from the Immunological Genome 
Project242 data base, identifying neutrophil specific genes. However the list of markers and 
genes to investigate was restricted by the availability of antibodies and quantity of mRNA 
obtained. Thus it is likely that there are indeed markers that define LdLN neutrophils, however 
they were not identified in this work. Ideally a gene expression analysis using a microarray 
would have been used in this project. This would have demonstrated any highly up-regulated or 
down-regulated genes specifically in LdLN neutrophils. Follow up of these markers to confirm 
protein expression could have given the answer to neutrophil function in the LdLN. This 
method was employed recently to find that in the lung, neutrophils can polarize their activation 
and response depending on the activating agent, for example LPS versus N. brasiliensis 
larvae63. 
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Definitions 
3D three-dimensions 
4D four-dimensions 
Ab antibody 
alum aluminium salts 
AM alveolar macrophage 
APC antigen presenting cell 
APRIL a proliferation-inducing ligand 
ARP2/3 actin-related protein 2/3 
ATP adenosine triphosphate 
BAFF B cell activating factor 
BAL bronchiolar lavage  
BCG Bacillus Calmette-Guérin  
BCR B cell receptor 
BH B helper neutrophil 
BHI brain-heart infusion 
BLT1 leukotriene B4 receptor 1 
BM basement membrane 
BSA bovine serum albumin  
C5a complement component 5a fragment  
CCL CC chemokine ligand 
CCR CC chemokine recepor 
CD cluster of differentiation 
CFA Complete Freund’s Adjuvant  
CFSE carboxyfluorescein succinimidyl ester 
CFU colony forming unit  
CLEC2 C-type lectin domain family 2 
CLR C-type lectin receptor 
CO2 carbon dioxide 
COX cyclooxygenase 
CR complement receptor 
CTL cytotoxic lymphocyte 
CTV CellTracker Violet  
CXCL CXC chemokine ligand 
CXCR CXC chemokine receptor 
DAMP danger-associated molecular pattern 
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DAPI 4′,6-Diamidino-2-phenylindole dihydrochloride  
DARC Duffy antigen/chemokine receptor 
DC dendritic cell 
DC-SIGN dendritic cell-specific intercellular adhesion molecule  
DHR 123 dihydrorhodamine 123  
dLN draining lymph node 
DMSO  dimethyl sulphoxide 
DTR diphtheria toxin receptor 
DTx diphtheria toxin  
ECM extracellular matrix 
EDTA ethylenediaminetetraacetic acid  
EP PGE2 receptor  
ESAM endothelial cell specific adhesion molecule 
F-actin filamentous actin 
FACS fluorescence-activated cell sorting  
FcR Fc receptor 
FCS fetal calf serum  
FDC fibroblastic dendritic cell 
FITC flourescein isothiocyanate 
fMLP N-Formylmethionyl-leucyl-phenylalanine 
FPR formul peptide receptor 
FRC fibroblastic reticular cell 
FS forward scatter 
G-CSF granulocyte-colony stimulating factor 
GC germinal center 
Gfi-1 growth factor independent-1 
GFP green fluorescent protein 
GLA glucopyranosyl lipid adjuvant 
GPCR G-protein coupled receptor 
GSK GlaxoSmithKline 
HEL hen egg white lysozyme 
HEV high endothelial venule 
HIV human immunodeficiency virus 
HK heat-killed 
HSPC hematopoietic stem and progenitor cell 
I-R ischemia-reperfusion injury  
i.n intranasal 
i.t intratracheal 
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IC immune complex 
IC50 half maximal inhibitory concentration 
ICAM intercellular adhesion molecule 
IFNγ interferon γ 
Ig immunoglobulin 
IL interleukin 
ILC innate lymphoid cell 
iNOS inducible nitric oxide synthase 
IPD invasive pneumococcal disease 
JAM junctional adhesion molecule 
LCMV lymphatic choriomeningitis virus 
LdLN lung draining lymph node 
LFA-1 lymphocyte function-associated antigen 1 
LN lymph node 
LPS lipopolysaccharide 
LS-MS/MS liquid chromatography-tandem mass spectrometry 
LT lympotoxin 
LTA lipoteichoic 
LTB4 leukotriene B4 
LTβR lympotoxin β receptor 
LXR liver X receptor 
LysM lysozyme M 
Lyve-1 lymphatic vessel endothelial hyaluronan receptor 1  
M2 alternatively activated macrophage 
mAb monocolonal antibodies 
MAC-1 macrophage-1 antigen 
MAdCAM-1 mucosal vascular addressin cell adhesion molecule 1  
MAPK mitogen-acivated protein kinase 
MARCO macrophage receptor with collagenous structure  
MFI mean fluoresecence intensity 
mG membrane targeted green fluorescent protein 
MHC major histocompatibility 
MIF macrophage inhibitory factor 
MMP matrix metalloproteinase 
MPL monophosphoryl lipid A  
MPO myeloperoxidase 
MRC marginal zone reticular cell 
MS medullary sinus 
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MSM medullary sinus macrophage 
mT membrane targeted tdTomato 
MZ marginal zone 
NE neutrophil elastase 
NET neutrophil extracellular trap 
NK natural killer cell 
NKT natural killer T cell 
NLR NOD-like receptor 
NO nitric oxide 
NOD nucleotide-binding oligomerisation domain 
OCT optimal cutting temperature medium 
OD optical density 
OVA ovalbumin 
PAMP pathogen-associated molecular pattern 
PBS phosphate-buffered saline  
PECAM platelet endothelial cell adhesion molecule 
PFA paraformaldehyde 
PG prostaglandin 
PI3K phosphoinositide 3-kinase  
PIP2 phosphatidylinositol-3,4-bisphosphate 
PIP3 phosphatidylinositol-3,4,5-triphosphate 
PNAd peripheral node addressins  
PRR pattern recognition receptor 
PSGL1 P-selectin glycoprotein ligand-1 
PTEN phosphatase and tensin homolog  
PTGS prostaglandin-endoperoxide synthase  
Q-PCR quantitative PCR 
RAG recomnination-activating gene 
RBC red blood cell  
RFP red fluorescent protein 
RNS reactive nitrogen species 
ROCK Rho-associated protein kinase  
ROS reactive oxygen species 
RPMI Roswell Park Memorial Institute medium  
rTEM reverse transendothelial migration 
S1P Sphingosine-1-phosphate 
S1PR Sphingosine-1-phosphate receptor 
SCS subcapsular sinus 
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SEC sinusoid endohelial cell 
SEM standard error of the mean 
SP surfactant protein 
SS side scatter 
SSM subcapsular sinus macrophage 
Syk spleen tyrosine kinase  
TCM central memory T cell 
TCR T cell receptor 
TD thymus-dependent 
TEM transendothelial migration 
TEM effector memory T cell 
TFH follicular T helper cell 
TFR regulatory follicular T helper cell 
TGFβ transforming growth factor β  
TH T helper cell 
TI thymus-independent 
TLR toll-like receptor 
TNFα tumor necrosis factor α 
Treg regulatory T cell 
TREM-1 triggering receptor expressed on myeloid cells 1 
VCAM-1 vascular cell adhesion protein 1 
VEGF vascular endothelial growth factor  
VEGFR vascular endothelial growth factor receptor 
VLA-4 very late antigen-4 
VSV vesicular stomatitis virus 
WAVE WASP family verprolin-homologous protein 
WHIM warts, hypogammaglobulinemia, infections and myelokathexis syndrome 
YFP yellow fluorescent protein 
ZAP-70 zeta-chain-associated protein kinase 70 
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